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1PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: TENTH ANNUAL REPORT 
The Health Quality and Safety Commission (the Commission) welcomes the tenth 
report of the Perinatal and Maternal Mortality Review Committee (the PMMRC). 
This report considers perinatal and maternal mortality and morbidity from 1 January to 31 December 2014; perinatal mortality 
from 2007 to 2014; maternal mortality from 2006 to 2014; and babies with neonatal encephalopathy from 2010 to 2014. 
This report also includes special topics on two causes of maternal mortality: suicide and amniotic fluid embolism
The perinatal related mortality rate, using the New Zealand definition, has been stable overall for the years 2007 to 2014. As 
noted in the report, the rate in 2014 was 11.2 per 1000 births, equivalent to one baby dying in pregnancy or during the first 
28 days of life for every 100 babies born. Interestingly if the World Health Organization’s recommended international definition 
for perinatal death had been used, there would have been a significant reduction in the death rate.
There were four maternal deaths recorded in 2014, the lowest rate since the PMMRC began reporting in 2006. The three-year 
average mortality ratio for 2012-2014 was 14.9/100,000 maternities.
While these results are encouraging, 13 percent of perinatal deaths were identified as being potentially avoidable. The 
proportion of potentially avoidable deaths was higher for babies of Māori and Pacific mothers, at 22 percent. The main 
contributory factors among these deaths were barriers to access and/or engagement with care, which were associated with 17 
and 19 percent of perinatal related deaths among babies of Māori and Pacific mothers respectively. Clearly more still needs to 
be done to ensure Māori and Pacific mothers receive the same level of maternity care as the rest of the population.
The review of maternal suicides from 2006 to 2013 found that many of these women had two or more risk factors for major 
depression, but that these factors were not always recognised, and that communication between services was not always 
adequate. These deaths are part of the wider problem of suicide in New Zealand – another area where more work is needed.
This report would not be possible without the substantial contribution of a dedicated team of people: the local coordinators 
across the country who provide data; Dr Sue Belgrave and the PMMRC; National Coordination Service based at the University 
of Auckland; New Zealand Mortality Review Data Group based at the University of Otago; and the Mortality Review 
Committee staff at the Commission.
On behalf of the Commission, I sincerely thank Dr Belgrave for leading this committee’s important work.
Professor Alan Merry, ONZM, FRSNZ




This tenth annual report of the Perinatal and Maternal Mortality Review 
Committee (the PMMRC) is my third as Chair. 
This report adds to the wealth of data we have previously reported on, and will continue to help guide clinical practice in 
maternity and highlight areas that need ongoing focus for improvement. When we review and report on this data we are 
mindful this information has come from families and whānau who have grieved over the loss of babies and mothers. The 
purpose of our review is to reduce mortality and morbidity in the hope of reducing distress to future families and whānau.
The PMMRC reports to the Health Quality & Safety Commission (the Commission) and is part of the quality framework in 
health care in New Zealand.
In the 10th report we are reporting on perinatal deaths from 2007 to 2014, maternal deaths from 2006 to 2014 and 
neonatal encephalopathy from 2010 to 2014.
For the first time our report has not been published in a printed format. Our report size has increased over time and in order 
to maintain the level of detail and keep the report and appendices together, we have decided on an online format for this and 
future reports.
We have changed the categories of preterm gestational age to reflect changes in survival in very preterm babies and potential 
changes in practice and management of pregnancies at these early gestations. In this report we are reporting losses at 20–22 
weeks, 23–24 weeks, 25–27 weeks and 28–36 weeks.
The overall perinatal mortality has not changed since we began reporting in 2007; however, there continues to be a 
significant reduction in perinatal related mortality using the international definition of perinatal deaths from 1000g or 28 
weeks if the birthweight is unknown. The significant reduction of stillbirth at term persists, and there has been a significant 
reduction in deaths occurring during labour. We continue to report difficulties with access and engagement with care among 
Māori and Pacific mothers and the increasing risk of stillbirth and neonatal death with increasing socioeconomic deprivation.
In 2014 there were four maternal deaths, which is the lowest number of deaths in a single year in New Zealand since we 
began reporting in 2006. This is reassuring, but it does not reach statistical significance. In our ninth report (PMMRC 2015) 
we reported a significantly higher rate of deaths from suicide and amniotic fluid embolism in New Zealand when compared 
to the UK, and we are reporting the findings of our review of all deaths due to these causes from 2006 to 2013. Our review 
of deaths from amniotic fluid embolism suggests improvements in the recognition and resuscitation of mothers with amniotic 
fluid embolism may improve the chance of survival for some mothers. In our fifth report (PMMRC 2011) we recommended all 
clinicians involved in the care of pregnant women should undertake regular multidisciplinary training in the management of 
obstetric emergencies. Consideration should be given to making this training mandatory.
We report on progress on all previous recommendations made by the PMMRC, some of which have been incorporated into 
the work stream of the maternity quality and safety programmes within DHBs.
The review of severe acute maternal morbidity (SAMM) undertaken by the University of Otago has been transferred to the 
Commission. Following advice from an expert advisory group, a Maternal Morbidity Working Group has been established 
under the umbrella of the PMMRC. The Maternal Morbidity Working Group will incorporate the review of rare and serious 
conditions of pregnancy and post-partum by the Australasian Maternity Outcomes Surveillance System (AMOSS) working 
group of the PMMRC and the review of severe acute maternal morbidity.
I wish to acknowledge the women and families/whānau for their support, and also the maternity practitioners and 
coordinators in each DHB who provide the data to inform our report and recommendations.
Dr Sue Belgrave
Chair, Perinatal and Maternal Mortality Review Committe
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First of all, on behalf of the Perinatal and Maternal Mortality Review Commitee (the PMMRC) and Sands New Zealand, I am so 
very sorry for the loss of your precious child. If you are reading this, you have a hole in your heart that is the shape of the child(ren) 
you have lost, and it all seems so grossly unfair. And it is. I too have lost a child, and as such I represent all bereaved parents on the 
PMMRC, so our point of view is heard, considered and understood.
Having a premature baby is very difficult. It is natural to feel a mixture of emotions, some negative, some positive. Many families 
and whānau of premature babies feel some or all of the following: overwhelmed, shocked, traumatised, worried, powerless, full 
of grief, angry, guilty, hopeful, intense love for your baby, longing to be with or hold your baby, and of course a profound sense 
of loss.
The point of this section of the report is to provide you with the ‘non-technical’ feedback as to how important your baby’s life 
is, and how real lessons have come from his or her short life. As you are probably aware, a review of your baby’s case was 
undertaken within your own District Health Board (DHB) shortly after they died and your baby’s case has been analysed at a 
national level by the PMMRC. The DHB review is to determine the cause of your baby’s death and to ensure the correct care 
was provided to you and your child. Both reviews look for factors that may have contributed to your baby’s death and areas for 
improvement so that, where possible, fewer families have to go through this life-changing situation. So, what can we learn from 
cases in 2014 (and beyond)?
Advances in neonatal medicine have worked wonders. Not long ago, extremely premature babies, or those born with very 
serious health problems, would inevitably have died. Today neonatologists can resuscitate babies born at ever-earlier stages of 
gestation. And very ill babies also benefit from advances in neonatal intensive care. Infant lives can be prolonged. Unfortunately 
some babies will not survive for long whatever is done for them. Others will live to leave hospital, but face severe health 
problems. 
The question that any parent is likely to ask when a decision must be made about whether or not to resuscitate the baby is 
‘What will happen to my baby?’ Sometimes the only honest answer the doctor can give to that question is ‘I don’t know.’ 
Many reasons might be advanced to urge giving the baby the benefit of the doubt, to resuscitate the infant and see how they 
progress. Your natural instincts may have suggested that your parental love will and should have given the baby a chance at 
life, however small. This is the tricky part, both medically and emotionally. Medical guidelines sometimes suggest some babies 
should not be offered aggressive intensive care. But your instincts may suggest that an extremely premature newborn life be 
given the same value as the lives of older babies. In New Zealand of course, all babies are entitled to appropriate care, even 
if this subjects the baby to intrusive and painful procedures. The ideal remains the ‘partnership of care’ with both the families/
whānau and the team of doctors. This is the case for all babies, not just the extremely premature ones, but the balance of these 
issues remains difficult for all involved, especially with trying to find a balance of ‘head over heart’. 
And here you sit, reading this, wishing your baby had survived and that you had no participation in a conversation like this 
at all. So, what can you do now? The first step is to recognise and accept your feelings; both now and at the time of your 
baby’s life. Try to talk to someone about how you feel or have felt, perhaps your partner, a friend, your midwife, your family 
or whānau, or a Sands representative. It is never too late to talk about (or write about) your feelings and the rollercoaster that 
comes with an extremely premature delivery.
The second step is to understand that, even though your baby died (whether premature or not), his or her life mattered, not 
just to you, but to the medical team that helped directly, to the DHB in which you live, and in the bigger picture too. Every 
single case of loss teaches us something. No lesson is unimportant. And it is the PMMRC’s purpose to learn whatever we can 
to make sure fewer families have to walk in the shoes you find yourselves in. We can’t bring the babies back, but your babies’ 
little lives have helped others in the future to survive.
This may have been a little life, but is not a little loss. There have been wonderfully positive things happen as a result of what 
your child has taught us medically. And for you, the families and whānau of these tiny champions, there are people out there 
who understand how you feel and are there to help, no matter when you need it, no matter what happened.
Kia kaha. You are not alone.
Linda Penlington
Parents, Families, Wha- nau
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Executive Summary
In this 2016 report, gestational age categories have been changed in line with national and international evidence of survival 
of babies born at 23 weeks, which is more in line with survival at 24 weeks than at 20–22 weeks. And so, throughout this 
report, gestational age has been  categorised as 20–22 weeks, 23–24 weeks, 25–27 weeks, and then 28–31, 32–36, 
37–40 and ≥41 weeks, as previously.
Terms of Reference and Mortality Definitions
Terms of reference of the Perinatal and Maternal Mortality Review Committee 
The Perinatal and Maternal Mortality Review Committee (PMMRC) is responsible for reviewing perinatal and maternal 
mortality and other mortality and morbidity as directed by the Health Quality & Safety Commission.
Mortality definitions used by the PMMRC
Fetal death is the death of a fetus at 20 weeks gestation or beyond (≥20 weeks) or weighing at least 400g if gestation is 
unknown. Fetal death includes stillbirth and termination of pregnancy.
Termination of pregnancy includes any interrupted pregnancy from 20 weeks whether the baby was stillborn or live born.
Neonatal death is the death of any baby showing signs of life at 20 weeks gestation or beyond or weighing at least 400g if gestation 
is unknown. Early neonatal death is a death that occurs up until midnight of the sixth day of life. Late neonatal death is a death that 
occurs between the seventh day and midnight of the 27th day of life.
Perinatal mortality is fetal and early neonatal death from 20 weeks gestation (or weighing at least 400g if gestation is 
unknown) until less than seven days of age.
Perinatal related mortality is fetal deaths (including terminations of pregnancy and stillbirths) and neonatal deaths (up to 28 
days) per 1000 total babies born at 20 weeks or beyond, or weighing at least 400g if gestation is unknown.
A maternal death is the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the 
duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management. It does not 
include accidental or incidental causes of death of a pregnant woman.
Maternities are all live births and all fetal deaths at 20 weeks or beyond or weighing at least 400g if gestation is unknown. 
The maternal mortality ratio is calculated per 100,000 maternities.
Findings 2016 Report (Data 2014)
Perinatal mortality
Perinatal mortality rates
1. There were 656 perinatal related deaths reported to the PMMRC in 2014. The perinatal related mortality rate was
11.2/1000 births (1 death per 89 births). There has been no significant change in overall perinatal related mortality in
New Zealand from 2007 to 2014.
2. There continues to be a significant reduction in perinatal related mortality, and more specifically in stillbirth, using the
international definition of perinatal deaths from 1000g or 28 weeks if birthweight is unknown.
3. The significant reduction in stillbirths and increase in terminations of pregnancy noted previously persists during the period
2007–2014. In 2014, the stillbirth rate was 5.5/1000 births and the termination of pregnancy rate was 2.5/1000 births.
4. In 2014, the neonatal mortality rate was 3.1/1000 births and has not changed significantly since 2007.
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5. The previously reported significant reduction in stillbirth at term persists. This is independent of a reduction in births at 
40 and 41+ weeks. There are numerous reasons why this might have occurred, such as:
a. improved peripartum care (suggested by a reduction in hypoxic peripartum death rate)
b. a reduction in deaths from perinatal infection
c. a reduction in deaths from antepartum haemorrhage
d. increased iatrogenic early birth of at-risk babies 
e. a reduction in smoking.
6. A statistically significant reduction in intrapartum stillbirth risk as a proportion of ongoing pregnancies at term since 
2007 is still evident in 2014 (p<0.0001). This is consistent with and probably due to a significant reduction in hypoxic 
peripartum deaths (p=0.0004).
Demographic associations
7. Perinatal related mortality is more common at the extremes of maternal age. The perinatal related mortality rate among 
mothers under 20 and over 40 years of age was 16/1000 births in 2014 compared to 10/1000 births among 
mothers 30–34 years of age, who had the lowest rate. Analysis in 2014 found that age was not independently 
associated with stillbirth or neonatal death after adjusting for ethnicity, socioeconomic deprivation, smoking, parity and 
body mass index (BMI).
8. Increasing socioeconomic deprivation is associated with increasing stillbirth and neonatal death rates and inversely 
associated with late termination of pregnancy rates. In 2014, stillbirth rates per 1000 births varied from 4.4 for mothers living 
in the least deprived areas to 6.8 for mothers living in the most deprived areas. Multivariate analyses in 2014 found that 
socioeconomic deprivation was independently associated with only neonatal death after birth from 20 to 27 weeks.
9. The perinatal related mortality rates among women residing in Counties Manukau and Northland District Health Board 
(DHB) regions were significantly higher than the national rate of 10.73/1000 births from 2007-2014. The perinatal 
related mortality rate in Counties  Manukau DHB region for 2007-2014 was 13.39/1000 births (95% Confidence 
Interval (CI) 12.53-14.27). The perinatal related mortality rate in Northland DHB region for 2007-2014 was 
12.47/1000 births (95% CI 10.86-14.07). 
10. The neonatal mortality rates among women residing in Waikato and Bay of Plenty DHB regions were significantly 
higher than the national rate of 2.83/1000 live births from 2007-2014. The neonatal mortality rate for 2007-2014 in 
the Bay of Plenty DHB region was 3.89/1000 births (95% CI 3.13-4.77). The neonatal mortality rate for 2007-2014 
in the Waikato DHB region was 3.43/1000 live births (95% CI 2.88-3.97). 
Māori disparities
11. Perinatal related mortality is more common among the children of Māori, Pacific and Indian mothers than Other Asian, 
Other, and New Zealand European mothers. Specifically, stillbirth and neonatal mortality are more common among the 
children of Māori, Pacific and Indian mothers, while termination of pregnancy is less common among Māori and Pacific 
mothers.
12. Babies of Māori and Pacific mothers continue to have increased crude perinatal related mortality rates from stillbirth 
and neonatal death. However, analyses in 2014 showed that only the association with neonatal death from 20–27 
weeks was significant after adjustment for the effects of socioeconomic deprivation, maternal age, smoking, parity and 
BMI (PMMRC 2014a).
13. Māori and Pacific perinatal related deaths are less likely to be optimally investigated than deaths in all other ethnic 
groups. While more Māori and Pacific perinatal related deaths are partially investigated than those of other ethnicities, 
overall they are less likely to have any investigation (optimal or partial) than babies of other ethnicities. Talking with 
health professionals about their experiences of offering post-mortem investigations to families/whānau and to Māori 
whānau who have experienced a death and listening to their stories of being offered post-mortem might help to inform 
practice changes.
14. The proportion of potentially avoidable perinatal related deaths was higher among babies of Māori and Pacific 
mothers, at 22 percent, than all other ethnicities due to an excess of barriers to access and/or engagement with care 
among potentially avoidable deaths, which were associated with 17 and 19 percent of perinatal related deaths in 
these ethnic groups.
Stillbirth
15. In 2015, a review of the placental pathology of unexplained antepartum deaths showed that 17 percent of babies 
6
classified as unexplained antepartum death from 2007 to 2013 were misclassified: 4 percent because there was 
another underlying pathology and 13 percent because there was a placental abnormality which has been shown to be 
consistently associated with perinatal related death. There is no current category in the Perinatal Society of Australia 
and New Zealand perinatal death classification (PSANZ-PDC) for these latter placental causes of death.
Neonatal mortality
16. Resuscitation was attempted for 7 of 21 (33 percent) neonatal deaths at 23 weeks compared to 16 of 18 deaths (89 
percent) at 24 weeks.
Screening
17. There has been a significant increase in screening for diabetes among eligible mothers whose babies died from 2007 
to 2014.
18. There has been no change in the proportion of mothers screened for family violence in pregnancy among mothers of 
perinatal related deaths from 2007 to 2014.
Contributory factors and potentially avoidable perinatal related death
19. In 2014, one-quarter of perinatal related deaths was determined at local review to have contributory factors and 
approximately half (13 percent) of these to be potentially avoidable deaths.
20. The most common main contributory factors to potentially avoidable perinatal related deaths are consistently access 
and/or engagement with care factors, responsible for 8 to 12 percent of perinatal related deaths each year from 2011 
to 2014. Personnel factors are the main contributory factor to avoidable perinatal related death in 5 to 6 percent of 
perinatal related deaths.
21. The largest numbers of potentially avoidable deaths in 2014 were among deaths due to maternal conditions (17), fetal 
growth restriction (14), and unexplained antepartum deaths (13).
22. Barriers to access and/or engagement with care contribute to most of the potentially avoidable deaths due to maternal 
conditions.
23. The proportion of potentially avoidable perinatal related deaths increases with increasing socioeconomic deprivation, 
due to increasing contribution from barriers to access and/or engagement with care.
Neonatal encephalopathy
1. In 2014 there were 55 cases of moderate and severe neonatal encephalopathy reported to the national dataset. This 
is the lowest number of cases reported since data were first collected in 2010 (82 cases in 2010, 67 in 2011, 79 in 
2012, 70 in 2013). While this is encouraging, there is no statistically significant reduction in rate, and the observed 
drop in 2014 may reflect random variation.
2. The neonatal encephalopathy rate for 2010–2014 was 1.14/1000 total births (95% CI 1.03–1.27), or 1.24/1000 
term births (95% CI 1.12–1.38).
3. Taranaki and Capital & Coast DHBs are represented as having statistically significantly higher neonatal 
encephalopathy rates than the national rate for 2010–2014. The rate at Waikato DHB, a previous outlier, is now 
consistent with the national rate.
4. Mothers having their first birth are over-represented among mothers of babies with neonatal encephalopathy. 
5. There has been a statistically significant reduction in the proportion of babies diagnosed with neonatal encephalopathy 
who do not have cord gases reported from 2010 to 2014 (chi-squared test for trend p=0.02).
6. The proportion of babies with moderate or severe neonatal encephalopathy who were treated with induced cooling 
increased from 2010 to 2013 and has remained stable at 82 percent in 2014. The proportion of those cooled who 
were cooled within six hours as recommended for maximal benefit at 87 percent remains high.
7. There has been an increasing trend in the proportion of surviving babies who had a magnetic resonance imaging 
(MRI) investigation since collection of neonatal encephalopathy data began in 2010 to 2014, from 70 percent in 
2010 to 86 percent in 2014 (chi-squared test for trend p=0.008).
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Maternal mortality
1. In 2014, only four deaths within the definition of maternal mortality were reported to the PMMRC. There has been no 
statistically significant change in maternal mortality ratio in New Zealand since data collection by the PMMRC began in 
2006.
2. The three-year average maternal mortality ratio, calculated to obtain a more robust estimate of the New Zealand 
ratio given small and variable numbers of deaths per year, for 2012–2014, was 14.9/100,000 maternities (95% CI 
10.2–21.7/100,000).
3. Review of suicide deaths between 2006 and 2013 found:
a. many women had two or more risk factors for major affective disorder 
b. lack of recognition of risk factors (and multiple factors) and lack of communication between services (primary and 
secondary and across disciplines) was evident, especially among post-termination suicides
c. two-thirds of women had a prior psychiatric history
d. alcohol and other substance use (often polysubstance use) and smoking were common
e. a third of women had been previously exposed to family violence
f. relationship stress was a feature of almost all deaths.
4. Review of 13 amniotic fluid embolism (AFE) deaths between 2006 and 2013 and five morbidities between 2010 and 
2013 found:
a. AFE deaths were not over-diagnosed in New Zealand
b. fatal AFE cases were not more severe in New Zealand
c. resuscitation could have been improved in some cases.
5. Maternal mortality is more common among mothers 40 years of age and older, and Māori and Pacific women, and 
increases with increased socioeconomic deprivation.
6. Mothers who died were significantly more likely to be obese, and to be current smokers, than all mothers birthing in 
New Zealand.
7. Alcohol and substance use and family violence are common among maternal deaths in New Zealand.
8. Thirty-six percent of maternal deaths were identified as potentially avoidable from 2006 to 2014, and contributory 
factors were identified in a further 26 percent. Contributory factors and potentially avoidable death were similarly 




That the Perinatal Society of Australia and New Zealand perinatal death classification (PSANZ-PDC) system be modified to 
allow the classification of babies dying with placental pathology outside of unexplained antepartum death.
Justification:  
A review of 177 placental pathology reports from unexplained stillbirths from 2007 to 2013 found that 23 (13 percent) 
could be assigned a placental cause of death, for which there is no category in the PSANZ-PDC system. These deaths are not 
unexplained.
The PMMRC will apply these changes in its use of the PSANZ-PDC system beginning 2017.
Rates of perinatal related mortality and neonatal encephalopathy
That district health boards with rates of perinatal related mortality and neonatal encephalopathy significantly higher than 
the national rate review, or continue to review, the higher rate of mortality or morbidity in their area and identify areas for 
improvement.
Justification: 
The perinatal related mortality rate among women residing in Counties Manukau and Northland DHB regions were 
significantly higher than the national rate of 10.73/1000 births from 2007-2014.
The perinatal related mortality rate in Counties Manukau DHB region for 2007-2014 was 13.39/1000 births (95% CI 12.53-
14.27). The perinatal related mortality rate in Northland DHB region for 2007-2014 was 12.47/1000 births (95% CI 10.86-
14.07). 
The PMMRC is aware of initiatives by both of these DHBs to address the rates in their areas and acknowledges it may take 
some time to see an impact on mortality.
The neonatal mortality rates among women residing in Waikato and Bay of Plenty DHB regions were significantly higher than 
the national rate of 2.83/1000 live births from 2007-2014.
There were 91 neonatal deaths reported from 2007-2014 in the Bay of Plenty DHB region and so the neonatal mortality rate 
was 3.89/1000  births (95% CI 3.13-4.77). There were 151 neonatal deaths reported from 2007-2014 in the Waikato DHB 
region and so the neonatal mortality rate was 3.43/1000 live births (95% CI 2.88-3.97). 
The neonatal encephalopathy rates for Taranaki and Capital & Coast DHBs are significantly higher than the national rate for 
2010-2014. There were 17 cases of neonatal encephalopathy diagnosed among babies whose mothers were resident in 
Taranaki DHB area from 2010-2014. The rate in Taranaki was 2.37/1000 term births (95% CI 1.38–3.79). There were 32 
cases of neonatal encephalopathy diagnosed among babies whose mothers were resident in the Capital & Coast DHB area 
from 2010-2014. The rate in Capital & Coast was 1.84/term births (95%CI 1.26-2.59). The national rate from 2010-2014 
was 1.24/1000 term births. 
This is not a new finding for Capital & Coast DHB and the PMMRC is aware of the review of neonatal encephalopathy 
currently underway in the DHB.
Evidence:
Audits of perinatal deaths are required to understand causes and focus prevention efforts (Lancet Stillbirth series 2016).
Previous reports have shown that review of neonatal encephalopathy using a confidential enquiry methodology revealed 
suboptimal care in more than 50 percent of cases (Draper et al 2002; Kernaghan 2006).
Maternal mortality
That a Perinatal and Infant Mental Health Network be established to provide an interdisciplinary and national forum to discuss 
perinatal mental health issues.
Justification: 
This recommendation highlights and supports a Healthy Beginnings 2012 recommendation (Ministry of Health 2012b).
An interface between services is important for the perinatal period when multiple services may be involved – primary care, 
maternity, general mental health, perinatal mental health, alcohol and other drugs, social services, and termination of 
pregnancy services. Better processes are required for sharing information and ensuring a consistent approach to care.
Consistency in screening and consistency of maternal mental health access pathways are required.
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Evidence: 
This is in keeping with recommendations within the UK, including the National Institute for Health and Care Excellence (NICE) 
guidelines on antenatal and postnatal mental health (NICE 2014), which recommend the establishment of perinatal mental 
health clinical networks of perinatal clinicians and resources and other stakeholders including service users, and the Scottish 
Intercollegiate Guidelines Network (SIGN) guidelines on the management of perinatal mood disorders (SIGN 2012).
The 2008 Ministry of Health guideline about management of depression in primary care describes the evidence around 
screening for depression (NZGG 2008).
Information on the establishment of a perinatal mental health network in the UK is described in a summary entitled Joining Up 
Care in Maternal Mental Health: Setting Up a Perinatal Mental Health Network (RCOG 2016). 
As recommended in the fifth report of the PMMRC (PMMRC 2011): 
‘All clinicians involved in the care of pregnant women should undertake regular multidisciplinary training in management of 
obstetric emergencies.’  
Justification:  
The maternal mortality ratio from AFE in New Zealand is 5.6 times higher than in the UK. The retrospective review from 2006-
2013 was based on only 18 cases, and as such, it was difficult to draw definitive conclusions. However, the analysis suggests 
resuscitation could have been improved in some cases.
Evidence:  
Systematic review of multidisciplinary training in obstetric emergencies showed it was associated with improved clinician 
knowledge or skills (Calvert et al 2013). It has also been shown to be associated with an improvement of 5 minute Apgar 
scores and hypoxic ischaemic encephalopathy (Merien et al 2010).
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Overview of the 2016 Report of the PMMRC
Perinatal mortality
Perinatal related mortality rate
The perinatal related mortality rate in New Zealand includes stillborn babies from 20 weeks gestation and deaths of live born 
babies to 27 days of life. In 2014 the perinatal related mortality rate was 11.2/1000 births. It has not changed between 
2007 and 2014. 
There has been a significant reduction in perinatal related mortality using the World Health Organization (WHO) international 
definition for perinatal related deaths from 1000g or 28 weeks if birthweight is unknown. This reduction is due to a significant 
reduction in stillbirths at term. This is independent of a reduction in total births at 40 and 41+ weeks. There are numerous reasons 
why this might have occurred such as: 
• improved peripartum care – this is supported by the observed reduction in hypoxic peripartum death rate
• a reduction in deaths from perinatal infection
• a reduction in deaths from antepartum haemorrhage
• increased early birth of at-risk babies, which is observed as a reduction in births at 40 and 41+ weeks and an 
increase in births at 36–39 weeks 
• a reduction in smoking, which is known to be associated with perinatal death.
The reduction in intrapartum stillbirth risk at term, which has been observed since 2007, remains highly significant 
(p=0.0001). This is consistent with and probably due to a significant reduction in hypoxic peripartum deaths (p=0.0004).
Demographic associations
Perinatal related mortality is more common at the extremes of maternal age. Analysis in 2014 found that age was not 
independently associated with stillbirth or neonatal death after adjusting for ethnicity, socioeconomic deprivation, smoking, 
parity and body mass index (BMI).
Perinatal related mortality is more common among the children of Māori, Pacific and Indian mothers than Other Asian, Other, 
and New Zealand European mothers. After adjusting for the effects of socioeconomic deprivation, maternal age, parity, 
smoking and BMI, only neonatal death of babies born at 20–27 weeks was significantly more common among babies of 
Māori and Pacific mothers. Babies of Indian mothers remained at increased risk of stillbirth after adjusting for these factors.
Increasing socioeconomic deprivation is associated with increasing stillbirth and neonatal death rates, and with reduced 
late termination of pregnancy rates. Multivariate analyses in 2014 found that socioeconomic deprivation was independently 
associated only with neonatal death after birth from 20 to 27 weeks.
The perinatal related mortality rate among women residing in Counties Manukau and Northland DHB regions were 
significantly higher than the national rate. 
The neonatal mortality rates among women residing in Waikato and Bay of Plenty DHB regions were significantly higher than 
the national rate.
Neonatal mortality
In this report, we have changed the gestational age categories for neonates. Babies born at 23 weeks are now classified with 
babies born at 24 weeks rather than with babies born at 20–22 weeks. This is because some babies at 23 weeks have been 
shown to have good quality survival, while babies at 20–22 weeks are pre-viable. Resuscitation was attempted for 7 of 21 
neonatal deaths (33 percent) at 23 weeks and 16 of 18 deaths (89 percent) at 24 weeks.
Screening
There has been a significant increase, from 2007 to 2014, in screening for diabetes among mothers without pre-existing 
diabetes where perinatal death occurred at 28 weeks or later.
There has been no change in the proportion of mothers screened for family violence in pregnancy from 2007 to 2014.
Investigation of perinatal death
In 2015, we reviewed the placental pathology reports of 177 unexplained antepartum deaths between 2007 and 2013. 
Of these, 23 (13 percent) had placental pathology which likely explained the stillbirth and seven were reclassified as due 
to infection or bleeding. There is no current category in the PSANZ-PDC system, which we use in New Zealand to classify 
perinatal deaths, for isolated placental causes of death. For this reason we are recommending a change in the classification 
system.
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Babies of Māori and Pacific mothers who die in the perinatal period are less likely to be optimally investigated (by post-
mortem, karyotype or clinical examination, or investigation confirming diagnosis) than babies from other ethnic groups. Māori 
and Pacific mothers’ babies are more likely to have no investigation following perinatal death than babies of other ethnicities. 
Talking with health professionals about their experiences of offering post-mortem investigations to families/whānau and to 
Māori  whānau who have experienced a death and listening to their stories of being offered post-mortem might help to inform 
practice changes.
Contributory factors and potentially avoidable perinatal related death
In 2014, one-quarter of deaths were determined when reviewed to have contributory factors (organisation and/or management, 
personnel, or barriers to access and/or engagement with care factors associated with the death). Of the deaths where 
contributory factors were identified, approximately half (13 percent) were believed to be potentially avoidable.
The factors that are most often associated with potentially avoidable deaths are factors related to barriers to access and/or 
engagement with care, which were responsible for 8 to 12 percent of perinatal related deaths each year from 2011 to 2014. 
Personnel factors were the main contributory factor to potentially avoidable death in 5 to 6 percent of deaths.
The proportion of potentially avoidable deaths was higher among babies of Māori and Pacific mothers, at 22 percent, than 
all other ethnicities. The main contributory factors among these deaths are barriers to access and/or engagement with care, 
which were associated with 17 and 19 percent of perinatal related deaths in these ethnic groups.
The proportion of potentially avoidable perinatal related deaths increases with increasing socioeconomic deprivation, and this 
is also associated with an increase in barriers to access and/or engagement with care.
Neonatal encephalopathy
From 2016 the neonatal encephalopathy data collection will include babies diagnosed with neonatal encephalopathy from 35 
weeks at birth. This is because these babies are managed in the same way as term babies with encephalopathy.
In 2014 there were 55 cases of moderate and severe neonatal encephalopathy reported to the national dataset. This is the 
lowest number of cases reported since data collection started in 2010. There were 82 cases reported in 2010, 67 in 2011, 
79 in 2012, and 70 in 2013. This is not a statistically significant reduction in the rate of neonatal encephalopathy, but it looks 
like an encouraging trend. The neonatal encephalopathy rate for 2010–2014 was 1.14/1000 total births (ie, approximately 
one baby of every 1000 born).
Taranaki and Capital & Coast DHBs are represented as having statistically significantly higher neonatal encephalopathy rates 
than the national rate for 2010–2014. Waikato DHB was previously noted to have a higher rate than the national rate, but 
now has a rate that is consistent with the national rate.
There have been improvements in the management of babies with neonatal encephalopathy. These include: 
• a significant increase in the proportion of babies diagnosed with neonatal encephalopathy who had cord blood 
gases taken
• an increase in the proportion of babies with moderate or severe neonatal encephalopathy who were treated with 
induced cooling. The proportion of those cooled who were cooled within six hours as recommended for maximal 
benefit at 87 percent remains high
• an increase in the proportion of surviving babies who had an MRI investigation as part of their management. 
Maternal mortality
In 2014, only four deaths of mothers during pregnancy or within the first 42 days of the end of pregnancy were reported in 
New Zealand. 
The three-year average maternal mortality ratio for 2012–2014 was 14.9/100,000 maternities (births from 20 weeks of 
pregnancy).
In 2015, the PMMRC reviewed the 22 maternal suicide deaths from 2006 to 2013. This review found:
• many women had two or more risk factors for major depression, and there was a lack of recognition of risk factors, 
and of communication between services, especially among post-termination suicides
• two-thirds of women had a prior psychiatric history
• alcohol and other substance use (often polysubstance use) and smoking were common
• a third of women had been previously exposed to family violence
• relationship stress was a feature of almost all deaths.
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In 2015, the PMMRC reviewed 13 deaths and five survivors of AFE and found: 
• the maternal mortality ratio from AFE in New Zealand is 5.6 times higher than in the UK, and the retrospective 
review concluded that death from AFE was accurately diagnosed in New Zealand
• there was no evidence that fatal cases were more severe in New Zealand, and in fact the data suggested that 
maybe the opposite was true
• the review suggested resuscitation could have been improved in some cases of AFE death and concluded that all 
clinicians involved in maternity care need to be able to recognise the possibility of AFE early in its presentation and 
need to be able to respond with timely and effective resuscitation. 
Thirty-six percent of maternal deaths were identified as potentially avoidable from 2006-2014, and contributory factors were 
identified in a further 26 percent.
13PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: TENTH ANNUAL REPORT 
Recommendations (PMMRC 9th Report) Progress to date (June 2016)
Methodology
1. As a matter of urgency, the Ministry of Health update the 
National Maternity Collection (MAT), including the ethnicity 
data as identified by the parents in the birth registration 
process. 
The dataset has been made available to the PMMRC from 2014. 
However, we acknowledge that the dataset still does not include 
registration data from all DHBs that are providing primary maternity 
care. The Ministry of Health is working towards a solution for 
including registration ethnicity data in the MAT dataset, but this has 
not been achieved at this time.
Perinatal mortality
1. That all maternity care providers identify women with 
modifiable risk factors for perinatal related death and work 
individually and collectively to address these.
       Strategies to address modifiable risk factors include:
a. improving uptake of peri-conceptual folate
b. pre-pregnancy care for known medical disease such as 
diabetes
c. access to antenatal care
d. accurate height and weight measurement in pregnancy 
with advice on ideal weight gain
e. prevention and appropriate management of multiple 
pregnancy
f. smoking cessation
g. antenatal recognition and management of fetal growth 
restriction
h. prevention of preterm birth and management of threatened 
preterm labour
i. following evidence-based recommendations for indications 
for induction of labour
j. advice to women and appropriate management of 
decreased fetal movements.
      All DHBs should report the availability and uptake of 
relevant services in their annual clinical report to ensure 
that these strategies are embedded and to identify areas for 
improvements.
DHBs are implementing strategies to address modifiable risk factors, 
and the Ministry of Health will also require DHBs to report on these 
strategies in their Annual Maternity Quality and Safety Reports. 
DHB strategies include early screening and encouraging women to: 
• engage early with a lead maternity carer (LMC) 
• take folic acid and iodine 
• eat well and be active 
• avoid alcohol, recreational drugs and smoking.
Examples of DHB programmes include ‘5 Things to Do in the First 10 
Weeks’ and ‘As Soon As Pregnant (ASAP)’, which both promote the 
importance of:
• booking with a midwife as soon as you are pregnant 
• avoiding smoking, alcohol and recreational drugs 
• taking folic acid and iodine
• making a decision about screening tests
• eating well and staying active.





The ‘Healthy Babies, Healthy Futures’ programme provides 
ethnically specific workshops, text messaging and support for new 
mothers, pregnant women and their families.
See the following website for more information: http://hbhf.org.nz/
Some DHBs have established a GP Liaison role within the hospital, 
which encourages pre-pregnancy and first trimester primary care. 
A pregnancy information pack has been developed to give to 
women at their first presentation to any health professional. This 
pack contains information about a wide variety of pregnancy issues 
including folate, smoking, diet and immunisation.
2.    Offer education to all clinicians so they are proficient at 
screening women, and are aware of local services and 
pathways to care, for the following:
a. family violence
b. smoking
c. alcohol and other substance use.
Family violence
All DHBs have measures in place for screening of family violence 
when women are admitted to hospital. They offer regular education 
sessions and training workshops to midwives and clinicians to help 
them identify, screen and refer women experiencing family violence. 
The shaken baby prevention programme has also been rolled out at 
a number of DHBs.
The Violence Intervention Programme supports health sector family 
violence programmes throughout New Zealand. 
See http://www.health.govt.nz/our-work/preventative-health-
wellness/family-violence
Summary of Key PMMRC 2015 Report Recommendations and Progress
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Recommendations (PMMRC 9th Report) Progress to date (June 2016)
The PMMRC will be collaborating with the Family Violence Death 
Review Committee to further identify strategies to improve screening 
for family violence in the maternity setting.
Smoking
Smoking cessation programmes are a national health priority. The 
Ministry of Health, DHBs and a wide range of non-governmental 
organisations have made significant progress on leading New 
Zealand towards being smokefree by 2025. 









Alcohol and other substance use
DHBs offer regular education sessions and training workshops to 
midwives and clinicians to help them identify, screen and refer 
women with alcohol and substance use.
3.    That multi-disciplinary fetal surveillance training be 
mandatory for all clinicians involved in intrapartum care.
a. This training includes risk assessment for mothers and 
babies throughout pregnancy as well as intrapartum 
observations.
b. The aims include strengthening of supervision and 
support to promote professional judgement, interdisciplinary 
conversations and reflective practice.
Some DHBs reported that mandatory attendance at multi-
disciplinary fetal surveillance training was required for all core staff. 
Other DHBs have responded that multi-disciplinary fetal surveillance 
training is occurring but is not compulsory.
LMCs and obstetric staff are encouraged to attend/undertake the 
online programme or workshop.
Other initiatives include education meetings where cardiotocograph 
(CTG) recordings from emergency caesareans or abnormal CTGs 
are reviewed as part of reflective practice, and all staff who provide 
intrapartum care are encouraged to undertake a ‘fresh eyes’ 
approach to CTG interpretation.
4.     There is observational evidence that improved detection 
of fetal growth restriction, accompanied by timely delivery, 
reduces perinatal morbidity and mortality. The PMMRC 
recommends (amended from previous PMMRC reports) that 
assessment of fetal growth should incorporate a range of 
strategies including:
a. assessment and appropriate referral for risk factors for 
fetal growth restriction at first antenatal visit and throughout 
pregnancy 
b. accurate measurement of maternal height and weight at 
first antenatal assessment
c. ongoing assessment of fetal growth by measuring fundal-
symphysial height in a standardised way, recorded at each 
antenatal appointment, preferably by the same person
d. plotting of fundal height on a tool for detection of fetal 
growth restriction, such as a customised growth chart, from 
26 weeks gestation
The Ministry of Health supports the implementation of the UK 
Perinatal Institute’s GROW system for assessing fetal growth in New 
Zealand. Work is underway to obtain a national licence so DHBs 
can implement the package, which includes clinician education and 
the customised GROW chart.
The Ministry expects that each DHB will be responsible for 
implementing the GROW system for local clinicians, including their 
LMC workforce.
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Recommendations (PMMRC 9th Report) Progress to date (June 2016)
e. if fetal growth restriction is confirmed by ultrasound, 
appropriate referral and assessment of fetal and maternal 
wellbeing and timely delivery are recommended. The 
New Zealand Maternal Fetal Medicine guideline (2013) 
describes criteria for the management of small for 
gestational age (SGA) pregnancies after 34 weeks.
The PMMRC supports the Ministry of Health initiative to 
explore the evidence and validate the use of customised 
growth charts in New Zealand, and to investigate the 
appropriate way to incorporate these into the national 
maternity record.
Maternal mortality
5.    Seasonal or pandemic influenza vaccination is 
recommended for all pregnant women regardless of 
gestation and for women planning to be pregnant during the 
influenza season.
a. Vaccination is also recommended for maternity care 
providers to reduce the risk to the women and babies under 
their care.
b. The PMMRC recommends that the Ministry of Health 
consult with women and maternity care providers to address 
barriers to the uptake of influenza vaccination in pregnancy 
and implement strategies to increase access to and 
awareness of the benefit of vaccination.
Immunisation against influenza is specifically promoted to pregnant 
women and available to all pregnant women free of charge.
The Ministry of Health immunisation team annually provides 
information and resources to clinicians and the public to support this 
recommendation. 
The Health Promotion Agency immunisation programme theme for 
2016 is Protecting Baby Begins at Pregnancy. Further information 
is available at: https://www.healthed.govt.nz/resource/protecting-
baby-starts-pregnancy 
A survey was recently conducted amongst pregnant women and 
women who had given birth in the last 12 months to understand 
their knowledge and attitudes towards influenza. The survey 
included attitudes to immunisation against influenza and whooping 
cough, and enablers and barriers to immunisation in pregnancy.
See the following website for more information: http://www.health.
govt.nz/publication/immunisation-pregnant-women-audience-
research-pregnant-women 
A website has also been developed to help midwives, nurses and 
childbirth educators to quickly and easily find useful information 
and resources about immunisation in New Zealand. See http://
learnonline.health.nz/ 
6.    All pregnant women with epilepsy on medication should be 
referred to a physician.
a. Women with a new diagnosis of epilepsy or a change 
in seizure frequency should be referred urgently.
b. The PMMRC recommends a review of epilepsy in the 
Guidelines for Consultation with Obstetric and Related 
Medical Services (Referral Guidelines).
The referral guidelines are due to be revised and work is expected 
to begin at the end of 2016. This recommendation will be taken to 
the referral guidelines working group. 
Neonatal encephalopathy 
7.    Widespread multidisciplinary education is required on 
the recognition of neonatal encephalopathy. This should 
include:
a. recognition of babies at increased risk by their history 
b. signs suggestive of encephalopathy
c. knowledge of clinical pathways to induced cooling if 
required.
ACC has facilitated a cross-Ministry initiative to look at reducing the 
incidence of treatment injury by developing strategies to address the 
issues raised by the Neonatal Encephalopathy Working Group. 
See ‘Practice Point: Recognising the Baby at Risk of Neonatal 




Recommendations (PMMRC 9th Report) Progress to date (June 2016)
8.    That all DHBs review local incident cases of neonatal 
encephalopathy (Sarnat stages 2 and 3). 
The findings of these reviews should be shared at 
multidisciplinary local forum and form the basis of quality 
improvements as appropriate.
Most DHBs have advised they review local incident cases of 
neonatal encephalopathy, which are conducted at a multi-
disciplinary level to identify areas of learning and improvement. 
The Ministry of Health has advised the Maternity Quality and Safety 
Coordinators of this recommendation.
8a.  Capital & Coast DHB should review cases of neonatal 
encephalopathy from 2010 to 2013.
Work commenced in 2015 on retrospectively reviewing 28 cases of 
neonatal encephalopathy that were diagnosed between 2010 and 
2013. The review consisted of a multidisciplinary team reviewing 
the notes with the assistance of an expert in ‘human factors’. 
A template has been devised to consider the management and 
outcomes for these babies.
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1.1 Introduction
Maternity care in New Zealand 
In New Zealand, maternity care is funded by the Ministry of Health. Maternity care is provided by 20 district health boards 
(DHBs) nationally and by lead maternity carers (LMCs), who receive funding from the Ministry of Health. LMCs may be self-
employed midwives, general practitioners (GPs), private obstetricians, or hospital-based midwives and obstetricians. Their 
services are free for eligible women, except in the case of private obstetricians, who have the right to charge co-payments for 
their services.
LMCs are required to sign access agreements with any maternity facility where they intend to provide care. Women have the 
right to choose whom they engage as their LMC. However, professional colleges and the Ministry of Health provide guidelines 
about appropriate care for mothers with risk factors.
The Guidelines for Consultation with Obstetric and Related Medical Services (Referral Guidelines) provide information about 
referring pregnant women, transferring clinical responsibility and transferring care in emergencies (Ministry of Health 2012a).
1.2 Methodology
Important changes to the methods in this 10th report of the PMMRC
In this report, gestational age categories have been changed, in line with national and international evidence of survival of 
babies born at 23 weeks (Gallagher et al 2014; Ishii et al 2013), which is more in line with survival at 24 weeks than at 
20–22 weeks. And so throughout this report, gestational age has been categorised as 20–22 weeks, 23–24 weeks, 25–27, 
and then 28–31, 32–36, 37–40, and ≥41, as previously. 
This year we have included 2014 New Zealand National Maternity Collection (MAT) data for some demographic variables 
such as smoking, parity, body mass index (BMI) and maternity care, but not as a denominator for all analyses. To use 
this dataset as a denominator for all analyses requires the inclusion of ethnicity at registration from the Births, Deaths and 
Marriages (BDM) dataset.
There were two late notifications in 2015: one termination of pregnancy in 2013 and one stillbirth in 2010. These cases have 
been included in the updated rates tables and figures but not in the analyses throughout the report. These will be included in 
all analyses in the 11th report in 2017.
Data sources
The perinatal deaths presented in this report occurred between 1 January and 31 December 2014. For fetal deaths, the date of birth 
is used in place of the date of death. For neonatal deaths, the actual date of death is used.
An expanded description of data collection methods for this report is available in the first Perinatal and Maternal Mortality Review 
Committee (PMMRC) report (PMMRC 2007). After the PMMRC was established in 2005 and following consultation with stakeholders, 
it was agreed that a review of all perinatal deaths would require the assistance of LMCs and the DHBs to collect detailed clinical 
information on each perinatal death.
The PMMRC approached all the DHBs, requesting their help to establish a network of local PMMRC coordinators. Individual 
coordinators within each DHB identify perinatal deaths and oversee the collection of the required data. These data are submitted to 
the Mortality Review Data Group at the University of Otago. The coordinators are also responsible for initiating local clinical reviews 
of each case, including assigning PSANZ-PDC for cause of death, determining contributory factors and potentially avoidable deaths 
and ensuring appropriate, timely follow-up with parents.
The dataset of perinatal deaths is a compilation of data submitted by LMCs, local coordinators, the Ministry of Health and  BDM. 
A website commissioned by the PMMRC and run by the University of Otago enables web-based data entry. LMCs and/or local 
coordinators are required to complete rapid reporting forms within 48 hours of a perinatal death.
One form contains information on the mother (eg, her past medical and obstetric history and details of the birth), and the other form 
contains information on the baby. The questions are reviewed and adjusted annually to ensure the data collection remains relevant 
and robust.
After local review, a multidisciplinary team led by the local coordinator completes the PMMRC classification form. The classification 
system that has been adopted is the Perinatal Society of Australia and New Zealand (PSANZ) system of classification of cause of 
perinatal death (PSANZ 2009). This system includes both perinatal and neonatal classifications (listed in Appendix E). The local 
coordinator also submits the post-mortem and histology reports with the classification form.
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Contributory factors and potentially avoidable mortality
An assessment of contributory factors and potentially avoidable perinatal related death is completed by a multidisciplinary 
team led by the PMMRC local coordinators following local review and submitted along with the PSANZ classification of 
perinatal death. The PMMRC contributory factors and potentially avoidable perinatal death form includes questions that 
identify contributory factors related to organisation and management, personnel, and barriers to accessing and/or engaging 
with care. A death is considered potentially avoidable if the absence of the contributory factors may have prevented the death. 
From 2011, local coordinators were asked to indicate the main contributory factor(s) in identifying the death as potentially 
avoidable. A copy of the form can be found in Appendix F.
The Maternal Mortality Review Working Group (MMRWG) has identified potentially avoidable maternal deaths since 2006. 
From 2009, the MMRWG started to use the same tool identifying contributory factors and potentially avoidable death as that 
used for perinatal deaths.
Figure 1.1 outlines the PMMRC process. A user guide describing the definitions and data elements used by the PMMRC 
(PMMRC 2014b) is available online at:
http://www.hqsc.govt.nz/assets/PMMRC/Publications/guidelines-mother-baby-forms-perinatal-death-v8.pdf
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PMMRC data validation
Data are regularly validated, using a standard set of queries, to eliminate duplicate records, complete missing mother or 
baby information, clarify DHB of residence (where this is inconsistent with the given residential address) and rectify other 
inconsistencies.
The national coordinator reviews all perinatal death classifications and discusses  complicated cases with a PMMRC member 
with expertise in PSANZ classifications.
Audit of perinatal related death data 2013 
Each year, an audit is undertaken to compare the data submitted to the PMMRC with clinical records to assess the accuracy 
and completeness of the data, including review of the PSANZ perinatal mortality classification. 
The audit of 2013 data focused on accuracy of data submitted to the PMMRC compared to that in the clinical records from 
LMCs and DHBs. 
The 2013 audit reviewed 60 perinatal related deaths (58 mothers), 14 late terminations of pregnancy, 29 stillbirths and 17 
neonatal deaths. The following information relates to the audit of these 60 perinatal related deaths. 
There was one death (2 percent) where the auditor’s and the original primary perinatal death classification (PSANZ-PDC) 
varied; the primary classification was considered at audit to be antepartum haemorrhage (PSANZ-PDC4) followed by the 
allocated classification of spontaneous preterm labour (PSANZ-PDC9). There was one death (2 percent) where there was 
a change in the sub-category allocated. 
There were three deaths (5 percent) where the audit identified contributory factors that were not identified in the data 
submitted to the PMMRC, and all three deaths were considered at audit to be potentially avoidable. There was one death (2 
percent) where the death was determined to be potentially avoidable at local review but not considered potentially avoidable 
at audit. The PMMRC data were updated to reflect these findings. 
Clinical information was missing or incorrectly noted in 18 deaths (30 percent), past obstetric history in two deaths (3 
percent), gestation of registration in 11 deaths (18 percent), smoking in three deaths (5 percent) and family violence in nine 
deaths (15 percent).
At times there was information missing from both the clinical notes and the PMMRC data. While the vast majority of data fields 
audited concurred with the clinical notes, there were some missing data or discrepancies in 30 deaths (50 percent). 
These findings were presented to the PMMRC local coordinators at their annual meeting to highlight areas for improvement, 
along with a reminder of the importance of complete and accurate data submission and further training on the PSANZ 
classification of cause of death and assessment of contributory factors.
Denominator data
New Zealand birth registrations
The denominator data used in this report consist of New Zealand birth registrations during the 2006–2014 calendar years. 
The New Zealand birth registration dataset approximates the number of births in a year in New Zealand. It is closer to the true 
number of births than the hospital discharge dataset as it includes births outside hospitals. Furthermore, it includes ethnicity 
data as notified by parents at birth registration.
This source of ethnicity is also used for the numerator where a birth registration has been made. Ethnicity in the hospital 
discharge dataset (otherwise known as the National Minimum Dataset (NMDS)) is also apparently provided by mothers 
for themselves and for their babies and becomes part of the National Health Index (NHI) dataset. However, comparisons 
of mother and baby ethnicity between the birth registration dataset and NMDS in previous years have shown significant 
differences.
The birth registration dataset of New Zealand births is collated by BDM from birth notifications supplied by public and private 
hospitals, and by LMCs in the case of home births. Births are only added to the birth registration dataset when the birth is 
registered by the parents, which can occur up to some years following birth. The registration dataset is based on date of 
registration and so includes births from previous years and fewer than all births from the current year. While this dataset is 
representative of the total number of births in a year, it does not truly represent the denominator.
A disadvantage of the birth registration dataset for reporting maternity analyses in New Zealand is that it includes limited 
maternity data. The dataset does not retain an individual’s unique NHI identification number (for either the mother or the 
baby), and so the data it contains cannot easily be linked to hospital discharge data or LMC data for further analyses.
The current year’s fetal death numbers have been removed from the denominator for the calculation of neonatal death rates.
New Zealand National Maternity Collection (MAT)
MAT is a relatively new initiative combining data collected by LMCs, which is required to enable claims for payment, with 
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hospital discharge data. This dataset now represents the best approximation of live births in New Zealand in any year and 
provides data on BMI, parity, smoking, LMC registration and gestation at registration for the maternity population of New 
Zealand.
The PMMRC would prefer to use this dataset as the denominator for analysis as it includes clinical variables which are known 
predictors of perinatal related death.
However, there are some limitations to the use of the MAT dataset at this time.
• DHBs are now providing registration data such as BMI, parity and smoking for some of the mothers for whom they 
provide primary maternity care. This accounts in 2014 for up to 9 percent of women who are currently recorded in 
the MAT dataset as ‘DHB’, ‘No LMC’, ‘Other’ or ‘Missing LMC’. Some of these women did not register with an LMC 
and some registered with a DHB LMC, but these data have not been provided to MAT. Mothers receiving primary 
maternity care from DHBs mostly reside in Counties Manukau, Auckland, West Coast, Nelson Marlborough, Northland 
and Whanganui DHB areas. They are more likely to reside in areas of higher deprivation (New Zealand Index of 
Deprivation (NZDep)) and are more often Pacific and Indian ethnicity. As these sociodemographic factors, along with 
associated clinical variables such as smoking, parity and BMI, are also known to be associated with perinatal related 
mortality rates, these systematically missing data between the numerator (deaths) and denominator (all births) may 
result in bias. 
• More than 90 percent of the smoking and BMI data are missing from the MAT dataset for live births in 2007. 
• The MAT and the PMMRC datasets derive and define ethnicity differently. Maternal ethnicity is derived from BDM 
birth registration in the PMMRC dataset, while the MAT dataset ‘derives ethnicity from ethnic codes reported to 
NMDS (National Minimum Dataset for hospital discharges) birth and postnatal events, LMC Labour and Birth claims 
and NHI at time of delivery. The three highest priority ethnic codes that reach a threshold proportion are stored in 
the Aggregated Pregnancy table’ (National Health Board Business Unit 2011). It is possible that this difference may 
introduce numerator–denominator bias.
Until the MAT dataset is complete, MAT data are referenced when no other denominator data exist, but with a statement 
noting that the data are incomplete. 
The birth registration dataset has been used as the denominator in the analyses in this report. This also allows current data to 
be compared with previous years.
Data analysis
Percentages
Percentages have been displayed with one decimal place or without decimal places when the denominator is small. In some 
cases, due to rounding, the percentages do not add to exactly 100 percent.
Figures
In figures where graphs have two y-axes, the data relating to the left-side y-axis are presented as bars, and the data relating to 
the right-side y-axis are presented as points, joined by a line where they represent continuous or ordinal data.
Tables
In any table where there are denominator data (from the birth registration dataset), the table includes a column for the absolute 
number of births and the proportion of all births in the time period, distributed by the levels of the variable of interest. There are 
columns for the absolute number of deaths that were terminations of pregnancy, stillbirths, neonatal deaths and total perinatal 
deaths, the proportions within each of these by the variable of interest, and the rate of death as a proportion of all births in that 
category of the variable of interest.
For example, Table 1.4 looks at perinatal related deaths by maternal age for 2014. There were 10,289 births registered to 
mothers 20–24 years of age in 2014, which was 17.5 percent of all births. There were 63 stillbirths among mothers 20–24 
years of age, which was 19.4 percent of all stillbirths in 2014. The stillbirth rate was 63/10,289 births or 6.12 stillbirths per 
1000 births in 2014 to women 20–24 years of age. 
Confidence intervals
Ninety-five percent confidence intervals (CIs) for perinatal mortality rates have been computed using the methods for vital 
statistics described by the Centers for Disease Control and Prevention (Heron 2011). The CI represents the degree of 
uncertainty around the point estimate of the rate for the particular period.
This uncertainty depends on the absolute number of deaths and the number of births from which the deaths arose. If the number 
of births is large, then the CI (ie, the level of uncertainty) is generally small; if the number of births is small, the CI is large. The CI 
represents the limits within which the ‘true’ rate is most likely to lie. This calculation is necessary when numbers are small because 
the point estimate of the rate calculated from the data given may by chance have taken a wide range of values. The CI describes this 
range.
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It is possible to compare rates by looking at the CIs. If the CIs for each rate dose not overlap the estimate of the other rate, it 
is likely that the rates are different. This is equivalent to the rates being statistically significantly different at the p<0.05 level. If 
the CIs does overlap the estimate, the rates may or may not be different.
Statistical testing
Where the text notes that there is a statistically significant difference or association, this indicates that a statistical test has 
been applied and that the p-value is less than (<) 0.05. Conversely, if a difference is said to be not statistically significant, then 
the p-value is equal to or greater than (≥) 0.05. If the words ‘statistically significant’ are not used to describe a difference or 
association, it can be assumed that a statistical test has not been applied.
Where tests for trend have been used, a score test for linear trend of the log odds has been performed in STATA9 using the ‘tabodds’ 
function or in EpiInfo using the chi-squared test for trend. A p-value of <0.05 has been used to indicate statistical significance.
Missing data
Cases that have missing data have still been included in the data tables and are generally discussed in the text. Percentages 
in the tables generally include missing data, although the text sometimes describes findings among women with complete data 
only. However, where missing data exceed 30 percent of all possible data points, the data have generally not been presented.
At the lower extremes of gestation and birthweight, denominator numbers are small. As the denominator set is registrations rather 
than births in the relevant year, the denominator is not an exact count of all births in the year. For this reason, perinatal related 
mortality rates at the lower extremes have not been reported.
Multiple year data
In this report, the figures illustrating perinatal related mortality rates sometimes include combined data for the eight full years 
that the PMMRC has collected data (2007–2014). This increases the numbers and so improves the confidence around the 
estimates given. In general, the data for the 2014 year alone are presented in table form in the text and the combined eight-
year data in table form in the appendices to each section.
1.3 Births in New Zealand 2014










Amended from Statistics New Zealand (2015) 
http://www.stats.govt.nz/browse_for_stats/population/births/BirthsAndDeaths_HOTPYeDec14.aspx
http://www.stats.govt.nz/~/media/Statistics/Browse%20for%20stats/BirthsAndDeaths/HOTPYeDec14/bd-Dec14-all-tables.xls
Total births in New Zealand have dropped in the years since the peaks in 2007–2010 back to previous levels. There were 
58,647 total births registered fitting the PMMRC definition in 2014.
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There has been a significant change in the distribution of gestation at birth in New Zealand between 2007 and 2014 (Figure 1.3).
Specifically there has been a significant reduction in total births at 40 and 41+ weeks and a significant increase in births at 36, 37, 38 
and 39 weeks gestation. This suggests that there has been an increase in iatrogenic births at and near term.
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There has been a consistent reduction in births among mothers under 20 years of age from 2008 so that these now constitute 5.2 
percent of births (Figure 1.4). The majority of births in New Zealand are to women aged 25–29 (26.6 percent) and 30–34 (29.8 
percent). There has been a small increase in mothers birthing at 40 years of age and older from 2007 to 2014, with 4.3 percent 
of mothers 40 or older in 2014. 
The greatest changes in maternal ethnicity from 2007 to 2014 are an increase in births among Other Asian mothers and a 
reduction in the proportion to New Zealand European mothers, who now make up 11.2 and 42.8 percent of mothers respectively 
(Figure 1.5).
In 2014, 22.1 percent of mothers identified to BDM as Māori and 10.0 percent as Pacific.
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Figure 1.7: Distribution of births by DHB of maternal residence among birth registrations in 2014 (total births=58,647)
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Figure 1.10: Distribution of maternal prioritised ethnicity by DHB of maternal residence among birth registrations in 2014 (total 
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Figure 1.11: Distribution of deprivation quintile (NZ Dep2013) by DHB of maternal residence, among birth registrations in 2014 
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1.4 Perinatal Mortality 2014
Perinatal mortality rates
The PMMRC perinatal related mortality rates are calculated from numerator data provided by LMCs, clinicians and DHB local 
coordinators, reviewed by local perinatal mortality review committees and collated centrally by a national coordinator, and 
denominator data from the registration of all births in New Zealand in a year. This differs from the methodology used by the 
Ministry of Health in its reports and so the rates presented in this report may differ slightly from those reported in Ministry of 
Health documents. 
The PMMRC considers that this report presents as complete a set of perinatal related deaths as can currently be achieved for 
the 2014 year in New Zealand.
Table 1.1: Summary of New Zealand perinatal mortality rates 2014 
The perinatal related mortality rate in New Zealand in 2014, which includes late terminations of pregnancy, stillbirths, and 
early and late neonatal deaths, from 20 weeks gestation to 27 days of life, was 11.2 per 1000 total births. 
There has been no statistically significant change in overall perinatal related mortality, using the New Zealand definition, from 
2007 to 2014. 
However, the significant decrease in the stillbirth rate and significant increase in the termination of pregnancy rate from 2007 
to 2014, which was reported previously, persists (chi-squared test for trend p=0.04, p=0.04 respectively). 
There has been a significant increase in perinatal related deaths from maternal conditions and a significant reduction in 




Using NZ definition Using UK definition* 
n Rate n Rate 
Total births 58,647   58,477   
Fetal deaths (terminations of pregnancy and stillbirths)# 474 8.1 259 4.4 
Terminations of pregnancy 149 2.5 64 1.1 
Stillbirths 325 5.5 195 3.3 
Early neonatal deaths <7 days 150   150   
Late neonatal deaths 7–27 days 32   32   
Neonatal deaths <28 days+ 182 3.1 182 3.1 
Perinatal mortalities^ 624 10.6 409 7.0  
Perinatal related mortalities• 656 11.2 441 7.5 
Perinatal mortalities excluding lethal and terminated fetal abnormalities~ 446 7.6 310 5.3 
Perinatal related mortalities excluding lethal and terminated fetal abnormalities~ 465 7.9 329 5.6 
 
* Rates calculated using UK definition for perinatal mortality: babies stillborn after 24 weeks gestation and deaths of live born babies per 1000 live births and stillbirths 
(CMACE 2011).
# Fetal death rate per 1000 babies born (includes terminations and stillbirths).
+ Neonatal death rate per 1000 live born babies.
^ Fetal deaths and early neonatal deaths per 1000 babies born.
• Fetal deaths and early and late neonatal deaths per 1000 babies born.
~ Lethal and terminated fetal abnormalities are all perinatal related deaths with PSANZ-PDC of congenital abnormality and neonatal deaths with PSANZ-NDC of 
congenital abnormality.
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2007 2008 2009 2010 2011 2012 2013 2014 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Total births 65,602   65,872   63,665   65,124   62,604   62,425   60,039   58,647   
Fetal deaths (terminations of pregnancy and stillbirths)* 513 7.8 524 8.0 547 8.6 498~ 7.6 503 8.0 492 7.9 448~ 7.5 474 8.1 
Terminations of pregnancy 144 2.2 145 2.2 138 2.2 151 2.3 171 2.7 172 2.8 141~ 2.3 149 2.5 
Stillbirths 369 5.6 379 5.8 409 6.4 347~ 5.3 332 5.3 320 5.1 307 5.1 325 5.5 
Early neonatal deaths <7 days 133   134   137   165   138   142   122   150   
Late neonatal deaths 7–27 days 34   43   46   45   25   36   31   32   
Neonatal deaths <28 days# 167 2.6 177 2.7 183 2.9 210 3.2 163 2.6 178 2.9 153 2.6 182 3.1 
Perinatal mortalities+ 646 9.8 658 10.0 684 10.7 663~ 10.2 641 10.2 634 10.2 570~ 9.5 624 10.6 
Perinatal related mortalities^ 680 10.4 701 10.6 730 11.5 708~ 10.9 666 10.6 670 10.7 601~ 10.0 656 11.2 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 462 7.0 488 7.4 515 8.1 465 7.1 445 7.1 445 7.1 418 7.0 446 7.6 
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
482 7.3 516 7.8 546 8.6 496 7.6 461 7.4 467 7.5 437 7.3 465 7.9 
 
* Fetal death rate per 1000 babies born (includes terminations and stillbirths).
# Neonatal death rate per 1000 live born babies.
+ Fetal deaths and early neonatal deaths per 1000 babies born.
^ Fetal deaths and early and late neonatal deaths per 1000 babies born.
• Lethal and terminated fetal abnormalities are all perinatal related deaths with PSANZ-PDC of congenital abnormality and neonatal deaths with PSANZ-NDC of congenital abnormality.
~ Included one late notification.
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Year of death 
Perinatal related mortalities Stillbirths Neonatal deaths Terminations of pregnancy
There has been a significant decrease in the perinatal related mortality and stillbirth rates from 2007 to 2014 (chi-squared test 
for trend p=0.0013, p=0.0002) using the international definition recommended by the World Health Organization (WHO) 
of perinatal related deaths from 1000g or from 28 weeks if birthweight is unknown. There has been no significant change in 
neonatal death or termination of pregnancy rates using the international definition from 2007 to 2014.
Statistically significant reductions in death from antepartum haemorrhage and hypoxic peripartum deaths are at least part 
responsible for the significant reduction in perinatal related mortality using the international definition.























Year of death 
Perinatal related mortalities Stillbirths Neonatal deaths Terminations of pregnancy
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International comparisons
Direct international comparisons of perinatal mortality rates are difficult due to differences in definitions and in ascertainment 
of cases.
The perinatal mortality rate (stillbirths and deaths under seven days) in England and Wales in 2014 was 6.7/1000 births. The 
stillbirth rate in England  and Wales was 4.7/1000 births in 2014, and the neonatal death rate was 2.7/1000 births (Office 
for National Statistics 2015). The equivalent rates in New Zealand in 2014 were 7.0/1000 (95% CI 6.3–7.7), 4.4/1000 
(95% CI 3.9–5.0), and 3.1/1000 births (95% CI 2.7–3.6) (Table 1.1). All rates in England and Wales  are within the 95% 
CIs of rates from New Zealand and so are not statistically significantly different.
Australia’s Mothers and Babies 2013 reported a perinatal death rate of 10/1000 total births for 2013 (Australian Institute of 
Health and Welfare 2015). The  equivalent rate for New Zealand (called perinatal related death rate in New Zealand) was 
also 10/1000 births. 
Causes of perinatal related death
Congenital abnormalities are the most common cause of perinatal related death (28.7 percent) using the PSANZ classification 
system, and 59 percent of these are deaths by termination of pregnancy. The second most common reason for perinatal 
related death is spontaneous preterm birth (16 percent). 
Table 1.3: Perinatal related deaths by primary perinatal death classification (PSANZ-PDC) 2014
 
Perinatal death classification 
(PSANZ-PDC) 
Fetal deaths 
Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=149 n=325 n=182 n=656 
n % n % n % n % 
Congenital abnormality 111 74.5  34 10.5  43 23.6  188 28.7  
Perinatal infection - - 12 3.7  12 6.6  24 3.7  
Hypertension 2 1.3  9 2.8  2 1.1  13 2.0  
Antepartum haemorrhage 7 4.7  33 10.2  29 15.9  69 10.5  
Maternal conditions 10 6.7  21 6.5  8 4.4  39 5.9  
Specific perinatal conditions 9 6.0  43 13.2  17 9.3  69 10.5  
Hypoxic peripartum death - - 7 2.2  10 5.5  17 2.6  
Fetal growth restriction 2 1.3  32 9.8  1 0.5  35 5.3  
Spontaneous preterm 8 5.4  44 13.5  53 29.1  105 16.0  
Unexplained antepartum death - - 90 27.7  - - 90 13.7  
No obstetric antecedent - - - - 7 3.8  7 1.1  
 



















































Perinatal death classification (PSANZ-PDC) 
Termination of pregnancy Stillbirths Neonatal deaths
Figure 1.14: Relative distribution of fetal and neonatal deaths by perinatal death classification (PSANZ-PDC) 2014
Epidemiology and perinatal mortality
Gender
There is no significant association between gender and perinatal related mortality rate in New Zealand (Table 1.27).
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<20 20–24 25–29 30–34 35–39 ≥40 years 
Maternal age
Maternal age is significantly associated with perinatal related death. Termination of pregnancy, stillbirth and neonatal death 
are all more frequent at the extremes of maternal age, although there are significant differences in the relationships among 
these (Figure 1.15). For example, although the ‘U-shaped’ association is evident for neonatal deaths, neonatal death is 
significantly more common among mothers under 20 years of age than all other ages of mothers, including mothers 40 years 
of age and older. Maternal age from 25 to 35 years is associated with the lowest rates of perinatal related mortality.
There have been significant changes in the distribution of maternal age in New Zealand from 2007 to 2014 with a reduction 
in mothers under 20 years of age and an increase in mothers aged 25–34 years and 40 years and older (Figure 1.4). 
Previous analyses have suggested that age is not an independent risk factor for stillbirth and neonatal death after adjusting for 
the effects of socioeconomic status, ethnicity, BMI, smoking and parity (PMMRC 2014a).








Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=58,647 n=149 n=325 n=182 n=656 
n % n % Rate n % Rate n % Rate n % Rate 
<20 3,040 5.2  9 6.0  2.96  26 8.0  8.55  15 8.2  4.99  50 7.6  16.45  
20–24 10,289 17.5  19 12.8  1.85  63 19.4  6.12  33 18.1  3.23  115 17.5  11.18  
25–29 15,607 26.6  39 26.2  2.50  78 24.0  5.00  48 26.4  3.10  165 25.2  10.57  
30–34 17,480 29.8  36 24.2  2.06  89 27.4  5.09  48 26.4  2.77  173 26.4  9.90  
35–39 9,705 16.5  29 19.5  2.99  53 16.3  5.46  30 16.5  3.12  112 17.1  11.54  
≥40 2,526 4.3  17 11.4  6.73  15 4.6  5.94  8 4.4  3.21  40 6.1  15.84  
Unknown - - - - - 1 0.3  - - - - 1 0.2  - 
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Figure 1.16 illustrates the association between maternal age and cause specific stillbirth and neonatal mortality. Especially 
noticeable are the associations between young maternal age and death from spontaneous preterm birth, fetal growth restriction, 
and antepartum haemorrhage, and the association of stillbirth and neonatal death from congenital abnormality with both extremes 
of maternal age. 
The higher rate of combined stillbirth and neonatal death from congenital abnormalities among teenage mothers is due to euploid 
(non-chromosomal) abnormalities, and among mothers 40 and older it is due to chromosomal abnormalities.
Figure 1.16: Perinatal death classification (PSANZ-PDC) specific perinatal related death rates (per 1000 births) (excluding 
termination of pregnancy) by maternal age (with 95% CIs) 2007–2014
 












PSANZ-PDC specific combined stillbirth/neonatal mortality rate/1000 births 
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34
Ethnicity
There is significantly higher perinatal related mortality among the children of mothers of Māori, Pacific and Indian ethnicity 
compared to mothers of Other Asian, Other (includes Other European, Middle Eastern, Latin American, African), and New 
Zealand European ethnicity. Termination of pregnancy deaths are significantly less common among Māori and Pacific mothers 
than mothers of all other ethnicities, and significantly more common among Indian and Other Asian mothers than among New 








Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=58,647 n=149 n=325 n=182 n=656 
n % n % Rate n % Rate n % Rate n % Rate 
Māori 12,942 22.1  20 13.4  1.55 88 27.1  6.80 58 31.9  4.52 166 25.3  12.83 
Pacific peoples 5,878 10.0  9 6.0  1.53 47 14.5  8.00 27 14.8  4.64 83 12.7  14.12 
Indian 2,777 4.7  12 8.1  4.32 18 5.5  6.48 15 8.2  5.46 45 6.9  16.20 
Other Asian 6,493 11.1  20 13.4  3.08 19 5.8  2.93 11 6.0  1.70 50 7.6  7.70 
Other (including unknown) 5,431 9.3  19 12.8  3.50 21 6.5  3.87 12 6.6  2.23 52 7.9  9.57 
NZ European 25,126 42.8  69 46.3  2.75 132 40.6  5.25 59 32.4  2.37 260 39.6  10.35 
 
Table 1.5: Perinatal related mortality rates (per 1000 births) by maternal prioritised ethnicity 2014
35PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: TENTH ANNUAL REPORT 
























Māori Pacific peoples Indian Other Asian Other (including unknown) NZ European
Figure 1.18 illustrates the associations between maternal prioritised ethnicity and cause specific combined stillbirth and 
neonatal mortality rates. 
Babies of Māori and Pacific mothers are at increased risk of combined stillbirth or neonatal mortality, compared to at least two 
other ethnic groups, from death without obstetric antecedent (mostly sudden unexpected death in infancy (SUDI)), unexplained 
antepartum death, spontaneous preterm birth, maternal conditions, and antepartum haemorrhage. Babies of Pacific mothers 
are also at increased risk of stillbirth or neonatal death from hypertension and congenital abnormality.
Māori perinatal related mortality 
Multivariate analysis of stillbirths and neonatal deaths from 2007 to 2012 showed that only the association of Māori ethnicity 
with neonatal death from 20-27 weeks was significant after adjustment for the effects of socioeconomic deprivation, maternal 
age, smoking, parity and BMI (PMMRC 2014a). This analysis highlights the importance of addressing amenable factors such 
as smoking, BMI, and socioeconomic deprivation in order to reduce Māori stillbirths and late neonatal deaths.
Indian perinatal related mortality
It is more difficult to determine the important causes for increased stillbirth or neonatal mortality rates among babies of Indian 
mothers as absolute numbers of deaths and births are small. However, there are significant increases in risk compared to at 
least two other ethnic groups, from spontaneous preterm birth, fetal growth restriction, and specific perinatal conditions (most 
commonly twin-to-twin transfusion, feto-maternal haemorrhage, and alloimmune disease).
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Figure 1.18: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1000 births) (excluding 
termination of pregnancy) by maternal prioritised ethnicity 2007–2014
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Figure 1.19 illustrates the clear associations between increased socioeconomic deprivation and perinatal related mortality. Paradoxically, 
there is an increase in perinatal related death from termination of pregnancy with decreasing socioeconomic deprivation and an increase 
in stillbirth and neonatal death with increasing deprivation. 
The increase in death from termination of pregnancy among babies of mothers with decreasing deprivation may be due to increased 
access to antenatal diagnostic and/or termination of pregnancy services, or to increased risk of abnormalities and diseases leading to 
termination of pregnancy.
Similarly, the mechanisms for increased stillbirth and neonatal death with increasing socioeconomic deprivation are not well described, 
and similarly may involve a combination of access and disease risk factors. The importance of access is supported by the association 
between socioeconomic status and access and/or engagement with care contributory factors to perinatal related death (Figure 1.34). 
In multivariate analysis, increasing socioeconomic deprivation was independently associated with increased risk of neonatal 

































Quintile 1 (least deprived) Quintile 2 Quintile 3 Quintile 4 Quintile 5 (most deprived)







Fetal deaths       
Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=58,647 n=149 n=325 n=182 n=656 
n % n % Rate n % Rate n % Rate n % Rate 
1 (least deprived) 9,317 15.9 31 20.8 3.33 41 12.6 4.40 13 7.1 1.41 85 13.0 9.12 
2 10,283 17.5 23 15.4 2.24 51 15.7 4.96 19 10.4 1.86 93 14.2 9.04 
3 11,366 19.4 37 24.8 3.26 53 16.3 4.66 34 18.7 3.02 124 18.9 10.91 
4 12,262 20.9 28 18.8 2.28 76 23.4 6.20 43 23.6 3.54 147 22.4 11.99 
5 (most deprived) 15,141 25.8 27 18.1 1.78 103 31.7 6.80 72 39.6 4.80 202 30.8 13.34 
Unknown 278 0.5 3 2.0 - 1 0.3 - 1 0.5 - 5 0.8 - 
 
Figure 1.19: Perinatal related mortality rates (per 1000 births) by deprivation quintile (with 95% CIs) 2007–2014
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PSANZ-PDC-specific combined stillbirth/neonatal mortality rate/1000 births 
Quintile 1 (least deprived) Quintile 2 Quintile 3 Quintile 4 Quintile 5 (most deprived)
Figure 1.20: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1000 births) (excluding 
termination of pregnancy) by deprivation quintile (with 95% CIs) 2007–2014
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Figure 1.20 illustrates the associations between socioeconomic deprivation quintile and cause specific stillbirth and neonatal 
mortality rates. There is a significant increase in all causes of stillbirth and neonatal death other than specific perinatal conditions 
(mostly complications associated with multiple pregnancy) with increasing socioeconomic deprivation. 
Body mass index





Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=149 n=325 n=182 n=656 
n % n % n % n % 
<18.50 1  0.7  11  3.4  3  1.6  15  2.3  
18.50–24.99 78  52.3  124  38.2  68  37.4  270  41.2  
25.00–29.99 42  28.2  83  25.5  49  26.9  174  26.5  
30.00–34.99 13  8.7  48  14.8  33  18.1  94  14.3  
35.00–39.99 9  6.0  31  9.5  14  7.7  54  8.2  
≥40 3  2.0  24  7.4  12  6.6  39  5.9  
Unknown 3  2.0  4  1.2  3  1.6  10  1.5  
 
Among mothers of babies who died in the perinatal period in 2014, 28.4 percent had a reported BMI of 30 or higher, and 
this was 31.7 percent among mothers of stillbirths. The MAT dataset reported 24.8 percent of mothers of births in 2014 had 
a BMI of 30 or higher. Approximately 5 percent of mothers have missing BMI data in MAT. It is unlikely that including these 
data would negate the apparent higher rate of obesity among mothers of perinatal related deaths. This finding is consistent 
with reported findings of an association between obesity and perinatal mortality (American Congress of Obstetricians and 
Gynecologists 2015).
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The red line in Figure 1.21 represents the New Zealand rate of perinatal related mortality for 2007–2014 (10.73/1000 births). DHB 
rates are compared to the national rate, represented by the point estimate for 2007–2014 and a 95% CI. If the CI includes the New 
Zealand rate then the DHB rate is not statistically significantly different from the national rate. But where the CI does not include the 
national rate this means that the regional rate is significantly different.
Perinatal related mortality rates for Capital & Coast, Nelson Marlborough and Southern DHBs are significantly lower than the national 
rate, and the rates for Northland and Counties Manukau DHBs are significantly higher than the national rate.
As with all factors associated with perinatal related mortality presented in this report, the association is univariate and does not 
account for potential confounding factors, and does not explain the causes for increased or decreased mortality. It is possible that 
different regions are able to provide more or better care to mothers and babies; but also probable that the differences are explained 
by significant differences in demographic risk factors by region, as illustrated in section 1.3: Births in New Zealand 2014.
Stillbirth and neonatal death rates by DHB are shown in Figures 1.35 and 1.36. The neonatal death rate among women residing in 
Waikato and Bay of Plenty DHB regions were significantly higher than the national rate of 2.83/1000 live births from 2007 to 2014.
DHB specific reports, comparing the intervals 2007–2010 and 2011–2014, will be provided to all regions in 2016. 
DHB of residence
Figure 1.21: Crude perinatal related mortality rates (per 1000 births) by DHB of residence (mother) compared to New Zealand 

























DHB of maternal residence 
DHB specific perinatal related mortality rate NZ perinatal related mortality rate 2007–2014 
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Maternal smoking, alcohol and substance use
Table 1.8: Maternal smoking, alcohol and substance use at the time of perinatal related death 2014
n % n % n % n %
Currently smoking
Yes 13 8.7 83 25.5 44 24.2 140 21.3
No 135 90.6 241 74.2 138 75.8 514 78.4
Never smoked 99 66.4 180 55.4 92 50.5 371 56.6
Stopped before this pregnancy 26 17.4 43 13.2 23 12.6 92 14.0
Stopped <16 weeks gestation 6 4.0 11 3.4 18 9.9 35 5.3
Stopped ≥16 weeks gestation - - 4 1.2 2 1.1 6 0.9
Unknown 4 2.7 3 0.9 3 1.6 10 1.5
Unknown 1 0.7 1 0.3 - - 2 0.3
Alcohol and substance use
Yes 9 6.0 31 9.5 14 7.7 54 8.2
No 131 87.9 269 82.8 154 84.6 554 84.5
Unknown 9 6.0 25 7.7 14 7.7 48 7.3
Specific drugs
Alcohol 8 5.4 16 4.9 10 5.5 34 5.2
Amphetamine/P - - 5 1.5 - - 5 0.8
Herbal highs - - - - 1 0.5 1 0.2
Marijuana 1 0.7 10 3.1 6 3.3 17 2.6
Methadone 1 0.7 2 0.6 - - 3 0.5
Smoking history (among current non-smokers)
Fetal deaths
Neonatal deaths Perinatal related deaths
Termination of pregnancy Stillbirths
n=149 n=325 n=182 n=656
There has been a decrease in the proportion of current smokers among mothers of perinatal related deaths from around 30 percent 
in 2007–2009 to 21 percent in 2014. This is associated with other changes in demography among the birthing population (eg, an 
increase in the proportion of Other Asian mothers, a reduction in births among women under 20 years of age who have a high rate 
of smoking) and probably reflects a reduction in smoking in the general population. The New Zealand Health Survey data show a 
statistically significant reduction in current smoking among women in New Zealand from 18.9 percent in 2006/2007 to 15.0 
percent in 2014/2015 (Ministry of Health 2015a). 
However, smoking rates are higher among mothers of babies who died than among mothers in the birthing population in New 
Zealand. In the MAT dataset the proportion of women smoking either at registration or at two weeks postpartum in 2014 among 
women with known smoking status was 15.9 percent. 
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Table 1.9: Maternal smoking cessation support offered and perinatal related death 2014
In 2014, among mothers of perinatal related deaths, smoking cessation support was offered to approximately half of mothers.
LMC = lead maternity carer.
Smoking cessation support offered    
(among current smokers and non-smokers 
other than those who have 'never smoked') 
Fetal deaths 
Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=49 n=144 n=90 n=283 
n % n % n % n % 
No 25  51.0  43  29.9  25  27.8  93  32.9  
Yes – by LMC only 11  22.4  30  20.8  15  16.7  56  19.8  
Yes – referred to external agents 1  2.0  12  8.3  15  16.7  28  9.9  
Yes – referral declined  7  14.3  31  21.5  14  15.6  52  18.4  
Unknown 5  10.2  28  19.4  21  23.3  54  19.1  
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Table 1.10: Perinatal related mortality rates (per 1000 births) by gestation and birthweight 2014
Gestation and birthweight and perinatal related mortality
In this report, gestational age categories have been changed in line with national and international evidence of survival of babies born at 23 weeks, which is more in line with survival at 






Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=58,647 n=149 n=325 n=182 n=656 
n % n % Rate n % Rate n % Rate n % Rate 
Gestation at birth (weeks)                             
20–22 207  0.4 90  60.4 * 109  33.5 * 52  28.6 * 251  38.3 * 
23–24 136  0.2 31  20.8 * 28  8.6 * 39  21.4 * 98  14.9 * 
25–27 183  0.3 10  6.7 54.64  25  7.7 136.61  14  7.7 94.59  49  7.5 267.76  
28–31 457  0.8 7  4.7 15.32  31  9.5 67.83  8  4.4 19.09  46  7.0 100.66  
32–36 3,661  6.2 5  3.4 1.37  57  17.5 15.57  22  12.1 6.11  84  12.8 22.94  
37–40 44,826  76.4 6  4.0 0.13  72  22.2 1.61  38  20.9 0.85  116  17.7 2.59  
≥41 9,157  15.6 - - - 3  0.9 0.33  9  4.9 0.98  12  1.8 1.31  
Unknown 20  0.0 - - - - - - - - - - - - 
Birthweight (g)                             
<500  242  0.4 88  59.1 * 116  35.7 * 45  24.7 * 249  38.0 * 
500–999 305  0.5 47  31.5 154.10  59  18.2 193.44  55  30.2 276.38  161  24.5 527.87  
1000–1499 339  0.6 6  4.0 17.70  22  6.8 64.90  12  6.6 38.59  40  6.1 117.99  
1500–1999 636  1.1 4  2.7 6.29  18  5.5 28.30  12  6.6 19.54  34  5.2 53.46  
2000–2499 2,185  3.7 2  1.3 0.92  28  8.6 12.81  13  7.1 6.03  43  6.6 19.68  
2500–2999 8,147  13.9 - - - 31  9.5 3.81  13  7.1 1.60  44  6.7 5.40  
3000–3499 19,781  33.7 1  0.7 0.05  27  8.3 1.36  18  9.9 0.91  46  7.0 2.33  
3500–3999 18,491  31.5 - - - 15  4.6 0.81  11  6.0 0.60  26  4.0 1.41  
4000–4499 7,013  12.0 - - - 6  1.8 0.86  2  1.1 0.29  8  1.2 1.14  
≥4500 1,482  2.5 - - - - - - 1  0.5 0.67  1  0.2 0.67  
Unknown 26  0.0 1  0.7 - 3  0.9 - - - - 4  0.6 - 
 
* Denominator data unreliable where asterisk is present, and therefore rates have not been calculated.
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There is a statistically significant increase in perinatal related mortality risk among ongoing pregnancies at 20–22 weeks 
gestation (p=0.0016) (Table 1.41). Specifically there is a significant increase in stillbirth and neonatal death among ongoing 
pregnancies at 20–22 weeks gestation (p=0.019, p=0.0052 respectively) (Table 1.42) but no increase in termination of 
pregnancy at this gestation. 
There is a significant reduction in perinatal related mortality risk among pregnancies at term (37–40 and 41+ weeks at birth), 
(p=0.017, p=0.00028 respectively) (Table 1.41).
Perinatal death classification (PSANZ-PDC and PSANZ-NDC) of fetal and neonatal deaths by gestational age at birth are 
available in Tables 1.43 and 1.44. 
Stillbirth
The significant reduction from 2007 to 2014 in perinatal related mortality from 37 weeks is due to a significant reduction in 
stillbirths (Figure 1.23) due to perinatal infection, antepartum haemorrhage and from hypoxic peripartum death (Table 1.45). 
Neonatal death rates have remained unchanged. 
Figure 1.22: Perinatal related mortality risk (per 1000 ongoing pregnancies) by gestational age at birth 2007–2014
There has been a reduction in the numbers of deaths of babies 4000g and above and in the rate of these deaths. This is in line with 
the reduction in perinatal related mortality at term. 
In parallel there has been a reduction in births of babies at 40+ weeks and coincidentally a reduction in births of babies 4000g and 
above. This is presumably due to increased iatrogenic birth at term, probably both induction of labour and elective caesarean  birth. 
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In 2014, there were 25 known intrapartum deaths from 23 weeks, and 13 at term (37+ weeks gestation).
Figure 1.23: Stillbirth risk (per 1000 ongoing pregnancies) by gestational age at birth and year 2007–2014




























Year of death 
20–22 23–24 25–27 28–31 32–36 37–40 ≥41 weeks 
 
Timing of stillbirth 
All stillbirths Stillbirths ≥23 weeks Stillbirths ≥37 weeks 
Stillbirths ≥37 weeks without 
congenital abnormality 
n=325 n=216 n=75 n=68 
n % n % n % n % 
Antepartum 218 67.1  175 81.0  54 72.0  50 73.5  
Intrapartum – total 75 23.1  25 11.6  13 17.3  10 14.7  
Intrapartum – first stage 33 10.2  12 5.6  6 8.0  6 8.8  
Intrapartum – second stage 9 2.8  5 2.3  3 4.0  3 4.4  
Intrapartum – unknown stage 33 10.2  8 3.7  4 5.3  1 1.5  
Unknown 32 9.8  16 7.4  8 10.7  8 11.8  
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There has been a statistically significant reduction in intrapartum stillbirth risk as a proportion of ongoing pregnancies at term. This 
is consistent with and probably due to a significant reduction in hypoxic peripartum deaths. 
In 2014, there were 17 hypoxic peripartum deaths. Sixteen were from 37 weeks, six of whom contributed to the 10 
intrapartum stillbirths at term in 2014 (the remaining four intrapartum stillbirths were due to fetal growth restriction, maternal 
conditions, unexplained antepartum death). In 2007 there were 25 intrapartum stillbirths at term. Eighteen were hypoxic 
peripartum deaths (the remaining seven were due to perinatal infection, antepartum haemorrhage, specific perinatal 
conditions, and fetal growth restriction). 
There appears to be a small reduction in intrapartum stillbirths at 23–27 and 28–36 weeks gestation, but this is not statistically 
significant (chi-squared test for trend p=0.65 and p=0.16 respectively).
Unexplained antepartum death 
In 2015, a review of the placental and post-mortem pathology of unexplained antepartum deaths showed that 17 percent 
of babies classified as unexplained antepartum death from 2007 to 2013 were misclassified, 4 percent because there was 
another underlying pathology, and 13 percent because there was a placental abnormality which has been shown to be 
consistently associated with perinatal related death. There is no current category in the PSANZ-PDC for these latter placental 
abnormalities and so the PMMRC has recommended a change to the PSANZ classification to allow these babies to be 
identified as having a cause of death.
Termination of pregnancy
There has been a significant increase in the late termination of pregnancy rate from 2007 to 2014 (chi-squared test for trend 
p=0.04) from 2.2/1000 total births in 2007 to 2.5/1000 total births in 2014.
Terminations of pregnancy from 20 weeks gestation at issue contributed 22.7 percent of perinatal related deaths in 2014; 
74.5 percent of these were associated with congenital abnormalities.
There were 28 terminations of pregnancy after 24 weeks in 2014. The primary antecedent classifications for these deaths 
were congenital abnormality in 16, and hypertension, maternal conditions, specific perinatal conditions, fetal growth 
restriction, and spontaneous preterm birth in the remainder.
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Table 1.12: Clinical details of neonatal deaths 2014
Neonatal death
There were 182 neonatal deaths in 2014 contributing 27.7 percent of all perinatal related mortalities. Almost one-quarter 
(24.7 percent) of neonatal deaths were babies with congenital abnormalities. Of the remainder, 38 percent died before 23 
weeks and 66 percent before 25 weeks. Twenty-four neonates (17.5 percent) died at term.
None of the neonatal deaths at 20–22 weeks were resuscitated at birth, while 7/21 (33 percent) at 23 weeks and 16/18 
(89 percent) at 24 weeks were resuscitated. One-third of term neonates who died were not resuscitated. These babies died of 
infection after one week or died of SUDI.
The association between PSANZ-PDC and PSANZ-NDC cause of death classifications for 2014 is shown in Table 1.47.
 
n       % n       % n       % n       % n       %     n       %     n       %
Age at death (days)
0 95 52.2 17 37.8 46 88.5 20 51.3 4 33.3 3 30.0 5 20.8
1–6 55 30.2 15 33.3 6 11.5 10 25.6 7 58.3 5 50.0 12 50.0
7–13 10 5.5 5 11.1 - - 2 5.1 - - 1 10.0 2 8.3
14–20 14 7.7 3 6.7 - - 5 12.8 1 8.3 1 10.0 4 16.7
21–27 8 4.4 5 11.1 - - 2 5.1 - - - - 1 4.2
Place of death
Home 13 7.1 8 17.8 - - - - - - 1 10.0 4 16.7
Hospital
Delivery suite 63 34.6 10 22.2 37 71.2 12 30.8 2 16.7 1 10.0 1 4.2
Antenatal ward 5 2.7 2 4.4 2 3.8 1 2.6 - - - - - -
Postnatal ward 5 2.7 1 2.2 2 3.8 1 2.6 - - - - 1 4.2
Neonatal unit 70 38.5 20 44.4 - - 21 53.8 9 75.0 6 60.0 14 58.3
Operating theatre 5 2.7 2 4.4 - - 2 5.1 - - - - 1 4.2
Emergency department 4 2.2 - - 1 1.9 - - - - - - 3 12.5
Other 14 7.7 1 2.2 10 19.2 2 5.1 - - 1 10.0 - -
Other 3 1.6 1 2.2 - - - - 1 8.3 1 10.0 - -
Apgar 5 minutes 
0–3 93 51.1 13 28.9 43 82.7 18 46.2 5 41.7 3 30.0 11 45.8
4–5 18 9.9 9 20.0 2 3.8 3 7.7 - - 3 30.0 1 4.2
6–7 21 11.5 7 15.6 - - 8 20.5 3 25.0 2 20.0 1 4.2
≥8 34 18.7 12 26.7 - - 7 17.9 3 25.0 2 20.0 10 41.7
Unknown 16 8.8 4 8.9 7 13.5 3 7.7 1 8.3 - - 1 4.2
Resuscitation at birth 
Yes 81 44.5 21 46.7 - - 23 59.0 11 91.7 10 100.0 16 66.7
No 101 55.5 24 53.3 52 100.0 16 41.0 1 8.3 - - 8 33.3
Outcome of resuscitation
Baby resuscitated and transferred to another clinical care area
70 38.5 19 42.2 - - 22 56.4 8 66.7 8 80.0 13 54.2
Baby unable to be resuscitated 10 5.5 2 4.4 - - 1 2.6 3 25.0 2 20.0 2 8.3




Neonatal deaths excluding congenital abnormalities
20–22 25–27 ≥37 weeks






PRACTICE POINT: CARE FOR PREGNANT WOMEN AT RISK OF DELIVERING AT THE LOWER EXTREMES 
OF GESTATIONAL AGE
Care for pregnant women at risk of birthing at the lower extremes of gestational age (23+0 to 24+6) remains a 
complex area of perinatal medicine. 
Practice variation reflects the medical complexity or co-morbidity of individual cases, locality, and resource availability, as 
well as parental wishes. 
Resuscitation has been offered across all New Zealand tertiary neonatal centres to infants born at 23–24 weeks gestation. 
Overall mortality is higher than at more mature gestations, but high quality survival is possible. 
In the context of threatened preterm labour or women requiring iatrogenic preterm birth at 23+0 to 24+6 weeks 
gestation, provision of an appropriate care pathway must recognise the needs of the mother as well as the baby. Mode 
of birth is an important part of this discussion as a caesarean section at this gestation not only has risks for the mother 
at the time of this birth but also has significant implications for subsequent pregnancies and may not improve neonatal 
outcomes.
Integrated care for women in threatened preterm labour or women requiring iatrogenic preterm birth at 23+0 to 24+6 
weeks gestation should include open discussion between the family and the LMC, obstetric, and neonatal or paediatric 
services. 
Morbidity and mortality for infants born at 23+0 to 24+6 weeks gestation reduces significantly if they deliver in a tertiary 
centre. Early consultation with tertiary obstetrics/neonates is recommended. 
Parents and whānau should be counselled that babies at 23 weeks gestation who have not been prepared for early 
birth (eg, antenatal steroids, magnesium sulphate) may occasionally appear more vigorous than anticipated at birth. 
Admission to a neonatal intensive care unit of an unprepared baby is likely to result in severe morbidity and/or 
mortality. 
Points for particular consideration in the context of imminent birth at 23+0 to 24+6 weeks gestation 
Parents and whānau should be counselled antenatally about the possible range of outcomes for the baby. Where 
possible this discussion should be in a tertiary centre and reflect local institutional outcome data as well as current 
international data on long-term outcomes, particularly in relation to neurodevelopmental and cognitive outcomes. 
Parents and whānau should be included in decision-making and be aware of the range of possible interventions 
at this gestation. 
Appropriate care options include:
1. Palliative
a. No maternal corticosteroids or magnesium sulphate
b. No fetal monitoring or operative birth
c.    A palliative care pathway for the baby from birth
2. Active
a. Maternal corticosteroids and magnesium sulphate
b. Fetal monitoring and intervention as agreed with parents and whānau prior to labour
c.   Resuscitation of baby at birth followed by neonatal intensive care unit care 
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Babies of Māori, Pacific and Indian mothers are significantly more likely to die as neonates after birth at 20–22 and 23–24 
weeks compared to babies of New Zealand European mothers (excluding babies dying with congenital abnormalities) (Figure 
1.25). The principal cause of neonatal death at 20–24 weeks is spontaneous preterm birth (Figure 1.26). 
Babies of Māori, Pacific and Indian mothers are not significantly more likely to die after birth from 25-36 weeks than babies 
of New Zealand European mothers. However, as illustrated in Figure 1.25, neonatal death at term is more common among 
babies of Māori and Pacific mothers than babies of New Zealand European mothers.
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Figure 1.26 illustrates the changing distribution of cause of death among neonates with increasing gestation at birth. Disease 
associated with extreme prematurity predominates at 20–24 weeks, while neurological causes become apparent from 23 weeks and 
are responsible for the majority of deaths at term.
Multiple birth
Figure 1.26: Distribution of neonatal death classification (PSANZ-NDC) among neonatal deaths without lethal 





























Gestation at birth (weeks) 
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Table 1.13: Perinatal related mortality rates (per 1000 births) and multiple* births 2014




Type of birth 
Total births 
Fetal deaths 
Neonatal deaths Perinatal related deaths 
Termination of 
pregnancy Stillbirths 
n=58,647 n=149 n=325 n=182 n=656 
n % n % Rate n % Rate n % Rate n % Rate 
Singleton 56,972 97.1  139 93.3  2.44 291 89.5  5.11 142 78.0  2.51 572 87.2  10.04 
Multiple 1,675 2.9  10 6.7  5.97 34 10.5  20.30 40 22.0  24.52 84 12.8  50.15 
Multiples (1/2 died)     4 2.7    10 3.1    10 5.5    24 3.7    
Multiples (2/2 died)     3 2.0    24 7.4    27 14.8    54 8.2    
Multiples (1/3 died)     1 0.7    - -   - -   1 0.2    
Multiples (2/3 died)     2 1.3    - -   - -   2 0.3    
Multiples (3/3 died)     - -   - -   3 1.6    3 0.5    
Twin 1,636 2.8  7 4.7  4.28 34 10.5  20.78 37 20.3  23.20 78 11.9  47.68 
Dichorionic diamniotic     2 1.3    15 4.6    23 12.6    40 6.1    
Monochorionic 
diamniotic 
    4 2.7    17 5.2    14 7.7    35 5.3    
Monoamniotic     1 0.7    2 0.6    - -   3 0.5    
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There has been a significant increase in perinatal related deaths among multiple births from 2007 to 2014, although there has 
been no apparent increase since 2011 (chi-squared test for trend p=0.00023) (Table 1.48). The increase in perinatal deaths among 
multiple births is due to an increase in terminations of pregnancy and neonatal deaths (chi-squared test for trend p=0.0013 and 
p=0.028 respectively). 
From 2007 to 2014, 344 twins died in pregnancies involving the death of both twins, while 195 babies died while their twin sibling 
survived. Some babies from twin pregnancies died after 28 days or were born before 20 weeks and so are not defined as perinatal 
related deaths and are excluded from the data.
Just over half of deaths among multiple pregnancies are from monochorionic twin pregnancies, where the zygote divides after 
fertilisation leading to identical twins (Table 1.49). Death most commonly occurs due to twin-to-twin transfusion syndrome as a 
result of communicating circulations in the placenta. As only approximately 30 percent of all twin pregnancies are monochorionic, 
this is a reminder of the higher rate of mortality (and morbidity) among these babies. 
Multiple pregnancies should be referred for specialist care (Ministry of Health 2012a). Chorionicity should be determined by 
ultrasound scan in early pregnancy. Fortnightly scans from 16 weeks gestation are then advised for monochorionic twins. Urgent 
referral (within 24 hours) to a regional fetal medicine unit is advised if there is a possible diagnosis of twin-to-twin transfusion 
syndrome as this condition can deteriorate rapidly (Parry 2015).
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Vaginal bleeding in pregnancy is commonly found in association with perinatal related death. Overall, 37 percent of mothers of 
babies who died in 2014 had some vaginal bleeding during pregnancy, and 30 percent had vaginal bleeding in the second half of 
pregnancy. Of those mothers who had bleeding before 20 weeks, almost 60 percent continued to have bleeding beyond 20 weeks.
Antepartum haemorrhage was the antecedent cause of death for 10.5 percent of perinatal related deaths in 2014, 10 percent of 
stillbirths and 16 percent of neonatal deaths. 
Fertility treatment is over-represented among multiple pregnancy deaths. Among deaths of babies in multiple pregnancies, 
15 percent were born to mothers who were given clomiphene or follicle stimulating hormone (FSH) or had in vitro fertilisation 
(IVF). Three percent of mothers of singleton babies who died received these fertility treatments. 
Vaginal bleeding in pregnancy





Singleton perinatal related deaths  Multiple perinatal related deaths  Perinatal related deaths  
n=4,823 n=584 n=5,409 
n % n % n % 
Clomiphene 42  0.9  21  3.6  63  1.2  
Follicle stimulating hormone (FSH) 3  0.1  4  0.7  7  0.1  
In vitro fertilisation (including ICSI) 113  2.3  70  12.0  183  3.4  
Any of clomiphene/FSH/IVF 156  3.2  90  15.4  246  4.5  
 
ICSI = intracytoplasmic sperm injection.





Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=149 n=325 n=182 n=656 
n % n % n % n % 
Yes 28 18.8 123 37.8 89 48.9 240 36.6 
No 116 77.9 184 56.6 84 46.2 384 58.5 
Unknown 5 3.4 18 5.5 9 4.9 32 4.9 
Gestation*                 
<20 weeks 21 14.1 52 16.0 36 19.8 109 16.6 
≥20 weeks 15 10.1 103 31.7 78 42.9 196 29.9 
 
Table 1.15: Perinatal related deaths and vaginal bleeding during pregnancy 2014
* Multiple bleeds can occur in pregnancy and can occur both before and after 20 weeks. 
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Small for gestational age infants
Table 1.16 shows the absolute numbers and proportions of customised small for gestational age (SGA) babies among singleton 
perinatal related deaths without congenital abnormality in 2014.
The overall rate of customised SGA among singleton deaths without congenital abnormalities in 2014 was 26.5 percent, which is 
perhaps at least twice the rate expected in the population of births in New Zealand.
Customised SGA is defined as the lowest 10 percent of ‘optimal’ birthweights (Anderson et al 2012), so we would expect a rate in the 
general population of more than 10 percent, but there are currently no New Zealand normative data as maternal height and weight 
are not captured in the MAT dataset.
At the Auckland tertiary maternity unit in New Zealand the rate of SGA in the whole birthing population was 14.1 percent in 
2014 (Auckland District Health Board 2015).
Customised SGA was more common among singleton deaths without congenital abnormalities at 23–36 weeks than at 20–22 weeks 
(p=0.013) and more common at 23–36 weeks than at term (p=0.09). These association are illustrated in Figure 1.28.
Twenty perinatal related deaths of singleton babies without congenital abnormalities at term in 2014 (23 percent) were babies 
who were SGA. The primary antecedent cause of death classification for these term SGA babies was most commonly unexplained 





Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
  n % n % n % n % 
Singleton deaths 20–22 weeks, excluding 
congenital abnormalities 
n=18 n=84 n=35 n=137 
SGA 8 44.4 15 17.9 5 14.3 28 20.4 
Singleton deaths 23–36 weeks, excluding 
congenital abnormalities 
n=13 n=110 n=42 n=165 
SGA 4 30.8 45 40.9 6 14.3 55 33.3 
Singleton deaths ≥37 weeks, excluding 
congenital abnormalities 
n=0 n=64 n=23 n=87 
SGA - - 17 26.6 3 13.0 20 23.0 
 
Table 1.16: Perinatal related deaths and small for gestational age (customised SGA) among singleton deaths without congenital 
abnormalities 2014
SGA = small for gestational age (birthweight less than 10th customised centile).
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Figure 1.28: Small for gestational age (customised SGA) by gestation among perinatal related deaths (excluding multiples and 
congenital abnormalities) 2007–2014
Maternity care and place of birth
Ninety-five percent of the mothers of babies who died in the perinatal period were registered with an LMC prior to diagnosis of 
perinatal related death. Registration status did not vary by whether the death was a termination of pregnancy, stillbirth or neonatal 
death.
Seventy-seven percent of mothers were registered with a self-employed midwife LMC, 13 percent with a hospital maternity 
service, and 4 percent with a private obstetrician. The MAT dataset shows that in 2014, 85 percent of all mothers booked with a 
self-employed midwifery LMC, 5.6 percent with a private obstetrician, and very few with a GP. The remaining women are registered 
with DHB maternity services or are unregistered. These data are currently incomplete in the MAT dataset and so perinatal related 
mortality rates by LMC at registration are not provided. 
Of mothers registered prior to perinatal death, 46.5 percent were registered before 10 weeks gestation, 77.6 percent before 14 
weeks, and 7.7 percent after 19 weeks (Table 1.50).
In previous PMMRC reports, data have been provided on LMC at birth among stillbirths and neonatal deaths. These data are not 
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Was the mother registered with a lead 
maternity carer (LMC)? 
Fetal deaths 
Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=149 n=325 n=182 n=656 
n % n % n % n % 
Yes 141 94.6 308 94.8 175 96.2 624 95.1 
Self-employed midwife 119 79.9 249 76.6 137 75.3 505 77.0 
Hospital 15 10.1 40 12.3 30 16.5 85 13.0 
General practitioner - - 1 0.3 1 0.5 2 0.3 
Obstetrician (private) 7 4.7 15 4.6 7 3.8 29 4.4 
Unknown LMC - - 3 0.9 - - 3 0.5 
No 8 5.4 17 5.2 7 3.8 32 4.9 
 
Table 1.17: Perinatal related deaths and maternal registration status 2014
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Table 1.18 shows the intended place of birth and actual place of birth for stillbirths and neonatal deaths in 2014. This shows 
that more than half of mothers of babies who died who were intending to birth their babies at home, in a birth unit or in a 
level 1 hospital ultimately birthed their baby in a level 2 or 3 hospital. This suggests that risk was evident and acted upon prior 
to birth. 
Six babies of the 46 whose birth was intended at home or in a birthing unit actually birthed in either of these places. These 
babies were born at 21, 29, 34, 38 (2) and 39 weeks gestation, three were stillbirths and three were neonatal deaths.
Screening in pregnancy 
Diabetes
From 2007 to 2014, there has been a steady increase in the proportion of mothers of babies who died in the perinatal 
period, and who were eligible for screening, who were screened for diabetes. In 2014, 86 percent of mothers of stillborn 
babies and neonates who died within a month of birth were screened for diabetes. Over the period there has been a 
significant reduction in unscreened mothers.
  
 
Intended place of birth 





1 Hospital level 2 Hospital level 3 Other Unknown 
  n % n % n % n % n % n % n % 
Home 13 1 7.7 1 7.7 1 7.7 7 53.8 3 23.1 - - - - 
Birthing unit 33 2 6.1 2 6.1 - - 5 15.2 23 69.7 1 3.0 - - 
Hospital level 1 19 - - - - 4 21.1 3 15.8 11 57.9 1 5.3 - - 
Hospital level 2 173 4 2.3 1 0.6 2 1.2 144 83.2 19 11.0 2 1.2 1 0.6 
Hospital level 3 241 2 0.8 1 0.4 - - 5 2.1 231 95.9 2 0.8 - - 
Other 2 - - - - - - - - 2 100.0 - - - - 
Not registered 19 4 21.1 1 5.3 1 5.3 2 10.5 9 47.4 2 10.5 - - 
Unknown 7 - - - - - - 2 28.6 4 57.1 - - 1 14.3 
Total 507 13 2.6 6 1.2 8 1.6 168 33.1 302 59.6 8 1.6 2 0.4 
 




Screened for diabetes 
2007 2008 2009 2010 2011 2012 2013 2014 
n=286 n=295 n=303 n=265 n=254 n=235 n=212 n=223 
n % n % n % n % n % n % n % n % 
Yes 167 58.4 162 54.9 199 65.7 179 67.5 195 76.8 177 75.3 170 80.2 183 86.3 
No 68 23.8 71 24.1 52 17.2 49 18.5 45 17.7 48 20.4 30 14.2 25 11.8 
Unknown 51 17.8 62 21.0 52 17.2 37 14.0 12 4.7 6 2.6 8 3.8 8 3.8 
Declined - - - - - - - - 2 0.8 4 1.7 4 1.9 7 3.3 
 
Table 1.19: Screening for diabetes among registered women with no pre-existing diabetes and where stillbirth and neonatal 
death occurred at or beyond 28 weeks gestation 2007–2014
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There has been no change in the proportion of mothers screened for family violence in pregnancy among mothers of perinatal 
related deaths. There are numerous studies describing the association between family violence and adverse maternity outcomes. 
There is evidence that screening tools have good accuracy in the identification of women experiencing intimate partner violence; 
however, there is insufficient evidence on the effect of interventions to prevent family violence on perinatal mortality. 
An updated Ministry of Health guideline on routine inquiry for family violence in pregnancy is anticipated in 2016.
First and second trimester screening for congenital anomalies
In 2013, an audit of screening among perinatal deaths associated with congenital abnormalities was published showing 
that among deaths from congenital cardiovascular, central nervous system, and chromosomal abnormalities, and whose first 
contact with a health professional was within 20 completed weeks gestation, 97 of 129 (75 percent) were offered first or 
second trimester (MSS1/MSS2) screening, suggesting that a barrier to access may exist for some women. Of those offered 
screening, 15 (15 percent) declined (Arroll et al 2013).
Among women birthing in New Zealand in 2014, 70.8 percent completed either first or second trimester screening for Down 
syndrome and other conditions. This screening provides a risk result for trisomy 21, 18, and 13 and some other rare genetic disorders. 
Rates of participation varied from 47.8 to 86.9 percent by DHB of residence, 36.4 to 88.4 percent by maternal ethnicity, and from 85.3 
to 52.6 percent by increasing socioeconomic deprivation (National Screening Unit 2016). 





2007 2008 2009 2010 2011 2012 2013 2014 
n=680 n=701 n=730 n=707 n=666 n=670 n=599 n=656 
n % n % n % n % n % n % n % n % 
Experienced family violence in this pregnancy                           
Yes 18 2.6 24 3.4 22 3.0 31 4.4 17 2.6 17 2.5 12 2.0 18 2.7 
No 305 44.9 270 38.5 306 41.9 282 39.9 291 43.7 317 47.3 295 49.2 314 47.9 
Not asked 215 31.6 226 32.2 145 19.9 148 20.9 178 26.7 137 20.4 121 20.2 186 28.4 
Unknown 142 20.9 181 25.8 257 35.2 246 34.8 180 27.0 199 29.7 171 28.5 138 21.0 
Referral to relevant support                               
Yes 12 66.7 16 66.7 13 59.1 19 61.3 15 88.2 12 70.6 8 66.7 11 61.1 
No 1 5.6 - - 3 13.6 4 12.9 - - 1 5.9 - - 2 11.1 
Unknown 5 27.8 8 33.3 6 27.3 8 25.8 2 11.8 4 23.5 4 33.3 5 27.8 
 
Table 1.20: Perinatal related deaths and screening for family violence 2007–2014 
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PRACTICE POINT: ANTENATAL SCREENING FOR DOWN SYNDROME AND OTHER CONDITIONS
All women who are less than 20 weeks pregnant must be advised of the availability of antenatal screening for Down 
syndrome and other conditions.
Knowing local services and referral pathways is important as detection of fetal anomalies offers women information 
that may help them prepare for the birth and care of their child. This includes giving birth in a setting that has access 
to specialist medical or surgical care, having access to support services, the possibility of considering termination, or 
palliative care in the newborn period.
Antenatal screening for Down syndrome and other conditions provides a risk estimate for Down syndrome (trisomy 
21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13) and some other rare genetic disorders.
Antenatal screening for Down syndrome and other conditions is optional for pregnant women. The right to decline 
screening, tests or further investigations should be made clear by the health practitioner.
Screening has a detection rate of 78 to 80 percent for trisomy 21, 18 and 13, which means that out of 100 
pregnant women with a fetus with one of trisomy 21, 18 or 13, 78–80 will be detected by this screening.
Women should be made aware that they need to complete both the blood test and the scan to receive a risk result for 
first trimester screening. The health practitioner requesting screening must fill in all sections of the screening request 
form (including accurate measurement of height and weight) to ensure that the woman receives an accurate risk 
assessment.
The blood tests are free but there is often a part charge for the NT scan. Women should be advised that second 
trimester screening is available if they are unable to access an NT scan.
A low risk result does not mean no risk and may falsely reassure parents. A false negative result where a woman 
receives a low risk result and later has a baby with trisomy 21 appears to have a greater level of impact and 
parenting stress (Petticrew et al 2000).
Informed decision-making for this screening must include a discussion about the screened conditions and the 
decisions that may need to be made as a result of participation. 
The National Screening Unit has produced a range of resources and guidelines, including a discussion aid as 
a support for health practitioners to help women make informed decisions about screening for themselves and 
their babies. While it can be used for all women, it has been designed to enhance discussions about screening 
where there are communication difficulties, including women who are deaf, have low literacy levels, have learning 







Timing is critical for screening; women can choose first or second trimester screening.
First trimester combined screening should be completed between 9 weeks and 13 weeks 6 days gestation. The 
recommended timing for the blood test is 9 to 10 weeks and the nuchal translucency (NT) scan is at 12 weeks.
OR
Second trimester maternal screening should be completed between 14 and 20 weeks gestation. The 
recommended timing for the blood test is 14 to 18 weeks.
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Investigation of perinatal related deaths 
  
 
Post-mortem examination offered 
Māori Pacific peoples Indian Other Asian Other (including 
unknown) 
NZ European Perinatal related deaths 
n=1,413 n=738 n=277 n=380 n=436 n=2,165 n=5,409 
n % n % n % n % n % n % n % 
Post-mortem offered and parental consent given 337 23.8 222 30.1 127 45.8 168 44.2 208 47.7 1,009 46.6 2,071 38.3 
Post-mortem offered and parents declined 892 63.1 435 58.9 132 47.7 166 43.7 173 39.7 882 40.7 2,680 49.5 
Post-mortem not offered 146 10.3 64 8.7 15 5.4 39 10.3 43 9.9 220 10.2 527 9.7 
Unknown 38 2.7 17 2.3 3 1.1 7 1.8 12 2.8 54 2.5 131 2.4 
Optimum investigation* 439 31.1 274 37.1 141 50.9 224 58.9 250 57.3 1,189 54.9 2,517 46.5 
Post-mortem 339 24.0 222 30.1 128 46.2 168 44.2 207 47.5 1,007 46.5 2,071 38.3 
Karyotype 84 5.9 49 6.6 12 4.3 57 15.0 44 10.1 214 9.9 460 8.5 
Clinical examination/investigations confirm 
diagnosis 
25 1.8 16 2.2 4 1.4 12 3.2 9 2.1 51 2.4 117 2.2 
Partial investigations only# 607 43.0 349 47.3 113 40.8 134 35.3 140 32.1 746 34.5 2,089 38.6 
No investigation+ 319 22.6 99 13.4 21 7.6 15 3.9 34 7.8 176 8.1 664 12.3 
Unknown 48 3.4 16 2.2 2 0.7 7 1.8 12 2.8 54 2.5 139 2.6 
 
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality or clinical examination/investigation confirming diagnosis. Note: more than 1 option can be selected.
# No post-mortem; investigations may have included placental pathology, MRI, ultrasound scan or x-ray.
+ No post-mortem, placental pathology, MRI, ultrasound scan or x-ray.
MRI = magnetic resonance imaging.
Table 1.21: Perinatal related deaths and perinatal death investigations by ethnicity 2007–2014
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Just on half of the deaths of babies in the perinatal period in 2014 were optimally investigated. Of the remainder, 12 percent 
were not investigated and 38 percent were partially investigated (Table 1.51). There has been no significant change in the 
rate of optimal investigation from 2007 to 2014. However there has been a significant increase in the proportion of babies 
who have been partially investigated (Chi square test for linear trend p=0.02) and a significant decrease in the proportion of 
babies with no investigation after death from 2007-2014 (Chi square test for linear trend p=0.0004).
Māori and Pacific perinatal related deaths are less likely to be optimally investigated than deaths in all other ethnic groups. 
While more Māori and Pacific perinatal related deaths are partially investigated than other ethnicities, overall they are less 
likely to have any investigation (optimal or partial) than babies of other ethnicities (Table 1.21). 
There is no difference in the proportion of parents and whānau offered post-mortem by ethnicity but Māori and Pacific parents 
and whānau are less likely to give consent for post-mortem.  Requesting post-mortems from recently bereaved family may be 
challenging for some health professionals and this may be more so if the professional is aware that, for some Māori whānau, 
post-mortems are not an acceptable practice.  It is possible that this knowledge affects the way health professionals discuss 
this with whānau and this, in turn, may impact on consent rates for optimum and partial post-mortem investigation.  Talking 
with health professionals about their experience of discussing post-mortem investigations with families/ whānau would provide 
valuable information about this process, and whether there are differences in approaches across ethnic groups.  Similarly, 
talking with Māori whānau who have experienced a death and listening to their stories of being offered post-mortem might 
help to inform practice changes.
In 2014, data on the usefulness of post-mortem were available for 212 (83 percent) of cases where post-mortem was 
performed. These data showed that in 123 deaths (58 percent) the post-mortem confirmed the clinical diagnosis, in 32 (15 
percent) the post-mortem changed the diagnosis and resulted in altered counselling to parents for future pregnancies, in 35 
(17 percent) additional information was gained but this did not change the clinical diagnosis, and in 22 (10 percent) of 
deaths, the post-mortem was inconclusive. 
There are currently no data collected on the offer of partial post-mortem. Options for partial investigation are listed in the text 
box below.
Table 1.51 and 1.52 report the completeness of perinatal investigation and offer and decline of post-mortem for 2014.  
Perinatal death investigations 
If families and whānau decline post-mortem examination they should be counselled on the other options, which while not 
as helpful in finding a cause for perinatal death as post-mortem may still contribute valuable information. 
Other investigations include:
• placental pathology 
• external examination by a perinatal pathologist, geneticist or paediatrician
• clinical photographs
• full body X-ray or babygram
• magnetic resonance imaging (MRI)
• needle biopsy of a particular organ or tissue
• ultrasound of specific organs.
None of these investigations will provide information that is as accurate as that obtained by a post-mortem examination 
but they provide more information than no examination at all. 
The findings of significant placental pathology can explain the cause of death and provide critical information for 
management and counselling of any future pregnancies.
Further information to help families and whānau who are trying to decide whether or not to consent to a post-mortem 
can be found at:   http://www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-resources/publication/32/
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Maternal outcome
There were two maternal deaths associated with perinatal related deaths in 2014, including one death from obstetric 
haemorrhage and one from a pre-existing medical condition. Ten mothers whose babies died experienced serious morbidity 
in pregnancy, including pre-eclampsia, antepartum and postpartum haemorrhage, intracranial haemorrhage, obstetric sepsis, 
morbidity associated with pre-existing medical conditions, and injuries in a motor vehicle accident (Table 1.54). 
Contributory factors and potentially avoidable perinatal related death
In 2014, one-quarter of perinatal related deaths were determined at local review to have contributory factors, and 
approximately half of these (13 percent) were determined to be potentially avoidable deaths.
Table 1.57 lists all contributory factors by year of perinatal related death for 2009–2014. The following text box provides a 





Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=149 n=325 n=182 n=656 
n % n % n % n % 
Contributory factors                 
Present 16 10.7 101 31.1 51 28.0 168 25.6 
Absent 133 89.3 220 67.7 131 72.0 484 73.8 
Missing data - - 4 1.2 - - 4 0.6 
Potentially avoidable                 
Yes 4 2.7 55 16.9 28 15.4 87 13.3 
Contributory factors present but not potentially avoidable 12 8.1 46 14.2 23 12.6 81 12.3 
 
Table 1.22: Contributory factors and potentially avoidable perinatal related deaths 2014
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The most common main contributory factors to potentially avoidable perinatal related deaths are consistently access and/
or engagement with care factors, responsible for 8 to 12 percent of perinatal related deaths each year from 2011 to 2014. 
Personnel factors are the main contributory factor to avoidable perinatal related death in 5 to 6 percent of perinatal related 
deaths.
Contributory Factors for Mortality and Morbidity
Organisation/management factors
• Poor organisational arrangements of staff
• Inadequate education and training
• Lack of policies, protocols or guidelines
• Inadequate numbers of staff
• Poor access to senior clinical staff
• Failure or delay in emergency response
• Delay in procedure (eg, caesarean section)
• Inadequate systems/process for sharing of clinical information between services
• Delayed access to test results or inaccurate results
• Equipment (eg, faulty equipment, inadequate maintenance, inadequate quality or lack of equipment)
• Building and design functionality (eg, space, privacy, ease of access, lighting, noise, power failure, 
operating theatre in distant location)
Personnel factors
• Knowledge and skills of staff were lacking
• Delayed emergency response by staff
• Failure to maintain competence
• Failure of communication between staff
• Failure to seek help/supervision
• Failure to offer or follow recommended best practice
• Lack of recognition of complexity or seriousness of condition by care giver
Barriers to access and/or engagement with care
• No antenatal care
• Infrequent care or late booking
• Declined treatment or advice
• Obesity impacted on delivery of optimal care (eg, ultrasound scan)
• Substance use
• Family violence
• Lack of recognition of complexity or seriousness of condition
• Maternal mental illness
• Cultural barriers
• Language barriers
• Not eligible to access free care































































Perinatal death classification (PSANZ-PDC) 
Contributory factors and potentially avoidable Contributory factors BUT NOT or unknown if potentially avoidable No contributory factors Unknown
Figure 1.29 illustrates the proportion of perinatal related deaths which were assessed as having contributory factors and to be 
potentially avoidable in 2014. The bottom bar (blue) represents potentially avoidable deaths, the second bar (red) deaths with 
contributory factors not assessed as potentially avoidable, and the top bar (green) deaths without contributory factors.
The greatest proportion of potentially avoidable deaths were identified among deaths from perinatal infection (8) (33 percent), 
maternal conditions (17) (44 percent), hypoxic peripartum deaths (7) (41 percent), fetal growth restriction (14) (40 percent), and 
deaths without obstetric antecedent (5) (71 percent). 
As the number of deaths varies considerably by cause, the proportion of potentially avoidable deaths does not necessarily also 
represent the largest absolute number of potentially avoidable deaths. The largest numbers of potentially avoidable deaths were 
among deaths due to maternal conditions (17), fetal growth restriction (14), and unexplained antepartum deaths (13) (Table 1.58).
Figure 1.29: Contributory factors and potentially avoidable perinatal related deaths by perinatal death classification (PSANZ-
PDC) 2014
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Figure 1.30: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a percentage of all deaths in each 


















































Perinatal death classification (PSANZ-PDC) 
Organisation/management Personnel Barriers Specific contributory factor not identified
Figure 1.30 illustrates the main contributory factors in potentially avoidable perinatal related deaths by cause of death (PSANZ-PDC). 
If more than one main contributory factor was identified then the death is attributed to both contributory factors. 
For example, among 135 perinatal deaths from maternal conditions during 2011–2014, organisation and management factors were 
responsible for five deaths (4 percent), personnel for 15 (11 percent), and barriers to access and/or engagement with care for 49 (36 
percent). In two potentially avoidable deaths no main contributory factor was specified (Table 1.58).
The proportion of potentially avoidable perinatal related deaths was higher among babies of Māori and Pacific mothers, at 22 
percent, than all other ethnicities (Figure 1.31). This is due to an excess of barriers to access and/or engagement with care 
among potentially avoidable deaths, which were responsible for 17 and 19 percent of perinatal related deaths in these ethnic 
groups (Figure 1.32).  
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Figure 1.31: Contributory factors and potentially avoidable perinatal related deaths by maternal prioritised ethnicity (95% CIs 
surround the estimate of the proportion of cases within each ethnicity where death was potentially avoidable) 2009–2014
 
Figure 1.32: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a percentage of all deaths) by 
























Maternal ethnicity (prioritised) 
Organisation/management Personnel Barriers Specific contributory factor not identified
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Figure 1.34: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a percentage of all deaths) by 





























Organisation/management Personnel Barriers Specific contributory factor not identified
The proportion of potentially avoidable perinatal related deaths increases with increasing socioeconomic deprivation, due to 
increasing contribution from barriers to access and/or engagement with care. (Tables 1.62 and 1.63)
Figure 1.33: Contributory factors and potentially avoidable perinatal related deaths by deprivation quintile 2009–2014
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2007 2008 2009 2010 2011 2012 2013 2014 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Total births 65,050   65,303   63,153   64,574   62,078   61,892   59,552   58,097   
Fetal deaths (terminations of pregnancy and stillbirths)* 212 3.26 207 3.17 231 3.66 199 3.08 191 3.08 166 2.79 155 2.60 161 2.70 
Terminations of pregnancy 6 0.09 14 0.21 9 0.14 17 0.26 24 0.39 13 0.22 12 0.20 13 0.22 
Stillbirths 206 3.17 193 2.96 222 3.52 182 2.82 167 2.69 153 2.57 143 2.40 148 2.49 
Early neonatal deaths <7 days 57   67   59   68   64   54   45   59   
Late neonatal deaths 7–27 days 28   35   30   31   18   24   24   23   
Neonatal deaths <28 days# 85 1.31 102 1.56 89 1.41 99 1.53 82 1.32 78 1.31 69 1.16 82 1.38 
Perinatal mortalities+ 269 4.14 274 4.20 290 4.59 267 4.13 255 4.11 220 3.69 200 3.36 220 3.69 
Perinatal related mortalities^ 297 4.57 309 4.73 320 5.07 298 4.61 273 4.40 244 4.10 224 3.76 243 4.08 
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 224 3.44 220 3.37 238 3.77 204 3.16 179 2.88 169 2.84 159 2.67 167 2.80 
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
238 3.66 240 3.68 254 4.02 221 3.42 188 3.03 179 3.01 171 2.87 177 2.97 
 
Table 1.23: New Zealand perinatal mortality rates (per 1000 births) using the international definition 2007–2014
* Fetal death rate per 1000 babies born (includes terminations and stillbirths).
# Neonatal death rate per 1000 liveborn babies.
+ Fetal deaths and early neonatal deaths per 1000 babies born.
^ Fetal deaths and early and late neonatal deaths per 1000 babies born.




Perinatal death classification 
(PSANZ-PDC)  




n=65,602 n=65,872 n=63,665 n=65,124 n=62,604 n=62,425 n=60,039 n=58,647   
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n % 
Congenital abnormality 197 3.00 185 2.81 182 2.86 211 3.24 203 3.24 201 3.22 158 2.63 188 3.21 1,525 28.2 0.55 
Perinatal infection 29 0.44 28 0.43 25 0.39 28 0.43 21 0.34 19 0.30 20 0.33 24 0.41 194 3.6 0.29 
Hypertension 19 0.29 22 0.33 29 0.46 27 0.41 21 0.34 18 0.29 13 0.22 13 0.22 162 3.0 0.088 
Antepartum haemorrhage 63 0.96 66 1.00 79 1.24 78 1.20 78 1.25 60 0.96 74 1.23 69 1.18 567 10.5 0.27 
Maternal conditions 27 0.41 23 0.35 38 0.60 32 0.49 26 0.42 36 0.58 34 0.57 39 0.66 255 4.7 0.020 
Specific perinatal conditions 57 0.87 71 1.08 76 1.19 69 1.06 73 1.17 70 1.12 63 1.05 69 1.18 548 10.1 0.26 
Hypoxic peripartum death 33 0.50 34 0.52 28 0.44 20 0.31 20 0.32 20 0.32 11 0.18 17 0.29 183 3.4 0.00035 
Fetal growth restriction 46 0.70 62 0.94 53 0.83 48 0.74 44 0.70 49 0.78 48 0.80 35 0.60 385 7.1 0.27 
Spontaneous preterm  98 1.49 94 1.43 110 1.73 113 1.74 84 1.34 102 1.63 81 1.35 105 1.79 787 14.5 0.63 
Unexplained antepartum death 100 1.52 102 1.55 103 1.62 71 1.09 92 1.47 86 1.38 91 1.52 90 1.53 735 13.6 0.79 
No obstetric antecedent 11 0.17 14 0.21 7 0.11 10 0.15 4 0.06 9 0.14 6 0.10 7 0.12 68 1.3 0.13 
 












 n=65,050   n=65,303   n=63,153   n=64,574   n=62,078   n=61,892   n=59,552   n=58,097  
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Perinatal death classification (PSANZ-
PDC) 
                                
Congenital abnormality 58 0.89 69 1.06 64 1.01 77 1.19 85 1.37 64 1.03 50 0.84 64 1.10 0.68 
Perinatal infection 16 0.25 16 0.25 15 0.24 13 0.20 12 0.19 9 0.15 9 0.15 12 0.21 0.16 
Hypertension 7 0.11 7 0.11 14 0.22 11 0.17 9 0.14 3 0.05 5 0.08 6 0.10 0.25 
Antepartum haemorrhage 23 0.35 25 0.38 24 0.38 23 0.36 17 0.27 13 0.21 18 0.30 11 0.19 0.019 
Maternal conditions 14 0.22 9 0.14 19 0.30 19 0.29 7 0.11 17 0.27 22 0.37 14 0.24 0.18 
Specific perinatal conditions 29 0.45 23 0.35 32 0.51 30 0.46 32 0.52 21 0.34 24 0.40 25 0.43 0.79 
Hypoxic peripartum death 33 0.51 34 0.52 28 0.44 20 0.31 20 0.32 20 0.32 11 0.18 17 0.29 0.00035 
Fetal growth restriction 29 0.45 32 0.49 31 0.49 31 0.48 18 0.29 32 0.52 21 0.35 19 0.33 0.14 
Spontaneous preterm  9 0.14 7 0.11 10 0.16 19 0.29 8 0.13 10 0.16 5 0.08 9 0.15 0.84 
Unexplained antepartum death 68 1.05 73 1.12 75 1.19 45 0.70 61 0.98 46 0.74 53 0.89 59 1.02 0.12 








Neonatal death classification 
(PSANZ-NDC) 
2007 2008 2009 2010 2011 2012 2013 2014 
n=65,602 n=65,872 n=63,665 n=65,124 n=62,604 n=62,425 n=60,039 n=58,647 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Congenital abnormality 38 0.58 43 0.66 43 0.68 46 0.71 50 0.81 38 0.61 32 0.54 44 0.76 
Extreme prematurity 57 0.88 52 0.80 58 0.92 84 1.30 54 0.87 68 1.10 63 1.06 69 1.19 
Cardio-respiratory disorders 11 0.17 11 0.17 11 0.17 18 0.28 11 0.18 14 0.23 6 0.10 16 0.28 
Infection 14 0.22 21 0.32 12 0.19 19 0.29 15 0.24 16 0.26 12 0.20 15 0.26 
Neurological 31 0.48 33 0.50 40 0.63 28 0.43 23 0.37 25 0.40 25 0.42 24 0.41 
Gastrointestinal 2 0.03 0 0.00 8 0.13 5 0.08 2 0.03 3 0.05 1 0.02 3 0.05 
Other 14 0.22 17 0.26 11 0.17 10 0.15 8 0.13 14 0.23 14 0.23 11 0.19 
 
Table 1.25: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rate using international definition (≥1000g or ≥28 weeks if birthweight unknown) 2007–2014





    Fetal deaths 
Neonatal deaths Perinatal related deaths 
Total births Termination of pregnancy Stillbirths 
n=58,647 n=149 n=325 n=182 n=656 
n % n % Rate n % Rate n % Rate n % Rate 
Male 30,329 51.3 85 57.0 2.80 176 54.2 5.80 96 52.7 3.19 357 54.4 11.77 
Female 28,318 48.7 60 40.3 2.12 145 44.6 5.12 86 47.3 3.06 291 44.4 10.28 
Unknown - - 4 2.7 - 4 1.2 - - - - 8 1.2 - 










n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate 
<20 42 5,091 8.25 70 5,365 13.05 61 4,764 12.80 42 4,624 9.08 44 4,093 10.75 46 3,914 11.75 56 3,436 16.30 36 3,040 11.84 0.074 
20–24 106 11,506 9.21 101 11,892 8.49 117 11,764 9.95 115 12,116 9.49 87 11,674 7.45 95 11,596 8.19 88 11,024 7.98 85 10,289 8.26 0.14 
25–29 124 15,931 7.78 114 16,020 7.12 126 15,609 8.07 115 16,231 7.09 106 15,736 6.74 109 15,937 6.84 105 15,573 6.74 117 15,607 7.50 0.37 
30–34 110 18,838 5.84 120 18,150 6.61 125 17,560 7.12 110 17,978 6.12 105 17,464 6.01 118 17,742 6.65 101 17,069 5.92 131 17,480 7.49 0.38 
35–39 81 11,794 6.87 89 11,997 7.42 97 11,472 8.46 91 11,502 7.91 96 11,049 8.69 68 10,540 6.45 57 10,291 5.54 74 9,705 7.62 0.41 
≥40 19 2,440 7.79 22 2,447 8.99 20 2,495 8.02 23 2,673 8.60 23 2,588 8.89 31 2,696 11.50 30 2,646 11.34 21 2,526 8.31 0.28 
Unknown - 2 - - 1 - - 1 - - - - - - - - - - - - - 1 - - - 
 
Table 1.27: Perinatal related mortality rates (per 1000 births) by gender 2014





2007 2008 2009 2010 2011 2012 2013 2014 Chi-
squared 
test for 
trend (p) n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate 
Māori 145 15,384 9.43 147 15,530 9.47 168 14,646 11.47 158 14,877 10.62 129 14,244 9.06 121 14,143 8.56 119 13,488 8.82 134 12,942 10.35 0.51 
Pacific peoples 67 6,774 9.89 80 6,987 11.45 87 6,823 12.75 73 6,999 10.43 56 6,832 8.20 76 6,631 11.46 69 6,161 11.20 68 5,878 11.57 0.83 
Indian 16 2,131 7.51 20 2,263 8.84 22 2,190 10.05 28 2,378 11.77 26 2,338 11.12 25 2,459 10.17 29 2,705 10.72 29 2,777 10.44 0.30 
Other Asian 15 4,264 3.52 30 4,394 6.83 23 4,590 5.01 31 5,088 6.09 30 5,231 5.74 32 6,199 5.16 21 6,002 3.50 29 6,493 4.47 0.33 
Other (including 
unknown) 
35 5,768 6.07 37 5,835 6.34 44 5,732 7.68 30 6,032 4.97 45 5,576 8.07 40 5,317 7.52 34 5,454 6.23 29 5,431 5.34 0.85 

















n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate 
1 (least deprived) 50 10,813 4.62 57 10,431 5.46 52 10,177 5.11 51 10,304 4.95 77 9,904 7.77 47 9,767 4.81 44 9,183 4.79 57 9,317 6.12 0.32 
2 61 11,610 5.25 79 11,580 6.82 76 11,225 6.77 77 11,485 6.70 82 11,125 7.37 82 10,928 7.50 51 10,651 4.79 65 10,283 6.32 0.93 
3 80 12,063 6.63 87 12,192 7.14 90 12,088 7.45 85 12,311 6.90 75 11,969 6.27 73 12,093 6.04 99 11,777 8.41 81 11,366 7.13 0.63 
4 112 13,395 8.36 104 13,768 7.55 127 13,342 9.52 98 13,797 7.10 97 13,174 7.36 84 13,241 6.34 83 12,366 6.71 105 12,262 8.56 0.21 
5 (most deprived) 172 17,245 9.97 184 17,554 10.48 185 16,530 11.19 176 16,862 10.44 127 16,182 7.85 176 16,184 10.87 153 15,830 9.67 153 15,141 10.11 0.50 
Unknown 7 476 - 5 347 - 16 303 - 9 365 - 3 250 - 5 212 - 7 232 - 4 278 - - 
 
Table 1.29: Perinatal related mortality rate (per 1000 births) by maternal prioritised ethnicity excluding congenital abnormalities 2007–2014
Table 1.30: Perinatal related mortality rate (per 1000 births) by deprivation quintile excluding congenital abnormalities 2007–2014







Neonatal deaths Total perinatal related deaths 
Termination of pregnancy Stillbirths 
n=503,978 n=1,209 n=2,787 n=1,413 n=5,409 
n % n % Rate n % Rate n % Rate n % Rate 
Maternal age (years)                           
<20 34,327 6.8 92 7.6 2.68 260 9.3 7.57 171 12.1 5.03 523 9.7 15.24 
20–24 91,861 18.2 192 15.9 2.09 562 20.2 6.12 298 21.1 3.27 1,052 19.4 11.45 
25–29 126,644 25.1 269 22.2 2.12 629 22.6 4.97 347 24.6 2.76 1,245 23.0 9.83 
30–34 142,281 28.2 316 26.1 2.22 683 24.5 4.80 293 20.7 2.07 1,292 23.9 9.08 
35–39 88,350 17.5 256 21.2 2.90 495 17.8 5.60 236 16.7 2.69 987 18.2 11.17 
≥40 20,511 4.1 84 6.9 4.10 156 5.6 7.61 67 4.7 3.31 307 5.7 14.97 
Unknown 4 0.0 - - - 2 0.1 - 1 0.1 - 3 0.1 - 
 
Table 1.32: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding termination of 




Perinatal death classification 
(PSANZ-PDC) 
Maternal age (years) 
<20 20–24 25–34 35–39 ≥40 
n=34,327 n=91,861 n=268,925 n=88,350 n=20,511 
n % Rate n % Rate n % Rate n % Rate n % Rate 
Congenital abnormality* 57 13.2 1.66 108 12.6 1.18 235 12.0 0.87 117 16.0 1.32 54 24.2 2.63 
Perinatal infection 26 6.0 0.76 35 4.1 0.38 89 4.6 0.33 23 3.1 0.26 6 2.7 0.29 
Hypertension 3 0.7 0.09 31 3.6 0.34 66 3.4 0.25 26 3.6 0.29 9 4.0 0.44 
Antepartum haemorrhage 58 13.5 1.69 114 13.3 1.24 257 13.2 0.96 86 11.8 0.97 19 8.5 0.93 
Maternal conditions 11 2.6 0.32 41 4.8 0.45 91 4.7 0.34 40 5.5 0.45 16 7.2 0.78 
Specific perinatal condition 34 7.9 0.99 69 8.0 0.75 259 13.3 0.96 100 13.7 1.13 33 14.8 1.61 
Hypoxic peripartum death 17 3.9 0.50 38 4.4 0.41 93 4.8 0.35 29 4.0 0.33 6 2.7 0.29 
Fetal growth restriction 40 9.3 1.17 76 8.8 0.83 174 8.9 0.65 58 7.9 0.66 14 6.3 0.68 
Spontaneous preterm# 117 27.1 3.41 164 19.1 1.79 317 16.2 1.18 109 14.9 1.23 29 13.0 1.41 
Unexplained antepartum death 55 12.8 1.60 166 19.3 1.81 342 17.5 1.27 136 18.6 1.54 36 16.1 1.76 
No obstetric antecedent 13 3.0 0.38 18 2.1 0.20 29 1.5 0.11 7 1.0 0.08 1 0.4 0.05 
 
Table 1.31: Perinatal related mortality rates (per 1000 births) by maternal age 2007–2014
* Excludes two maternal age missing.








Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=503,978 n=1,209 n=2,787 n=1,413 n=5,409 
n % n % Rate n % Rate n % Rate n % Rate 
Ethnicity (mother)                             
Māori 115,254 22.9 188 15.6 1.63 764 27.4 6.63 461 32.6 4.03 1,413 26.1 12.26 
Pacific peoples 53,085 10.5 98 8.1 1.85 419 15.0 7.89 221 15.6 4.20 738 13.6 13.90 
Indian 19,241 3.8 77 6.4 4.00 130 4.7 6.76 70 5.0 3.68 277 5.1 14.40 
Other Asian 42,261 8.4 148 12.2 3.50 153 5.5 3.62 79 5.6 1.88 380 7.0 8.99 
Other (including unknown) 45,145 9.0 122 10.1 2.70 224 8.0 4.96 90 6.4 2.01 436 8.1 9.66 
NZ European 228,992 45.4 576 47.6 2.52 1,097 39.4 4.79 492 34.8 2.16 2,165 40.0 9.45 
Ethnicity (baby)                             
Māori 146,703 29.1 267 22.1 1.82 925 33.2 6.31 514 36.4 3.53 1,706 31.5 11.63 
Pacific peoples 55,729 11.1 100 8.3 1.79 419 15.0 7.52 225 15.9 4.08 744 13.8 13.35 
Indian 20,219 4.0 80 6.6 3.96 132 4.7 6.53 72 5.1 3.60 284 5.3 14.05 
Other Asian 41,543 8.2 145 12.0 3.49 158 5.7 3.80 76 5.4 1.84 379 7.0 9.12 
Other (including unknown) 30,875 6.1 72 6.0 2.33 171 6.1 5.54 59 4.2 1.93 302 5.6 9.78 










Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=58,647 n=149 n=325 n=182 n=656 
n % n % Rate n % Rate n % Rate n % Rate 
Ethnicity (baby)                             
Māori 16,567 28.2 27 18.1 1.63 101 31.1 6.10 61 33.5 3.71 189 28.8 11.41 
Pacific peoples 6,231 11.5 7 4.7 1.12 46 14.2 7.38 28 15.4 4.53 81 12.3 13.00 
Indian 2,951 3.9 13 8.7 4.41 19 5.8 6.44 15 8.2 5.14 47 7.2 15.93 
Other Asian 6,418 8.2 19 12.8 2.96 21 6.5 3.27 12 6.6 1.88 52 7.9 8.10 
Other (including unknown) 3,704 6.1 9 6.0 2.43 20 6.2 5.40 8 4.4 2.18 37 5.6 9.99 
NZ European 22,776 41.3 74 49.7 3.25 118 36.3 5.18 58 31.9 2.57 250 38.1 10.98 
 
Table 1.34: Perinatal related mortality rates (per 1000 births) by maternal and baby prioritised ethnicity 2007–2014
Table 1.33: Perinatal related mortality rates (per 1000 births) by baby prioritised ethnicity 2014







Perinatal death classification 
(PSANZ-PDC) 
Māori Pacific peoples Indian Other Asian Other 
(including unknown) 
NZ European 
n=115,254 n=53,085 n=19,241 n=42,261 n=45,145 n=228,992 
n % Rate n % Rate n % Rate n % Rate n % Rate n % Rate 
Congenital abnormality 146 11.9 1.27 91 14.2 1.71 20 10.0 1.04 43 18.5 1.02 47 15.0 1.04 226 14.2 0.99 
Perinatal infection 49 4.0 0.43 30 4.7 0.57 7 3.5 0.36 11 4.7 0.26 19 6.1 0.42 63 4.0 0.28 
Hypertension 35 2.9 0.30 29 4.5 0.55 8 4.0 0.42 7 3.0 0.17 7 2.2 0.16 49 3.1 0.21 
Antepartum haemorrhage 171 14.0 1.48 77 12.0 1.45 26 13.0 1.35 30 12.9 0.71 31 9.9 0.69 199 12.5 0.87 
Maternal conditions 61 5.0 0.53 53 8.3 1.00 12 6.0 0.62 7 3.0 0.17 10 3.2 0.22 56 3.5 0.24 
Specific perinatal conditions 109 8.9 0.95 62 9.7 1.17 31 15.5 1.61 31 13.4 0.73 46 14.6 1.02 216 13.6 0.94 
Hypoxic peripartum death 49 4.0 0.43 18 2.8 0.34 7 3.5 0.36 6 2.6 0.14 20 6.4 0.44 83 5.2 0.36 
Fetal growth restriction 88 7.2 0.76 47 7.3 0.89 25 12.5 1.30 23 9.9 0.54 28 8.9 0.62 151 9.5 0.66 
Spontaneous preterm  281 22.9 2.44 114 17.8 2.15 38 19.0 1.97 33 14.2 0.78 47 15.0 1.04 224 14.1 0.98 
Unexplained antepartum death 200 16.3 1.74 106 16.6 2.00 25 12.5 1.30 40 17.2 0.95 59 18.8 1.31 305 19.2 1.33 
No obstetric antecedent 36 2.9 0.31 13 2.0 0.24 1 0.5 0.05 1 0.4 0.02 - - - 17 1.1 0.07 
 
Table 1.35: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding termination of 
pregnancy) by maternal prioritised ethnicity 2007–2014
Table 1.36: Distribution of births by deprivation decile (NZDep2013) 2014  
 
  
   
  
 
NZ Deprivation Index (NZDep 2013) 
Total births 
n=58,647 
n  % 
1 (least deprived) 4,333 7.4 
2 4,984 8.5 
3 5,133 8.8 
4 5,150 8.8 
5 5,597 9.5 
6 5,769 9.8 
7 5,866 10.0 
8 6,396 10.9 
9 6,883 11.7 
10 (most deprived) 8,258 14.1 









Deprivation quintile  
Total births 
Fetal deaths 
Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=503,978 n=1,209 n=2,787 n=1,413 n=5,409 
n % n % Rate n % Rate n % Rate n % Rate 
1 (least deprived) 79,896 15.9 230 19.0 2.88 323 11.6 4.04 145 10.3 1.83 698 12.9 8.74 
2 88,887 17.6 232 19.2 2.61 406 14.6 4.57 183 13.0 2.07 821 15.2 9.24 
3 95,859 19.0 245 20.3 2.56 484 17.4 5.05 234 16.6 2.46 963 17.8 10.05 
4 105,345 20.9 249 20.6 2.36 587 21.1 5.57 302 21.4 2.89 1,138 21.0 10.80 
5  (most deprived) 131,528 26.1 242 20.0 1.84 948 34.0 7.21 530 37.5 4.07 1,720 31.8 13.08 







Perinatal death classification 
(PSANZ-PDC) 
Quintile 1 (least deprived) Quintile 2 Quintile 3 Quintile 4 Quintile 5 (most deprived) 
n=79,896 n=88,887 n=95,859 n=105,345 n=131,528 
n % Rate n % Rate n % Rate n % Rate n % Rate 
Congenital abnormality 76 16.2 0.95 64 10.9 0.72 98 13.6 1.02 130 14.6 1.23 200 13.5 1.52 
Perinatal infection 20 4.3 0.25 27 4.6 0.30 39 5.4 0.41 31 3.5 0.29 61 4.1 0.46 
Hypertension 9 1.9 0.11 13 2.2 0.15 26 3.6 0.27 32 3.6 0.30 52 3.5 0.40 
Antepartum haemorrhage 48 10.3 0.60 77 13.1 0.87 80 11.1 0.83 112 12.6 1.06 210 14.2 1.60 
Maternal conditions 16 3.4 0.20 12 2.0 0.14 24 3.3 0.25 40 4.5 0.38 105 7.1 0.80 
Specific perinatal condition 72 15.4 0.90 80 13.6 0.90 106 14.8 1.11 100 11.2 0.95 131 8.9 1.00 
Hypoxic peripartum death 15 3.2 0.19 34 5.8 0.38 33 4.6 0.34 44 4.9 0.42 53 3.6 0.40 
Fetal growth restriction 49 10.5 0.61 49 8.3 0.55 67 9.3 0.70 75 8.4 0.71 120 8.1 0.91 
Spontaneous preterm 63 13.5 0.79 101 17.1 1.14 108 15.0 1.13 163 18.3 1.55 284 19.2 2.16 
Unexplained antepartum 
death 
95 20.3 1.19 122 20.7 1.37 127 17.7 1.32 148 16.6 1.40 234 15.8 1.78 
No obstetric antecedent 5 1.1 0.06 10 1.7 0.11 10 1.4 0.10 14 1.6 0.13 28 1.9 0.21 
 
Table 1.38: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1000 births) (excluding 
termination of pregnancy) by deprivation quintile 2007–2014
Table 1.37: Perinatal related deaths by deprivation quintile 2007–2014






n % n % Rate n % Rate n % Rate n % Rate
Northland 2,149 3.7 6 4.0 2.79 14 4.3 6.51 6 3.3 2.82 26 4.0 12.10
Waitemata 7,768 13.2 30 20.1 3.86 30 9.2 3.86 20 11.0 2.59 80 12.2 10.30
Auckland 6,114 10.4 24 16.1 3.93 18 5.5 2.94 20 11.0 3.29 62 9.5 10.14
Counties Manukau 8,144 13.9 17 11.4 2.09 69 21.2 8.47 30 16.5 3.72 116 17.7 14.24
Waikato 5,270 9.0 10 6.7 1.90 36 11.1 6.83 22 12.1 4.21 68 10.4 12.90
Bay of Plenty 2,707 4.6 8 5.4 2.96 23 7.1 8.50 13 7.1 4.86 44 6.7 16.25
Lakes 1,375 2.3 7 4.7 5.09 8 2.5 5.82 6 3.3 4.41 21 3.2 15.27
Tairawhiti 673 1.1 1 0.7 1.49 2 0.6 2.97 2 1.1 2.99 5 0.8 7.43
Taranaki 1,539 2.6 2 1.3 1.30 7 2.2 4.55 7 3.8 4.58 16 2.4 10.40
Hawke's Bay 2,114 3.6 5 3.4 2.37 12 3.7 5.68 4 2.2 1.91 21 3.2 9.93
Whanganui 799 1.4 - - - 2 0.6 2.50 3 1.6 3.76 5 0.8 6.26
MidCentral 2,100 3.6 3 2.0 1.43 8 2.5 3.81 1 0.5 0.48 12 1.8 5.71
Wairarapa 495 0.8 - - - 2 0.6 4.04 1 0.5 2.03 3 0.5 6.06
Capital & Coast 3,571 6.1 1 0.7 0.28 12 3.7 3.36 10 5.5 2.81 23 3.5 6.44
Hutt Valley 1,827 3.1 5 3.4 2.74 15 4.6 8.21 2 1.1 1.11 22 3.4 12.04
Nelson Marlborough 1,463 2.5 2 1.3 1.37 8 2.5 5.47 6 3.3 4.13 16 2.4 10.94
West Coast 382 0.7 - - - 1 0.3 2.62 2 1.1 5.25 3 0.5 7.85
Canterbury 6,033 10.3 20 13.4 3.32 34 10.5 5.64 15 8.2 2.51 69 10.5 11.44
South Canterbury 626 1.1 1 0.7 1.60 2 0.6 3.19 0 0.0 0.00 3 0.5 4.79
Southern 3,284 5.6 5 3.4 1.52 22 6.8 6.70 11 6.0 3.38 38 5.8 11.57
Other* 214 0.4 2 1.3 - - - - 1 0.5 - 3 0.5 -
n=182 n=656




Neonatal deaths Perinatal related deaths
Termination of pregnancy Stillbirths
n=58,647 n=149 n=325
Table 1.39: Perinatal related mortality rates (per 1000 births) by DHB of maternal residence 2014






n % n % Rate n % Rate n % Rate n % Rate
Northland 18,531 3.7 37 3.1 2.00 127 4.6 6.85 67 4.7 3.65 231 4.3 12.47 
Waitemata 63,269 12.6 206 17.0 3.26 309 11.1 4.88 121 8.6 1.93 636 11.8 10.05 
Auckland 52,509 10.4 191 15.8 3.64 254 9.1 4.84 134 9.5 2.57 579 10.7 11.03 
Counties Manukau 69,778 13.8 167 13.8 2.39 496 17.8 7.11 269 19.0 3.89 932 17.2 13.36 
Waikato 44,415 8.8 98 8.1 2.21 242 8.7 5.45 151 10.7 3.43 491 9.1 11.05 
Bay of Plenty 23,555 4.7 41 3.4 1.74 117 4.2 4.97 91 6.4 3.89 249 4.6 10.57 
Lakes 12,735 2.5 30 2.5 2.36 79 2.8 6.20 48 3.4 3.80 157 2.9 12.33 
Tairawhiti 6,140 1.2 9 0.7 1.47 29 1.0 4.72 21 1.5 3.44 59 1.1 9.61 
Taranaki 12,707 2.5 17 1.4 1.34 74 2.7 5.82 36 2.5 2.85 127 2.3 9.99 
Hawke's Bay 18,520 3.7 43 3.6 2.32 102 3.7 5.51 52 3.7 2.83 197 3.6 10.64 
Whanganui 7,085 1.4 16 1.3 2.26 46 1.7 6.49 18 1.3 2.56 80 1.5 11.29 
MidCentral 18,289 3.6 53 4.4 2.90 98 3.5 5.36 51 3.6 2.81 202 3.7 11.04 
Wairarapa 4,248 0.8 9 0.7 2.12 29 1.0 6.83 10 0.7 2.38 48 0.9 11.30 
Capital & Coast 31,264 6.2 62 5.1 1.98 136 4.9 4.35 58 4.1 1.87 256 4.7 8.19 
Hutt Valley 16,798 3.3 39 3.2 2.32 98 3.5 5.83 38 2.7 2.28 175 3.2 10.42 
Nelson Marlborough 13,125 2.6 23 1.9 1.75 59 2.1 4.50 33 2.3 2.53 115 2.1 8.76 
West Coast 3,370 0.7 5 0.4 1.48 17 0.6 5.04 16 1.1 4.78 38 0.7 11.28 
Canterbury 51,156 10.2 104 8.6 2.03 283 10.2 5.53 122 8.6 2.40 509 9.4 9.95 
South Canterbury 5,097 1.0 9 0.7 1.77 26 0.9 5.10 15 1.1 2.96 50 0.9 9.81 
Southern 29,247 5.8 48 4.0 1.64 160 5.7 5.47 57 4.0 1.96 265 4.9 9.06 
Other* 2,140 0.4 2 0.2 - 6 0.2 - 5 0.4 - 13 0.2 -
n=1,413 n=5,409




Neonatal deaths Perinatal related deaths
Termination of pregnancy Stillbirths
n=503,978 n=1,209 n=2,787
Table 1.40: Perinatal related mortality rates (per 1000 births) by DHB of maternal residence 2007–2014
* Other includes Overseas, Unknown and Other.
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Figure 1.35: Crude stillbirth rate (per 1000 births) by DHB of residence (mother) compared to New Zealand stillbirth rate (with 
95% CIs) 2007–2014
Figure 1.36: Crude neonatal death rate (per 1000 live births) by DHB of residence (mother) compared to New Zealand neonatal 
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Table 1.41: Perinatal related mortality risk (per 1000 ongoing pregnancies) 2007–2014  
 
   
  2007 2008 2009 2010 2011 2012 2013 2014 Chi-
squared 
test for 

























Gestation at birth (weeks)                                               
20–22 200 217 3.31 234 218 3.31 151 216 3.39 195 247 3.79 208 235 3.75 207 247 3.96 179 216 3.60 207 251 4.28 0.002 
23–24 106 81 1.24 130 98 1.49 117 105 1.65 117 81 1.25 110 95 1.52 98 94 1.51 116 85 1.42 136 98 1.68 0.20 
25–27 244 64 0.98 231 62 0.95 213 70 1.10 234 73 1.13 187 52 0.83 209 70 1.13 196 55 0.92 183 49 0.84 0.44 
28–31 539 58 0.89 574 65 1.00 527 66 1.04 551 52 0.81 521 58 0.93 519 50 0.81 472 49 0.82 457 46 0.79 0.17 
32–36 3,912 88 1.36 4,075 80 1.24 3,930 90 1.44 4,116 101 1.58 3,938 86 1.40 3,992 73 1.19 3,771 91 1.54 3,661 84 1.46 0.53 
37–40 47,925 137 2.26 48,492 141 2.33 46,950 150 2.55 47,992 127 2.12 46,578 123 2.13 46,680 116 2.02 45,508 89 1.61 44,826 116 2.15 0.017 
≥41 12,625 34 2.68 12,090 37 3.05 11,721 32 2.72 11,890 26 2.18 11,039 17 1.54 10,700 20 1.87 9,775 14 1.43 9,157 12 1.31 0.00028 
Unknown 51 1 - 46 - - 56 1 - 29 - - 23 - - 20 - - 22 - - 20 - - - 
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20–22 200 103 1.57 234 94 1.43 151 88 1.38 195 92 1.41 208 107 1.71 207 118 1.89 179 81 1.35 207 90 1.53 0.54
23–24 106 22 0.34 130 25 0.38 117 31 0.49 117 20 0.31 110 29 0.46 98 32 0.51 116 32 0.53 136 31 0.53 0.030
25–27 244 10 0.15 231 14 0.21 213 9 0.14 234 20 0.31 187 15 0.24 209 14 0.23 196 16 0.27 183 10 0.17 0.42
28–31 539 6 0.09 574 7 0.11 527 4 0.06 551 6 0.09 521 11 0.18 519 5 0.08 472 5 0.08 457 7 0.12 0.68
≥32 64,462 3 0.05 64,657 5 0.08 62,601 6 0.10 63,998 13 0.20 61,555 9 0.15 61,372 3 0.05 59,054 5 0.08 57,644 11 0.19 0.12
Unknown 51 - - 46 - - 56 - - 29 - - 23 - - 20 - - 22 - - 20 - - -
Stillbirths
20–22 200 79 1.20 234 95 1.44 151 88 1.38 195 93 1.43 208 90 1.44 207 85 1.36 179 89 1.48 207 109 1.86 0.019
23–24 106 25 0.38 130 40 0.61 117 43 0.68 117 31 0.48 110 37 0.59 98 28 0.45 116 29 0.48 136 28 0.48 0.69
25–27 244 39 0.60 231 34 0.52 213 39 0.62 234 32 0.49 187 24 0.39 209 36 0.58 196 25 0.42 183 25 0.43 0.11
28–31 539 43 0.66 574 38 0.58 527 48 0.76 551 32 0.50 521 34 0.55 519 30 0.48 472 32 0.54 457 31 0.53 0.13
32–36 3,912 64 0.99 4,075 54 0.83 3,930 60 0.96 4,116 66 1.03 3,938 55 0.89 3,992 54 0.88 3,771 63 1.07 3,661 57 0.99 0.65
37–40 47,925 98 1.62 48,492 99 1.63 46,950 111 1.89 47,992 78 1.30 46,578 83 1.44 46,680 78 1.36 45,508 60 1.08 44,826 72 1.33 0.0028
≥41 12,625 20 1.58 12,090 19 1.57 11,721 19 1.61 11,890 14 1.17 11,039 9 0.81 10,700 9 0.84 9,775 9 0.92 9,157 3 0.33 0.00054
Unknown 51 1 - 46 - - 56 1 - 29 - - 23 - - 20 - - 22 - - 20 - - -
Neonatal deaths
20–22 200 35 0.53 234 29 0.44 151 40 0.63 195 62 0.95 208 38 0.61 207 44 0.70 179 46 0.77 207 52 0.89 0.0032
23–24 106 34 0.52 130 33 0.50 117 31 0.49 117 30 0.46 110 29 0.46 98 34 0.55 116 24 0.40 136 39 0.67 0.58
25–27 244 15 0.23 231 14 0.21 213 22 0.35 234 21 0.32 187 13 0.21 209 20 0.32 196 14 0.23 183 14 0.24 0.98
28–31 539 9 0.14 574 20 0.31 527 14 0.22 551 14 0.22 521 13 0.21 519 15 0.24 472 12 0.20 457 8 0.14 0.56
32–36 3,912 21 0.33 4,075 21 0.32 3,930 25 0.40 4,116 26 0.41 3,938 23 0.37 3,992 16 0.26 3,771 24 0.41 3,661 22 0.38 0.72
37–40 47,925 39 0.64 48,492 42 0.69 46,950 38 0.65 47,992 45 0.75 46,578 39 0.68 46,680 38 0.66 45,508 28 0.51 44,826 38 0.70 0.70
≥41 12,625 14 1.10 12,090 18 1.48 11,721 13 1.10 11,890 12 1.01 11,039 8 0.72 10,700 11 1.03 9,775 5 0.51 9,157 9 0.98 0.11
Unknown 51 - - 46 - - 56 - - 29 - - 23 - - 20 - - 22 - - 20 - - -
Gestation at 
birth (weeks)




 n=65,602  n=65,872  n=63,665  n=65,124  n=62,604  n=62,425 
2011
 n=60,039  n=58,647 
2012 2013 2014








Perinatal death classification          
(PSANZ-PDC) 
Total 
20–22 23–27 28–31 32–36 37–40 ≥41 weeks 
n % n % n % n % n % n % 
Congenital abnormality 1,199 690 57.5 284 23.7 72 6.0 84 7.0 57 4.8 12 1.0 
Perinatal infection 125 36 28.8 25 20.0 12 9.6 14 11.2 29 23.2 9 7.2 
Hypertension 131 17 13.0 45 34.4 24 18.3 25 19.1 18 13.7 2 1.5 
Antepartum haemorrhage 382 179 46.9 73 19.1 29 7.6 47 12.3 52 13.6 2 0.5 
Maternal conditions 212* 62 29.2 52 24.5 21 9.9 32 15.1 43 20.3 2 0.9 
Specific perinatal conditions 424 132 31.1 91 21.5 39 9.2 72 17.0 87 20.5 3 0.7 
Hypoxic peripartum death 81 - - - - - - 5 6.2 54 66.7 22 27.2 
Fetal growth restriction 355 25 7.0 81 22.8 61 17.2 81 22.8 90 25.4 17 4.8 
Spontaneous preterm  350* 237 67.7 89 25.4 14 4.0 10 2.9 - - - - 
Unexplained antepartum death 735 123 16.7 105 14.3 67 9.1 145 19.7 262 35.6 33 4.5 
Total 3,994 1,501 37.6 845 21.2 339 8.5 515 12.9 692 17.3 102 2.6 
 
* Gestation of two babies unknown.









Death classification (PSANZ) Total 
20–22 23–27 28–31 32–36 37–40 ≥41 weeks 
n % n % n % n % n % n % 
Perinatal death classification (PSANZ-PDC)                         
Congenital abnormality 326 2 0.6 9 2.8 46 14.1 108 33.1 130 39.9 31 9.5 
Perinatal infection 69 15 21.7 18 26.1 5 7.2 6 8.7 14 20.3 11 15.9 
Hypertension 31 2 6.5 17 54.8 7 22.6 4 12.9 1 3.2 - - 
Antepartum haemorrhage 185 92 49.7 68 36.8 8 4.3 10 5.4 6 3.2 1 0.5 
Maternal conditions 42 8 19.0 10 23.8 6 14.3 8 19.0 9 21.4 1 2.4 
Specific perinatal conditions 124 52 41.9 34 27.4 8 6.5 13 10.5 16 12.9 1 0.8 
Hypoxic peripartum death 102 - - - - 1 1.0 4 3.9 69 67.6 28 27.5 
Fetal growth restriction 30 1 3.3 6 20.0 4 13.3 4 13.3 12 40.0 3 10.0 
Spontaneous preterm  436 174 39.9 225 51.6 20 4.6 17 3.9 - - - - 
No obstetric antecedent 68 - - - - - - 4 5.9 50 73.5 14 20.6 
Neonatal death classification (PSANZ-NDC) 
Congenital abnormality 334 2 0.6 8 2.4 46 13.8 113 33.8 134 40.1 31 9.3 
Extreme prematurity 505 344 68.1 160 31.7 1 0.2 - - - - - - 
Cardio-respiratory disorders 98 - - 79 80.6 11 11.2 2 2.0 6 6.1 - - 
Infection 124 - - 55 44.4 16 12.9 15 12.1 24 19.4 14 11.3 
Neurological 229 - - 55 24.0 17 7.4 30 13.1 95 41.5 32 14.0 
Gastrointestinal 24 - - 18 75.0 5 20.8 1 4.2 0 0.0 - - 
Other 99 - - 12 12.1 9 9.1 17 17.2 48 48.5 13 13.1 
Total 1,413 346 24.5 387 27.4 105 7.4 178 12.6 307 21.7 90 6.4 
 










Perinatal death classification 
(PSANZ-PDC) 





n=60,550 n=60,582 n=58,671 n=59,882 n=57,617 n=57,380 n=55,283 n=53,983 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Congenital abnormality 9 0.15 9 0.15 9 0.15 6 0.10 11 0.19 7 0.12 4 0.07 7 0.13 0.41 
Perinatal infection 7 0.12 6 0.10 9 0.15 7 0.12 3 0.05 0 0.00 3 0.05 2 0.04 0.0071 
Hypertension 1 0.02 2 0.03 8 0.14 3 0.05 3 0.05 3 0.05 - - - - 0.16 
Antepartum haemorrhage 10 0.17 10 0.17 10 0.17 11 0.18 3 0.05 3 0.05 2 0.04 5 0.09 0.0047 
Maternal conditions 7 0.12 4 0.07 8 0.14 9 0.15 1 0.02 7 0.12 7 0.13 2 0.04 0.45 
Specific perinatal condition 12 0.20 8 0.13 14 0.24 12 0.20 16 0.28 10 0.18 7 0.13 7 0.13 0.43 
Hypoxic peripartum death 18 0.30 14 0.23 10 0.17 7 0.12 7 0.12 11 0.19 3 0.05 6 0.11 0.0020 
Fetal growth restriction 13 0.22 19 0.32 10 0.17 15 0.25 12 0.21 18 0.32 11 0.20 8 0.15 0.44 
Unexplained antepartum death 41 0.68 46 0.76 52 0.89 22 0.37 36 0.63 28 0.49 32 0.58 38 0.71 0.21 
 
Table 1.45: Perinatal death classification (PSANZ-PDC) specific stillbirth rates at term (≥37 weeks) (per 1000 births) 2007–2014











2007 2008 2009 2010 2011 2012 2013 2014 Chi-
squared 
test for 
trend (p) n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate n N Rate 
23–27 8 65,256 0.12 13 65,495 0.20 18 63,356 0.28 13 64,780 0.20 16 62,254 0.26 10 62,091 0.16 10 59,744 0.17 8 58,311 0.14 0.65 
28–36 6 64,938 0.09 5 65,164 0.08 5 63,060 0.08 2 64,472 0.03 4 61,992 0.06 3 61,827 0.05 2 59,470 0.03 3 58,031 0.05 0.16 
≥37 25 60,522 0.41 21 60,552 0.35 22 58,643 0.38 16 59,850 0.27 9 57,582 0.16 12 57,353 0.21 3 55,262 0.05 10 53,950 0.19 0.000019 
 























Congenital abnormality 43 42 - 1 - - - - 
Perinatal infection 12 - 5 - 7 - - - 
Hypertension 2 - - 1 - - 1 - 
Antepartum haemorrhage 29 - 19 3 - 7 - - 
Maternal conditions 8 2 3 1 1 1 - - 
Specific perinatal conditions 17 - 14 2 - 1 - - 
Hypoxic peripartum death 10 - - - 2 7 - 1 
Fetal growth restriction 1 - - - - - - 1 
Spontaneous preterm  53 - 28 7 4 8 2 4 
No obstetric antecedent 7 - - 1 1 - - 5 
 
Table 1.47: Association between perinatal death classification (PSANZ-PDC) and neonatal death classification (PSANZ-NDC) 
among all neonatal deaths 2014












Neonatal deaths Perinatal related deaths Termination of 
pregnancy 
Stillbirths 
n=69 n=291 n=224 n=584 
n Rate n Rate n Rate n Rate 
2007 2,033 3 1.48 34 16.72 25 12.53 62 30.50 
2008 1,940 3 1.55 33 17.01 18 9.45 54 27.84 
2009 1,803 5 2.77 32 17.75 31 17.55 68 37.71 
2010 1,896 9 4.75 35 18.46 35 18.90 79 41.67 
2011 1,811 18 9.94 48 26.50 27 15.47 93 51.35 
2012 1,749 14 8.00 34 19.44 32 18.81 80 45.74 
2013 1,753 7 3.99 41 23.39 16 9.38 64 36.51 
2014 1,675 10 5.97 34 20.30 40 24.52 84 50.15 
Chi-squared test 











2007 2008 2009 2010 2011 2012 2013 2014 Total 
n=60 n=49 n=57 n=76 n=86 n=73 n=61 n=78 n=540 
n % n % n % n % n % n % n % n % n % 
Twin type                                     
Dichorionic diamniotic 29 48.3 20 40.8 19 33.3 37 48.7 42 48.8 26 35.6 24 32.9 40 54.8 237 43.9 
Monochorionic diamniotic 29 48.3 25 51.0 33 57.9 31 40.8 37 43.0 42 57.5 34 46.6 35 47.9 266 49.3 
Monoamniotic 2 3.3 - - 4 7.0 5 6.6 2 2.3 2 2.7 - - 3 4.1 18 3.3 
Other multiple - - 4 8.2 - - 1 1.3 2 2.3 1 1.4 - - - - 8 1.5 
Unknown - - - - 1 1.8 2 2.6 3 3.5 2 2.7 3 4.1 - - 11 2.0 
Loss of twin pairs or one twin                                   
Both twins died 34 54.7 26 49.1 32 52.5 48 60.8 60 66.7 48 66.7 42 66.7 54 66.7 344 63.7 
One twin died 26 45.3 23 50.9 25 47.5 28 39.2 26 33.3 25 33.3 19 33.3 24 33.3 196 36.3 
 








Lead maternity carer 
Gestation (weeks) at registration 
Total 
<10  10–13 14–19 ≥20  Unknown 
n % n % n % n % n % 
Self-employed midwife 505 248 49.1 147 29.1 61 12.1 40 7.9 9 1.8 
Hospital 85 25 29.4 34 40.0 15 17.6 7 8.2 4 4.7 
General practitioner 2 - - 1 50.0 - - 1 50.0 - - 
Obstetrician (private) 29 17 58.6 11 37.9 - - - - 1 3.4 
Unknown LMC 3 - - 1 33.3 - - - - 2 66.7 
Total 624 290 46.5 194 31.1 76 12.2 48 7.7 16 2.6 
 
Table 1.50: Gestation at registration by lead maternity carer (LMC) among perinatal related deaths 2014








Perinatal death investigation 
Fetal deaths 




n=149 n=325 n=182 n=656 
n % n % n % n % 
Optimum investigation* 93 62.4 154 47.4 77 42.3 324 49.4 
Post-mortem 58 38.9 138 42.5 60 33.0 256 39.0 
Karyotype 28 18.8 20 6.2 11 6.0 59 9.0 
Clinical examination/investigations confirm diagnosis 14 9.4 6 1.8 14 7.7 34 5.2 
Partial investigations only# 44 29.5 120 36.9 88 48.4 252 38.4 
No investigation+ 12 8.1 51 15.7 17 9.3 80 12.2 
 
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality or clinical examination/investigation confirming diagnosis. Note: more 
than 1 option can be selected.
# No post-mortem; investigations may have included placental pathology, MRI, ultrasound scan or x-ray.
+ No post-mortem, placental pathology, MRI, ultrasound scan or x-ray.
MRI = magnetic resonance imaging.












deaths Termination of 
pregnancy 
Stillbirths 
n=149 n=325 n=182 n=656 
n % n % n % n % 
Post-mortem offered and parental consent given 58 38.9 138 42.5 59 32.4 255 38.9 
Post-mortem offered and parents declined 75 50.3 173 53.2 113 62.1 361 55.0 
Post-mortem not offered 14 9.4 12 3.7 8 4.4 34 5.2 
Unknown 2 1.3 2 0.6 2 1.1 6 0.9 
 











n n % n %
Northland 26 22 84.6 10 38.5
Waitemata 80 75 93.8 33 41.3
Auckland 62 59 95.2 36 58.1
Counties Manukau 116 113 97.4 59 50.9
Waikato 68 68 100.0 24 35.3
Bay of Plenty 44 39 88.6 20 45.5
Lakes 21 19 90.5 14 66.7
Tairawhiti 5 5 100.0 1 20.0
Taranaki 16 16 100.0 6 37.5
Hawke's Bay 21 17 81.0 10 47.6
Whanganui 5 5 100.0 4 80.0
MidCentral 12 9 75.0 8 66.7
Wairarapa 3 3 100.0 2 66.7
Capital & Coast 23 23 100.0 8 34.8
Hutt Valley 22 21 95.5 18 81.8
Nelson Marlborough 16 15 93.8 7 43.8
West Coast 3 3 100.0 2 66.7
Canterbury 69 63 91.3 42 60.9
South Canterbury 3 3 100.0 1 33.3
Southern 38 35 92.1 19 50.0
Overseas 3 3 100.0 - -
DHB of maternal residence 
Offered post-mortem Optimal investigation*
Table 1.53: Optimal investigation of perinatal related death by DHB of maternal residence 2014
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality or clinical examination/investigation confirming diagnosis.










Neonatal deaths Perinatal related deaths 
Termination of pregnancy Stillbirths 
n=149 n=325 n=182 n=656 
n % n % n % n % 
Alive and generally well 149 100.0 314 96.6 180 98.9 643 98.0 
Alive but with serious 
morbidity - - 8 2.5 2 1.1 10 1.5 
Maternal death - - 2 0.6 - - 2 0.3 
Unknown - - 1 0.3 - - 1 0.2 
 

















n=656 n=656 n=656 n=656 
n % n % n % n %* 
Congenital abnormality 188 28.7 11 1.7 0 0.0 194 29.6 
Perinatal infection 24 3.7 4 0.6 0 0.0 28 4.3 
Hypertension 13 2.0 4 0.6 1 0.2 18 2.7 
Antepartum haemorrhage 69 10.5 28 4.3 1 0.2 98 14.9 
Maternal conditions 39 5.9 7 1.1 0 0.0 45 6.9 
Specific perinatal condition 69 10.5 7 1.1 0 0.0 72 11.0 
Hypoxic peripartum death 17 2.6 5 0.8 0 0.0 21 3.2 
Fetal growth restriction 35 5.3 15 2.3 4 0.6 54 8.2 
Spontaneous preterm 105 16.0 72 11.0 3 0.5 179 27.3 
Unexplained antepartum death 90 13.7 0 0.0 0 0.0 90 13.7 
No obstetric antecedent 7 1.1 0 0.0 0 0.0 7 1.1 
 
Table 1.55: Perinatal related deaths by primary and associated perinatal death classification (PSANZ-PDC) 2014








n % n % n % n %*
Congenital abnormality 44 24.2 3 1.6 0 0.0 45 24.7
Extreme prematurity 69 37.9 0 0.0 0 0.0 69 37.9
Cardio-respiratory disorders 16 8.8 12 6.6 3 1.6 26 14.3
Infection 15 8.2 3 1.6 2 1.1 19 10.4
Neurological 24 13.2 7 3.8 1 0.5 32 17.6
Gastrointestinal 3 1.6 0 0.0 0 0.0 3 1.6













Table 1.56: Neonatal deaths by primary and associated neonatal death classification (PSANZ-NDC) 2014
* Percentages are not mutually exclusive.
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Table 1.57: Detail of contributory factors among perinatal related deaths 2009–2014
 
n % n % n % n % n % n %
Any contributory factor 173 23.7 191 27.0 188 28.2 184 27.5 161 26.9 168 25.6
Organisational/Management factors 37 5.1 30 4.1 42 5.8 32 4.4 31 4.2 25 3.4
Poor organisational arrangements of staff 10 2 7 3 0 5
Inadequate education and training 10 5 5 4 3 3
Lack of policies, protocols or guidelines 10 4 13 4 6 4
Inadequate numbers of staff 0 3 3 3 0 3
Poor access to senior clinical staff 2 4 3 1 2 0
Failure or delay in emergency response 5 5 2 3 5 7
Delay in procedure (eg, caesarean section) 3 10 6 8 11 2
Inadequate systems for sharing of clinical information 0 0 0 0 1 2
Delayed access to test results or inaccurate results 6 1 6 5 1 2
Equipment (eg, faulty equipment, inadequate maintenance, 
inadequate quality or lack of equipment)
4 3 4 4 2 3
Building and design functionality (eg, space, privacy, ease of access, 
lighting, noise, power failure, operating theatre in distant location)
0 0 0 1 2 0
Other 6 4 13 7 6 2
Not stated 0 0 0 0 0 2
Personnel factors 49 6.7 47 6.4 56 7.7 52 7.1 45 6.2 53 7.3
Knowledge and skills of staff were lacking 17 13 18 16 13 12
Delayed emergency response by staff 9 4 3 3 3 4
Failure to maintain competence 4 1 2 1 0 0
Failure of communication between staff 11 8 13 8 7 6
Failure to seek help/supervision 8 5 14 3 3 2
Failure to offer or follow recommended best practice 31 26 31 30 19 27
Lack of recognition of complexity or seriousness of condition by care 
giver
2 0 4 14 12 23
Other 0 1 0 2 3 2
Not stated 0 0 1 0 2 0
Barriers to access and/or engagement with care 123 16.8 143 19.6 131 17.9 134 18.4 120 16.4 123 16.8
No antenatal care 24 26 24 37 29 21
Infrequent care or late booking 27 37 46 45 46 42
Declined treatment or advice 12 14 17 22 26 27
Obesity impacted on delivery of optimal care (eg, USS) 1 6 0 5 7 2
Substance use 25 17 18 17 8 13
Family violence 6 9 11 4 6 13
Lack of recognition of complexity or seriousness of condition by the 
woman and/or family
11 30 32 27 32 25
Maternal mental illness 4 9 3 7 1 7
Cultural barriers 10 4 18 2 4 2
Language barriers 2 7 7 6 2 2
Not eligible to access free care 3 2 4 5 1 2
Environment (eg, isolated, long transfer, weather prevented transport) 12 12 12 13 6 11
Other 14 11 11 11 19 10
Not stated 4 0 0 0 0 0
20142013
Contributory factors
2009 2010 2011 2012
USS = ultrasound scan.
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n=656 n % n % n % n %
Congenital abnormality 188 2 1.1 15 8.0 171 91.0 - -
Perinatal infection 24 8 33.3 2 8.3 14 58.3 - -
Hypertension 13 2 15.4 3 23.1 8 61.5 - -
Antepartum haemorrhage 69 6 8.7 12 17.4 51 73.9 - -
Maternal conditions 39 17 43.6 4 10.3 18 46.2 - -
Specific perinatal conditions 69 4 5.8 6 8.7 59 85.5 - -
Hypoxic peripartum death 17 7 41.2 2 11.8 8 47.1 - -
Fetal growth restriction 35 14 40.0 7 20.0 13 37.1 1 2.9
Spontaneous preterm 105 9 8.6 16 15.2 79 75.2 1 1.0
Unexplained antepartum death 90 13 14.4 14 15.6 61 67.8 2 2.2
No obstetric antecedent 7 5 71.4 - - 2 28.6 - -
Perinatal death classification
(PSANZ-PDC)
Contributory factors and 
potentially avoidable
Contributory factors BUT 
NOT or unknown if 
potentially avoidable
No contributory factors Unknown









n n % n % n % n %
Congenital abnormality 750 - - 3 0.4 5 0.7 - -
Perinatal infection 84 3 3.6 9 10.7 14 16.7 2 2.4
Hypertension 65 3 4.6 7 10.8 13 20.0 2 3.1
Antepartum haemorrhage 281 4 1.4 8 2.8 29 10.3 2 0.7
Maternal conditions 135 5 3.7 15 11.1 49 36.3 2 1.5
Specific perinatal conditions 275 12 4.4 16 5.8 15 5.5 2 0.7
Hypoxic peripartum death 68 12 17.6 19 27.9 10 14.7 6 8.8
Fetal growth restriction 176 9 5.1 29 16.5 25 14.2 5 2.8
Spontaneous preterm 372 5 1.3 13 3.5 53 14.2 1 0.3
Unexplained antepartum death 359 6 1.7 12 3.3 37 10.3 - -























Contributory factors and potentially 
avoidable 
Contributory factors 







n=4,028 n % 95% CI n % n % n % 
Māori 1,064 238 22.4 19.90–24.99 181 17.0 608 57.1 37 3.5 
Pacific peoples 553 124 22.4 19.01–26.13 78 14.1 327 59.1 24 4.3 
Indian 222 31 14.0 9.69–19.23 13 5.9 170 76.6 8 3.6 
Other Asian 305 30 9.8 6.74–13.74 19 6.2 252 82.6 4 1.3 
Other (including unknown) 325 28 8.6 5.80–12.21 33 10.2 256 78.8 8 2.5 
NZ European 1,559 204 13.1 11.45–14.86 86 5.5 1,222 78.4 47 3.0 
 
Table 1.60: Contributory factors and potentially avoidable perinatal related death by maternal prioritised ethnicity (95% CIs 










Potentially avoidable  
Organisation/management Personnel Barriers 
Specific contributory factor 
not identified 
n n % 95% CI n % 95% CI n % 95% CI n % 95% CI 
Māori 661 10 1.5 0.73–2.76 28 4.2 2.83–6.06 109 16.5 13.74–19.54 7 1.1 0.43–2.17 
Pacific peoples 338 9 2.7 1.22–4.99 14 4.1 2.28–6.85 65 19.2 15.17–23.84 2 0.6 0.07–2.12 
Indian 155 2 1.3 0.16–4.58 13 8.4 4.54–13.92 8 5.2 2.25–9.92 2 1.3 0.16–4.58 
Other Asian 209 7 3.3 1.36–6.78 9 4.3 1.99–8.02 8 3.8 1.67–7.40 0 0.0 - 
Other (including unknown) 227 2 0.9 0.11–3.15 8 3.5 1.53–6.83 5 2.2 0.72–5.07 3 1.3 0.27–3.81 
NZ European 1,001 30 3.0 2.03–4.25 62 6.2 4.78–7.87 69 6.9 5.40–8.64 8 0.8 0.35–1.57 
 
Table 1.61: Main contributory factor(s) in potentially avoidable perinatal related deaths by maternal prioritised ethnicity (with 
95% CIs) 2011–2014













Contributory factors and potentially 
avoidable 
Contributory factors 







n=4,028 n % 95% CI n % n % n % 
1 (least deprived) 514 56 10.9 8.34–13.91 18 3.5 426 82.9 14 2.7 
2 614 86 14.0 11.36–17.01 37 6.0 471 76.7 20 3.3 
3 722 83 11.5 9.26–14.05 65 9.0 560 77.6 14 1.9 
4 832 135 16.2 13.78–18.91 72 8.7 598 71.9 27 3.2 
5 (most deprived)  1,293 280 21.7 19.44–24.00 211 16.3 755 58.4 47 3.6 
Unknown 53 15 28.3 16.79–42.35 7 13.2 25 47.2 6 11.3 
 
Table 1.62: Contributory factors and potentially avoidable perinatal related death by deprivation quintile (95% CIs surround the 












Potentially avoidable  
Organisation/management Personnel Barriers 
Specific contributory factor 
not identified 
n n % 95% CI n % 95% CI n % 95% CI n % 95% CI 
1 (least deprived) 347 10 2.9 1.39–5.24 12 3.5 1.80–5.96 15 4.3 2.44–7.03 3 0.9 0.18–2.51 
2 401 4 1.0 0.27–2.53 29 7.2 4.90–10.22 27 6.7 4.48–9.65 6 1.5 0.55–3.23 
3 474 14 3.0 1.62–4.91 18 3.8 2.27–5.94 31 6.5 4.49–9.15 2 0.4 0.05–1.52 
4 526 14 2.7 1.46–4.43 30 5.7 3.88–8.04 49 9.3 6.97–12.13 3 0.6 0.12–1.66 
5 (most deprived)  817 15 1.8 1.03–3.01 45 5.5 4.05–7.30 133 16.3 13.81–18.99 8 1.0 0.42–1.92 
Unknown 26 3 11.5 - - - - 9 34.6 - - - - 
 
Table 1.63: Main contributory factor(s) in potentially avoidable perinatal related deaths by deprivation quintile (with 95% CIs) 
2011–2014
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Table 1.64: Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–2014
 
n n n n n n n n n
Congenital abnormality
1.1 Central nervous system 44 42 35 36 41 35 32 47 312
1.2 Cardiovascular system 20 31 23 29 27 23 23 24 200
1.3 Urinary system 9 16 8 18 16 12 13 10 102
1.4 Gastrointestinal system 7 3 4 3 4 4 1 6 32
1.5 Chromosomal 60 48 62 72 55 64 46 62 469
1.6 Metabolic 3 1 6 1 3 3 1 2 20
1.7 Multiple/Non-chromosomal syndromes 31 20 22 24 29 29 17 16 188
1.8 Other congenital abnormality
1.81 Musculoskeletal 4 4 7 9 14 11 16 8 73
1.82 Respiratory 1 1 1 1 1 1 - - 6
1.83 Diaphragmatic hernia 4 5 7 8 4 6 2 4 40
1.84 Haematological - - - 2 3 1 2 - 8
1.85 Tumours 3 5 1 1 2 2 1 3 18
1.88 Other specified congenital abnormality 10 3 1 5 1 6 4 1 31
1.9 Unspecified congenital abnormality 1 6 5 2 3 4 - 5 26
Perinatal infection
2.1 Bacterial - - - - - - - - -
2.11 Group B Streptococcus 9 4 8 8 3 - 3 6 41
2.12 E. coli 2 3 4 3 1 1 3 2 19
2.13 Listeria monocytogenes 1 2 2 2 - 1 3 3 14
2.14 Spirochaetal (eg, syphilis) - - - - - 1 - - 1
2.18 Other bacterial 1 6 1 - 3 3 3 5 22
2.19 Unspecified bacterial 2 3 1 3 1 3 - 3 16
2.2 Viral
2.21 Cytomegalovirus 3 6 4 7 3 3 3 1 30
2.22 Parvovirus 3 1 - - 4 4 - - 12
2.23 Herpes simplex virus 2 1 1 - 1 - 3 - 8
2.28 Other viral - - 1 - - - - - 1
2.29 Unspecified viral 2 1 - - - - - - 3
2.3 Protozoal (eg, Toxoplasma ) 1 - - 3 3 1 - 3 11
2010
n=680 n=701 n=5,409n=599n=707 n=666 n=670
2011 2012 2013 2007–20142014
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n n n n n n n n n
2.5 Fungal - - - - - - - 1 1
2.8 Other specified organism - - - - 1 - - - 1
2.9 Other unspecified organism 3 1 3 2 1 2 2 - 14
Hypertension
3.1 Chronic hypertension: essential 1 2 1 1 1 3 3 2 14
3.2 Chronic hypertension: secondary, (eg, renal disease) - 3 - 1 1 - - 1 6
3.3 Chronic hypertension: unspecified - 2 1 1 - - 1 1 6
3.4 Gestational hypertension 2 1 3 1 3 2 1 1 14
3.5 Pre-eclampsia 12 10 15 18 12 8 6 7 88
3.51 Pre-eclampsia: With laboratory evidence of thrombophilia - - 2 1 - 1 - - 4
3.6 Pre-eclampsia superimposed on chronic hypertension 4 2 5 1 4 4 2 1 23
3.61
Pre-eclampsia superimposed on chronic hypertension: With laboratory 
evidence of thrombophilia
- 1 - 2 - - - - 3
3.9 Unspecified hypertension - 1 2 1 - - - - 4
Antepartum haemorrhage (APH)
4.1 Placental abruption 37 40 44 37 38 29 39 22 286
4.11 Placental abruption: With laboratory evidence of thrombophilia 3 5 2 3 4 2 1 - 20
4.2 Placenta praevia 3 - 5 3 1 1 - 2 15
4.3 Vasa praevia 1 - 1 1 1 - - - 4
4.8 Other APH 10 7 9 9 11 4 15 22 87
4.9 APH of undetermined origin 9 14 18 25 23 24 19 23 155
Maternal conditions
5.1 Termination of pregnancy for maternal psychosocial indications 4 5 3 2 5 4 1 4 28
5.2 Diabetes/Gestational diabetes 12 7 14 18 7 16 16 11 101
5.3 Maternal injury - - - - - - - 1 1
5.31 Maternal injury: Accidental 2 - 1 2 - 3 - 5 13
5.32 Maternal injury: Non-accidental - 3 1 1 - - 1 2 8
5.4 Maternal sepsis 1 - 3 2 2 1 4 1 14
5.5 Antiphospholipid syndrome 3 2 6 4 3 - 2 5 25
5.51 Other maternal thrombophilia (if considered cause of death) - 1 - - 1 1 - - 3
5.6 Obstetric cholestasis - - - - - - - 1 1
5.8 Other specified maternal conditions 5 5 10 3 8 11 10 9 61
n=666 n=670 n=599 n=656 n=5,409
2011 2012 2013 2014 2007–2014
Perinatal death classification (PSANZ-PDC)
2007 2008 2009 2010
n=680 n=701 n=730 n=707
Continued Table 1.64: Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–2014
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n n n n n n n n n
Specific perinatal conditions
6.1 Twin–twin transfusion 17 15 32 22 18 23 21 15 163
6.2 Fetomaternal haemorrhage 6 4 13 8 12 8 2 5 58
6.3
Antepartum cord complications (eg, cord haemorrhage; true knot with 
evidence of occlusion)
15 12 - - - - - - 27
6.31 Cord haemorrhage - 2 1 1 - 2 2 1 9
6.32 True knot with evidence of occlusion - 1 2 3 6 1 2 2 17
6.38 Other - 1 8 15 12 6 6 5 53
6.4 Uterine abnormalities, eg, bicornuate uterus, cervical incompetence 10 15 12 10 10 14 12 14 97
6.5
Birth trauma (typically infants of >24 weeks gestation or >600g 
birthweight)
- - 1 - - - - - 1
6.6 Alloimmune disease
6.61 Alloimmune disease: Rhesus - - - - - 1 1 - 2
6.64 Alloimmune disease: Alloimmune thrombocytopenia 1 - 1 2 - - - 2 6
6.7 Idiopathic hydrops - 7 2 3 3 5 4 2 26
6.8
Other specific perinatal conditions (includes iatrogenic conditions such as 
rupture of membranes after amniocentesis, termination of pregnancy for 
suspected but unconfirmed congenital abnormality)
6.81 Rupture of membranes after amniocentesis 2 4 - 1 1 2 1 - 11
6.82
Termination of pregnancy for suspected but unconfirmed congenital 
abnormality
- - - - - - 3 - 3
6.83 Fetal subdural haematoma - 2 - 2 - - - 1 5
6.88 Other 6 8 4 2 11 8 9 21 69
6.89 Unspecified - - - - - - - 1 1
Hypoxic peripartum death
7.1 With intrapartum complications
7.11 With intrapartum complications: Uterine rupture 1 1 2 1 1 1 - - 7
7.12 With intrapartum complications: Cord prolapse 2 1 1 5 4 2 - 1 16
7.13 With intrapartum complications: Shoulder dystocia 1 1 2 - - - - - 4
7.18 With intrapartum complications: Other 6 4 2 3 2 3 1 3 24
7.2
Evidence of non-reassuring fetal status in a normally grown infant (eg, 
abnormal fetal heart rate, fetal scalp ph/lactate, fetal pulse oximetry 
without intrapartum complications)
16 11 13 7 9 11 7 10 84
7.3
No intrapartum complications and no evidence of non-reassuring fetal 
status
1 2 1 1 1 2 3 1 12
7.9 Unspecified hypoxic peripartum death 6 14 7 3 3 1 - 2 36
Fetal growth restriction (FGR)
8.1
With evidence of reduced vascular perfusion on Doppler studies and/or 
placental histopathology (eg, significant infarction, acute atherosis, 
maternal and/or fetal vascular thrombosis or maternal floor infarction)
34 37 28 33 33 30 31 20 246
8.2 With chronic villitis 1 - 1 - 1 - 3 - 6
8.3 No placental pathology 2 9 6 5 3 2 3 3 33
n=666 n=670 n=599 n=656 n=5,409
2011 2012 2013 2014 2007–2014
Perinatal death classification (PSANZ-PDC)
2007 2008 2009 2010
n=680 n=701 n=730 n=707
Continued Table 1.64: Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–2014
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n n n n n n n n n
8.4 No examination of placenta 4 3 3 2 3 4 1 3 23
8.8 Other specified placental pathology 4 12 14 8 4 13 10 9 74
8.9 Unspecified or not known whether placenta examined 1 1 1 - - - - - 3
Spontaneous preterm
9.1
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery
- - - - - - - 2 2
9.11
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery: With chorioamnionitis
19 17 26 29 17 23 25 30 186
9.12
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery: Without chorioamnionitis
17 15 13 14 13 6 5 11 94
9.13
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery: No examination of placenta
- 1 - 3 3 - 5 4 16
9.17 No clinical signs of chorioamnionitis, no examination of placenta 12 4 14 17 11 13 4 10 85
9.19
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery: Unspecified or not known whether placenta 
examined
6 10 10 6 1 6 2 1 42
9.2 Spontaneous preterm with membrane rupture ≥24 hours before delivery - - - - - - - - -
9.21
Spontaneous preterm with membrane rupture ≥24 hours before delivery: 
With chorioamnionitis
18 25 26 34 22 23 32 25 205
9.22
Spontaneous preterm with membrane rupture ≥24 hours before delivery: 
Without chorioamnionitis
3 5 3 2 1 8 2 1 25
9.23
Spontaneous preterm with membrane rupture ≥24 hours before delivery: 
With clinical evidence of chorioamnionitis, no examination of placenta
1 4 3 4 7 3 3 3 28
9.27 No clinical signs of chorioamnionitis, no examination of placenta 4 2 4 2 3 9 1 12 37
9.29
Spontaneous preterm with membrane rupture ≥24 hours before delivery: 
Unspecified or not known whether placenta examined
2 3 3 - 3 2 - - 13
9.3
Spontaneous preterm with membrane rupture of unknown duration before 
delivery
9.31
Spontaneous preterm with membrane rupture of unknown duration before 
delivery: With chorioamnionitis
6 1 2 - 2 3 1 2 17
9.32
Spontaneous preterm with membrane rupture of unknown duration before 
delivery: Without chorioamnionitis
3 1 1 - 1 - - 3 9
9.33
Spontaneous preterm with membrane rupture of unknown duration before 
delivery: With clinical evidence of chorioamnionitis, no examination of 
placenta
- 3 - - - 1 - - 4
9.37 No clinical signs of chorioamnionitis, no examination of placenta - - 2 1 - 2 1 - 6
9.39
Spontaneous preterm with membrane rupture of unknown duration before 
delivery: Unspecified or not known whether placenta examined
7 3 3 1 - 3 - 1 18
Unexplained antepartum death
10.1
With evidence of reduced vascular perfusion on Doppler studies and/or 
placental histopathology (eg, significant infarction, acute atherosis, 
maternal and/or fetal vascular thrombosis or maternal floor infarction)
14 14 13 10 11 17 7 9 95
10.2 With chronic villitis 3 - 1 - 3 2 1 1 11
10.3 No placental pathology 31 25 28 21 27 12 29 18 191
10.4 No examination of placenta 18 25 21 14 13 20 12 17 140
10.8 Other specified placental pathology 28 31 34 24 38 34 42 45 276
10.9 Unspecified or not known whether placenta examined 6 7 6 2 - 1 - - 22
n=666 n=670 n=599 n=656 n=5,409
2011 2012 2013 2014 2007–2014
Perinatal death classification (PSANZ-PDC)
2007 2008 2009 2010
n=680 n=701 n=730 n=707
Continued Table 1.64: Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–2014
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Continued Table 1.64: Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–2014
 
n n n n n n n n n
No obstetric antecedent
11.1 Sudden infant death syndrome (SIDS)
11.11 SIDS Category IA: Classic features of SIDS present, completely documented - - - - - - 1 - 1
11.13
SIDS Category II: Infant deaths that meet Category I except for one or more 
features
1 - 2 - - - - - 3
11.2 Postnatally acquired infection 1 2 1 2 2 3 1 1 13
11.3 Accidental asphyxiation 1 2 - - - 1 - 1 5
11.4 Other accident, poisoning or violence (postnatal) - 1 - - 1 1 - - 3
11.8 Other specified - 1 - 1 - 1 1 1 5
11.9 Unknown/Undetermined 1 1 - - - 2 - 1 5
11.91 Unclassified sudden infant death 7 7 3 7 1 1 3 3 32
11.92 Other Unknown/Undetermined - - 1 - - - - - 1
n=666 n=670 n=599 n=656 n=5,409
2011 2012 2013 2014 2007–2014
Perinatal death classification (PSANZ-PDC)
2007 2008 2009 2010
n=680 n=701 n=730 n=707
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Table 1.65: Neonatal death and primary neonatal death classification (PSANZ-NDC) 2007–2014
 
n n n n n n n n n
Congenital abnormality
1.1 Central nervous system 2 2 6 6 5 4 4 6 35
1.2 Cardiovascular system 9 12 6 7 6 3 5 7 55
1.3 Urinary system 4 7 3 6 6 4 2 2 34
1.4 Gastrointestinal system 2 1 - - 1 2 1 2 9
1.5 Chromosomal 6 7 8 12 14 11 5 11 74
1.6 Metabolic 1 1 5 1 3 3 1 2 17
1.7 Multiple/Non-chromosomal syndromes 9 6 8 6 6 4 9 6 54
1.8 Other congenital abnormality
1.81 Musculoskeletal - - - 1 4 1 2 3 11
1.82 Respiratory - 1 - 1 1 1 - - 4
1.83 Diaphragmatic hernia 2 4 7 4 3 3 - 3 26
1.84 Haematological - - - 1 - - 1 - 2
1.85 Tumours 1 2 - - - - 1 1 5
1.88 Other specified congenital abnormality 2 - - 1 1 2 1 1 8
Extreme prematurity
2.1 Not resuscitated 48 37 52 71 45 60 58 68 439
2.2 Unsuccessful resuscitation 9 15 6 13 9 8 4 1 65
2.9 Unspecified or not known whether resuscitation attempted - - - - - - 1 - 1
Cardio-respiratory disorders
3.1
Hyaline membrane disease/Respiratory distress syndrome 
(RDS)
6 7 5 8 3 5 1 8 43
3.2 Meconium aspiration syndrome - - - - - - 1 1 2
3.3 Primary persistent pulmonary hypertension - - - 1 - 2 1 - 4
3.4 Pulmonary hypoplasia 3 4 2 3 5 1 1 5 24
3.5
Chronic neonatal lung disease (typically, bronchopulmonary 
dysplasia)
- - 2 2 - 1 - - 5
3.6 Pulmonary haemorrhage - - 2 3 2 2 2 - 11
3.7 Pneumothorax - - - - - - - 1 1
3.8 Other 2 - - 1 1 3 - 1 8
2010 2011 2012 2013 2014












4.111 Congenital bacterial: Group B Streptococcus 4 4 2 6 2 - 2 2 22
4.112 Congenital bacterial: E. coli 1 - - 3 3 3 1 1 12
4.113 Congenital bacterial: Listeria monocytogenes - 1 - - - - - 2 3
4.118 Congenital bacterial: Other bacterial - 3 2 - 2 2 1 3 13
4.119 Congenital bacterial: Unspecified bacterial 3 - 1 3 - 2 1 2 12
4.12 Acquired bacterial
4.121 Acquired bacterial: Group B Streptococcus - - - - 3 1 - - 4
4.122 Acquired bacterial: E. coli - 3 - 1 - - - - 4
4.125
Acquired bacterial: Other Gram negative bacilli (other than 
E. coli )
1 1 - 1 - 1 1 - 5
4.126 Acquired bacterial: Staphylococcus aureus 1 2 - 1 - 1 1 2 8
4.127 Acquired bacterial: Coagulase negative Staphylococcus - 3 - - - - - 1 4
4.128 Acquired bacterial: Other specified bacterial - - 2 3 1 1 1 - 8
4.129 Acquired bacterial: Unspecified bacterial 1 1 - - - - - - 2
4.2 Viral
4.21 Congenital viral
4.211 Congenital viral: Cytomegalovirus - 1 - - 2 - - - 3
4.213 Congenital viral: Herpes simplex virus 2 - - - 1 - 3 - 6
4.218 Congenital viral: Other specified viral - - - - 1 1 - - 2
4.22 Acquired viral
4.223 Acquired viral: Herpes simplex virus - - 1 - - 1 1 - 3
4.228 Acquired viral: Other specified viral - 1 - 1 - 1 - - 3
4.229 Acquired viral: Unspecified viral - 1 - - - - - - 1
4.5 Fungal - - - - - - - 1 1
4.9 Unspecified organism 1 - 4 - - 2 - 1 8
Neurological
2007–2014
n=167 n=177 n=183 n=210 n=163 n=178 n=153 n=182 n=1,413
2010 2011 2012 2013 2014
Neonatal death classification (PSANZ-NDC)
2007 2008 2009
Continued Table 1.65: Neonatal death and primary neonatal death classification (PSANZ-NDC) 2007–2014
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Continued Table 1.65: Neonatal death and primary neonatal death classification (PSANZ-NDC) 2007–2014
 
n n n n n n n n n
5.1
Hypoxic ischaemic encephalopathy/Perinatal asphyxia 
(typically infants of >24 weeks gestation or >600g 
birthweight)
26 28 31 25 15 18 16 13 172
5.2 Intracranial haemorrhage
5.21 Intraventrical haemorrhage 5 2 7 1 8 6 8 10 47
5.22 Subgaleal haemorrhage - 1 1 - - - - - 2
5.23 Subarachnoid haemorrhage - 1 - - - - - - 1
5.24 Subdural haemorrhage - - - 1 - - 1 - 2
5.28 Other intracranial haemorrhage - - 1 - - - - 1 2
5.8 Other - 1 - 1 - 1 - - 3
Gastrointestinal
6.1 Necrotising enterocolitis 2 - 6 5 2 2 1 3 21
6.8 Other - - 2 - - 1 - - 3
Other
7.1 Sudden infant death syndrome (SIDS)
7.11
SIDS Category IA: Classic features of SIDS present and 
completely documented
- - - - - - 1 - 1
7.13
SIDS Category II: Infant deaths that meet category I except for 
one or more features
1 - 2 - - - - - 3
7.2 Multisystem failure - - - - - - - 1 1
7.21
Multisystem failure: Secondary to intrauterine growth 
restriction
- - 3 - - - 2 - 5
7.28 Multisystem failure: Other specified - - 1 - 2 1 2 1 7
7.29
Multisystem failure: Unspecified/undetermined primary cause 
or trigger event
- - - - - 1 - - 1
7.3 Trauma
7.31 Trauma: Accidental - 3 - - - 3 1 1 8
7.32 Trauma: Non accidental - - - - 1 - - - 1
7.4 Treatment complications 3 - - - - - - - 3
7.42 Treatment complications: Medical - 2 - - - - - 1 3
7.8 Other specified - 3 - 2 - 2 4 2 13
7.9 Unknown/Undetermined - 1 - - - 2 - 1 4
7.91 Unclassified sudden infant death 10 1 - - - - - - 11
7.911 Unclassified sudden infant death: Bed sharing - 7 4 7 3 5 4 3 33
7.912 Unclassified sudden infant death: Not bed sharing - - 1 1 2 - - 1 5
2007–2014
n=167 n=177 n=183 n=210 n=163 n=178 n=153 n=182 n=1,413
2010 2011 2012 2013 2014
Neonatal death classification (PSANZ-NDC)
2007 2008 2009
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The New Zealand Maternal Mortality Review Working Group (MMRWG) was established in 
2006 to develop a process for the national collection of data, to review maternal deaths and to 
identify potentially avoidable causes, with the expectation that this would lead to improvements in 
care.
The terms of reference of the PMMRC require the committee to review ‘direct’ maternal deaths. The MMRWG also reviews 
‘indirect’ deaths, in particular (but not solely) those related to medical conditions exacerbated by pregnancy and those related 
to mental health.
2 New Zealand Maternal Mortality 2014
2.1 Introduction
Prior to 1992, maternal mortality in New Zealand was reported by the Maternal Deaths Assessment Committee (MDAC). This 
committee stopped meeting in 1995, and maternal mortality was then reported from data held in the National Minimum Data 
Set (NMDS) of hospital discharges and in the Mortality Collection from Birth Deaths and Marriages (BDM). During this period 
of reporting from national datasets, the maternal mortality ratio was considerably lower than it had been during the years of 
the existence of the MDAC. When the PMMRC was established in 2006, and maternal mortality ratio reported again in the 
context of mandatory facilitated reporting, the maternal mortality ratio appeared to increase again. In the years 2006–2014 
the ratio was 16.7/100,000 maternities, 2.3 times higher than the 7.14/100,000 maternities reported from 1995 to 2005. 
In reality, the maternal mortality ratio reported from routine data from 1991 to 2006 was artefactually low (Figure 2.1). 
As the PMMRC ascertainment process collects more cases than are found in routine datasets, the PMMRC estimate of the New 
Zealand maternal mortality ratio is necessarily higher, and a comparable ratio should be used when comparing New Zealand 




































MMR: MDAC MMR: routine sources MMR: PMMRC
Figure 2.1: New Zealand maternal mortality ratio by mortality data source 1973–2014 
MMR = maternal mortality ratio.
MDAC = Maternal Deaths Assessment Committee.
* Data from the MDAC, including maternal deaths to three months postpartum.
# Data from routine New Zealand datasets (ie, the Mortality Collection (BDM) and hospital discharge datasets (NMDS)) including maternal deaths to six weeks postpartum.
+ Data from the PMMRC, including maternal deaths to six weeks postpartum.
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2.2 Definitions
The definitions adopted by the MMRWG are based on the WHO definitions from the International Classification of Diseases 
(10th edition) as follows.
Maternal related death: death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the 
duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management, but not 
from accidental or incidental causes (WHO n.d.).
The cause of each death is sub-classified using the Confidential Enquiry into Maternal and Child Health (CEMACH) 
classification system (Lewis 2007).
• Direct maternal deaths: those resulting from obstetric complications of the pregnant state (pregnancy, labour or 
puerperium), from interventions, omissions, incorrect treatment or from a chain of events resulting from the above.
• Indirect maternal deaths: those resulting from previous existing disease or disease that developed during pregnancy 
and was not due to direct obstetric causes but that was aggravated by the physiologic effects of pregnancy. All 
maternal deaths by suicide are included in the New Zealand data as indirect deaths.
• Coincidental maternal deaths: deaths from unrelated causes that happen to occur in pregnancy or the puerperium.
These definitions exclude late maternal deaths, occurring between 42 days and one year following the birth, even though it 
is known that some pregnancy related deaths occur in this later period. The MMRWG may consider and review these deaths 
where they can be identified.
Maternal mortality ratio is the number of maternal related deaths per 100,000 maternities. 
Maternities are defined here as all births at 20 weeks or beyond or weighing 400g or more if gestation was unknown. 
Pregnancies ending before 20 weeks are not included in this working definition because the absolute number of pregnancies 
ending before this time is unknown.
The term ‘ratio’ is used to describe ‘incidence’ of maternal mortality because cases included in the numerator may arise from 
pregnancies that end before 20 weeks. From 2006 to 2014, 27 percent of all maternal deaths (50 percent of antepartum 
(in pregnancy) maternal deaths and 13 percent of postpartum deaths) occurred under 20 weeks. As the total number of 
pregnancies ending before 20 weeks is unknown, the denominator cannot include all women at risk and thus the estimate 
cannot truly be called a ‘rate’.
The variable definition of ‘maternities’ creates unnecessary confusion when making international comparisons. The WHO 
recommends 100,000 live births as the most available denominator in countries with limited vital statistics collection. In 
countries where fetal deaths are also collected, the WHO recommends the denominator be 100,000 live births plus fetal 
deaths of 20 weeks or greater gestation. The UK uses the number of pregnancies that result in a live birth at any gestation 
or a stillbirth at or after 24 completed weeks gestation (as only stillbirths at 24 or more weeks gestation are required to be 
notified by law) (Lewis 2007). Australia reports the number of women who gave birth to either a live or stillborn baby of 20 or 
more completed weeks gestation or weighing at least 400g at birth (as required to be reported to the National Perinatal Data 
Collection) (Sullivan et al 2007).
Contributory factors are organisational and/or management factors (eg, delays in procedures or accessing results; lack of 
policies, protocols or guidelines; lack of maintenance of equipment), personnel factors (eg, failure to maintain competence) 
and barriers to access and/or engagement with care (eg, unregistered pregnancies, language barriers, distance from 
adequate facilities) that the MMRWG considered influenced care in the death reviewed. The subcategories within each 
group of factors considered are given in the ‘PMMRC Classification of Contributory Factors and Potential Avoidability’ form 
(Appendix F).
A potentially avoidable maternal death is where the absence of the contributory factor(s) may have prevented the death.
More details on the process of development of the tool to assess contributory factors and potentially avoidable death have 
been published (Farquhar et al 2011).
As outlined in recent reports, incomplete ascertainment of cases in the absence of mandatory and facilitated reporting leads 
to under-reporting of maternal mortality internationally (Johnson et al 2014; Knight et al 2014; PMMRC 2014a).
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2.3 Methodology
Since 2006, the PMMRC has requested that all clinicians aware of a maternal death notify either their PMMRC DHB local coordinator 
or the PMMRC national coordinator. 
Deaths are brought to the MMRWG’s attention in the main by PMMRC DHB local coordinators (47 percent) and other clinicians within 
DHBs (42 percent). Other sources include pathologists, Coronial Services and media reports. Often multiple notifications are received. 
At the end of each year, known deaths are cross-referenced with the Mortality Collection at the BDM Registry to ensure the collection 
is complete. This process ascertained a further seven indirect maternal deaths (due to suicide) in the 2006–2014 period. 
Since July 2007, it has been a statutory requirement that all maternal deaths are notified to Coronial Services and a specific tick box 
on the death certificate reminds practitioners of the statutory requirement to report and to assist in ascertainment of all cases.
The MMRWG has developed a data collection tool for maternal deaths. Following notification of a maternal death, the PMMRC 
national coordinator issues maternal death reporting forms to the appropriate local coordinator, who is then responsible for 
gathering the relevant clinical information from practitioners involved with the woman’s care.
All completed reporting forms, along with relevant clinical information and reports from DHBs, Coronial Services and any other 
relevant investigative processes, are reviewed by designated members of the MMRWG, who present a summary of each case to 
the working group. The MMRWG then discusses each case in detail, including assessing the presence of contributory factors and 
potential avoidability.
From 2006 to 2008, the MMRWG of the PMMRC prospectively assessed whether maternal deaths were potentially avoidable but did 
not use a tool for identifying contributory factors. In early 2010, an expert panel that included a midwife researcher, an obstetrician 
and an epidemiologist, one of whom was also a member of the working group, considered each death from 2006 to 2008 and 
completed the tool for identifying contributory factors (Farquhar et al 2011). For 2009–2014 deaths, the working group applied the 
new tool in reviewing the maternal deaths. The findings of the expert panel review of deaths from 2006 to 2008 combined with the 
committee’s reviews for 2009–2014 are presented in this report.
The year 2014 was the ninth year of maternal death reporting under the auspices of the PMMRC. The number of maternal deaths 
each year is small. In this report, time trends in maternal mortality in New Zealand have been explored along with analyses that 
include all years of maternal mortality data (2006–2014).




2006 2007 2008 2009 2010 2011 2012 2013 2014 2006–2014
Cause specific 
ratio
n n n n n n n n n n %
/100,000 
maternities
Maternities 60,659 65,602 65,872 63,665 65,124 62,604 62,425 60,039 58,647 - -
Direct maternal death 6 5 4 5 1 2 2 5 2 32 34.0 5.67
Amniotic fluid embolism 3 - 1 4 1 - 1 2 - 12 12.8 2.13
Obstetric haemorrhage
<20/40 gestation - 1 - - - - - 1 - 2 2.1 0.35
≥20/40 gestation 1 - 1 - - - - - 1 3 3.2 0.53
Venous thrombo-embolism - 1 1* - - 1 - - 1 4 4.3 0.71
Peripartum cardiomyopathy - 1 - - - - - - - 1 1.1 0.18
Pre-eclampsia/Eclampsia - 2 1 1 - - - - - 4 4.3 0.71
Obstetric sepsis 2 - - - - 1 1 2 - 6 6.4 1.06
Indirect maternal death 7 5 5 9 8 6 8 7 1 56 59.6 9.92
Pre-existing medical condition 
Cardiac 1 1 1 - 1 1 4 - - 9 9.6 1.59
Neurological 1 1 - 1 1 2 1 2 - 9 9.6 1.59
Other pre-existing medical condition 1 2 1 - 1 1 - 1 1 8 8.5 1.42
Non-obstetric sepsis - 1 - 5 1 - - 1 - 8 8.5 1.42
Suicide 4 - 3 3 4 2 3 3 - 22 23.4 3.90
Unclassifiable 2 1 - - - 1 - 1 1 6 6.4 1.06
Total maternal deaths 15 11 9 14 9 9 10 13 4 94 100.0 16.65
Single-year MMR 24.7 16.8 13.7 22.0 13.8 14.4 16.0 21.7 6.8 - - -
- - 06–08 07–09 08–10 09–11 10–12 11–13 12–14 - - -
18.2 17.4 16.4 16.7 14.7 17.3 14.9 - - -




* Pulmonary embolism and sepsis.
MMR = maternal mortality ratio.
Table 2.1: Maternal mortality ratio (per 100,000 maternities) and cause of maternal death 2006–2014
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There has been no statistically significant change in maternal mortality ratio in New Zealand since data collection by the 
PMMRC began in 2006.
In 2014, only four deaths within the definition of maternal mortality were reported to the PMMRC. There were no coincidental 
deaths reported in 2014. The maternal mortality ratio in New Zealand was therefore 6.8/100,000 maternities (95% CI 
1.9–17.5/100,000) for the year 2014. The three-year average maternal mortality ratio, calculated to obtain a more robust 
estimate of the New Zealand ratio given small and variable numbers of deaths per year, for 2012–2014, was 14.9/100,000 
maternities (95% CI 9.8–21.7/100,000).
In 2014, there were two direct deaths, one from postpartum haemorrhage and one from venous thromboembolism. There was 
one indirect death from a pre-existing medical condition. There was one death where cause was not able to be classified. 
The maternal mortality ratio for direct deaths alone for the most recent five years of data (2010–2014) was 3.9/100,000 
maternities (95% CI 2.0-6.8/100,000), and for indirect deaths 9.7/100,000 maternities (95% CI 6.6–13.9/100,000).
Suicide (22), amniotic fluid embolism (12), and pre-existing medical diseases (26) are the most frequent causes of maternal 
mortality in New Zealand during 2006–2014. Suicide continues to be the leading ‘single’ cause of maternal death in New 
Zealand. Suicide and AFE deaths from 2006 to 2014 are discussed in detail later in this chapter.
Figure 2.2 demonstrates maternal mortality ratios for each year, and three-year rolling average total, direct and indirect 
maternal mortality ratios. The three-year rolling average ratios are represented as an estimate plotted at the final year of the 
three-year period. For example, the three-year ratio for 2006–2008 is plotted for 2008.
International comparisons
It is difficult to compare maternal mortality ratios internationally due to differences in definitions and variations in systems for 
ascertainment of maternal death. 
Small differences in the denominator (number of maternities) result in very small changes when calculating the ratio, whereas 
small changes in the numerator (number of deaths) have a substantial impact on the ratio. 
It has been calculated that countries without dedicated maternal mortality confidential enquiry systems have poorer case 
ascertainment leading to under-reporting of 15 to 93 percent of cases (Cliffe et al 2008; Deneux-Tharaux et al 2005; Donati 
et al 2011; EURO-PERISTAT et al 2008; Johnson and Sullivan 2013; Knight et al 2014). This fact is well illustrated by Mothers 
and Babies: Reducing Risk through Audits and Confidential Enquiries (MBRRACE-UK) in the 2009–2012 report for the UK and 
Ireland, which reported a maternal mortality ratio for 2009–2011 of 5.57/100,000 from routine statistics and a ratio of twice 































Year of death 
3-year rolling direct MMR 3-year rolling indirect MMR 3-year rolling MMR 1-year MMR
MMR = maternal mortality ratio. 
Three-year rolling maternal mortality ratio represented at final year of triennium.
Figure 2.2: Maternal mortality ratios (per 100,000 maternities) (one-year and three-year rolling) 2006–2014
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The maternal mortality ratio for the United Kingdom based on confidential enquiry data for the triennium 2011–2013 was 
9.02/100,000 maternities (2.91/100,000 direct maternal mortality ratio; 6.11/100,000 indirect maternal mortality ratio) 
(Knight et al 2015). This was significantly lower than the maternal mortality ratio in the two previous triennia and similar to 
that reported for the 1985–1987 triennium. Over this time interval, there was a decrease in direct maternal mortality ratio but 
an increase in the indirect maternal mortality ratio.
The New Zealand maternal mortality ratio for the triennium 2011–2013 was significantly higher than that reported by the UK 
at 17.3/100,000 maternities with 95% CI 12.2–24.4/100,000 (direct maternal mortality ratio 4.9/100,000 maternities 
(2.6–9.2/100,000); indirect maternal mortality ratio 11.3/100,000 maternities (7.4–17.3/100,000)). Thus, the New 
Zealand direct maternal mortality ratio was not statistically different to the UK ratio for this triennium, but the indirect ratio was 
significantly higher. This may reflect in part differing demography of birthing women in the two countries.
In 2008–2012, there were 105 maternal deaths in Australia that occurred within 42 days of the end of pregnancy, 
representing a maternal mortality ratio of 7.1 deaths per 100,000 women who gave birth in Australia. The number of 
maternal deaths increased each year from 2008 to 2012. It is uncertain whether this is an actual increase or reflects 
improvements in case ascertainment (Humphrey et al 2015). 
The Australian ratio is very similar to the New Zealand ratio at 7.14/100,000 maternities reported for 1995–2005, when 
New Zealand was using routine data sources for case ascertainment. As noted in the Australian report published in 2014, ‘the 
higher MMR [maternal mortality ratio] for New Zealand may reflect enhanced surveillance and centralised mortality review’, 
and numerous international papers on ascertainment of maternal mortalities would support this statement (Johnson et al 2014). 
The report also notes that the limited national level maternal mortality review process has a ‘significant impact on the quality 
and utility of the data collected’ and limits the ‘capacity for meaningful comparison of cases’. Australia also classifies some 
maternal deaths in a different manner to New Zealand, so inter-country comparisons between categories are also limited.
Reporting of maternal deaths to New Zealand Coronial Services 2006–2014
In 2014, all four maternal deaths were reported to Coronial Services and jurisdiction taken. A post-mortem was performed in 
all four deaths.
The MMRWG recommends that where a coroner declines jurisdiction in the case of a maternal death, a post-mortem should 
be offered as part of full investigation of cause of death. The MMRWG reviewed the role of post-mortems in determining cause 
of maternal death from 2006 to 2014 and found clinical diagnosis was confirmed in 44 (47 percent), was changed in 11 (12 
percent), there were additional clinical findings in 9 (10 percent), and the clinical diagnosis was inconclusive in 6 (6 percent). 
The remaining 26 percent of maternal deaths (24) did not have a post-mortem.
Causes of maternal death
Direct causes
As noted above, direct causes of maternal mortality contribute approximately one-third of maternal deaths compared to two-
thirds from indirect causes. Direct causes include AFE, postpartum haemorrhage, thrombo-embolic disease, pre-eclampsia and 
sepsis. In New Zealand, AFE contributes almost 40 percent of direct deaths.
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Figure 2.3 shows cause specific maternal mortality ratios for direct maternal deaths, comparing ratios for New Zealand and 
England and Ireland. The most notable difference is in deaths from AFE, which over the periods compared was five times 
higher in New Zealand than in the UK (p<0.0001). The highest cause specific ratio for AFE in the UK in any triennium since 
1985 was 0.80/100,000, one-third the rate in New Zealand from 2006 to 2014. The similarity of the direct maternal 
mortality ratio for New Zealand to that in the UK overall and for all other direct causes raised a concern for New Zealand, 
which led to a review of AFE cases. Further review of amniotic fluid embolism deaths 2006–2013 can be found in Section 
2.5. 
Indirect causes
Pre-existing medical disease and suicide were the most frequent causes of maternal mortality in New Zealand in 2006–2014, 
suicide being the leading ‘single’ cause of maternal death in New Zealand (3.7/100,000 maternities). In comparison, 
cause specific maternal mortality ratio for psychiatric causes for the UK for 2009–2011 was 0.55/100,000 maternities, and 
0.85/100,000 maternities is the highest ratio reported from the UK since 1994–1996 (Figure 2.4). The New Zealand ratio 
for psychiatric maternal deaths is 6.7 times that reported for the UK, and although the numbers of deaths in New Zealand are 
small (n=21), the difference is highly statistically significant (p<0.0001). Further review of maternal suicide deaths 2006–2013 



































Direct cause of death 
NZ2006-2014 UK2006-2011
Figure 2.3: Cause specific direct maternal mortality ratios in New Zealand 2006–2014 and the UK 2006–2011 (with 95% 
CIs) 
* Includes anaesthesia, cardiomyopathy, other.
AFE = amniotic fluid embolism.
PPH = postpartum haemorrhage.
VTE = venous thromboembolism. 





































































Maternal age (years) 
Figure 2.4: Cause specific indirect maternal mortality ratios in New Zealand 2006–2014 and the UK 2006–
2011 (with 95% CIs)
* Includes cardiac, indirect neurological, indirect malignancies.
# Includes non-obstetric sepsis.
Figure 2.5: Maternal mortality ratios (per 100,000 maternities) by maternal age 2006–2014
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Mothers aged 40 years and older contributed 13 percent of maternal deaths but only 4 percent of maternities from 2006 
to 2014. The maternal mortality ratio for mothers aged 40 years and older was 52.8/100,000 maternities compared to 
15.1/100,000 among mothers under 40 years of age during this period.
There have been 12 mortalities among mothers 40 years of age and older between 2006 and 2014, including seven direct 
and five indirect deaths. Numbers are small so it is hard to determine any statistically significant associations between age 
and cause of death, although suicide tends to be more often a cause of maternal death among younger women, and pre-
existing medical conditions among older women. 
The maternal mortality ratio for Māori and Pacific mothers is two to three times that of Other Asian, Other, and New Zealand 
European mothers. Maternal mortality among Māori and Pacific mothers is statistically significantly higher than among New 
Zealand European, Other Asian and Other ethnicity mothers. 
The maternal mortality ratio (direct deaths only) for Māori and Pacific peoples was 10.6/100,000 (95% CI 6.5–16.4) 
compared to 3.2/100,000 (1.6–5.6) for all other ethnicities combined. For indirect deaths the ratios were respectively 
18.0/100,000 (12.5–25.2) compared to 5.9/100,000 (3.7–8.9). 
The maternal mortality ratios for Māori and Pacific combined for both direct and indirect deaths were approximately three 






































Figure 2.6: Maternal mortality ratios (per 100,000 maternities) by prioritised ethnicity 2006–2014
111PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: TENTH ANNUAL REPORT 
The risk of maternal mortality increased significantly with increasing deprivation quintile during 2006–2014. The risk for 
women living in the most deprived 20 percent of residential areas from 2006 to 2014 was 2.5 times that of those in the least 
deprived 20 percent.
These analyses do not attempt to separate out the independent effects of ethnicity, maternal age and socioeconomic status, 
which are likely to have inter-related effects on maternal mortality. 
The 2015 report on maternal deaths in the UK 2011–2013 reported that the relative risk of maternal mortality was 1.44 (95% 
CI 0.87–2.46) for women residing in the most deprived ‘Index of Multiple Deprivation’ quintile areas in England compared to 




































Figure 2.7: Maternal mortality ratios (per 100,000 maternities) by deprivation quintile 2006–2014
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Clinical characteristics
Table 2.2: Clinical characteristics among maternal deaths 2006–2014

























Family violence in this pregnancy
Yes 9 9.6
No 48 51.1
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Over the years 2006–2014, approximately one-quarter of mothers who died were having their first baby, while a further 
quarter had had four or more prior births. In 2014, 39.7 percent of women birthed their first baby in New Zealand, and 4.9 
percent birthed their fourth or later baby, according to data from the MAT dataset. 
The data suggest that nulliparous women are less likely to suffer a death related to pregnancy than women having subsequent 
births. This association is likely to be confounded by age, which is associated with parity and with risk of maternal death.
Of the 94 maternal deaths from 2006 to 2014, 41 (44 percent) had a BMI of 30 or more. Although the MAT dataset is 
missing BMI data for 5 percent of mothers who birthed in 2014, and the missing data are for women who probably had 
higher than average BMI, the proportion of women birthing in 2014 in New Zealand with known BMI who had a BMI of 30 
or higher was significantly lower than that among maternal deaths at 25 percent. 
The rate of smoking among mothers who died (34 percent) is high compared to smoking among mothers birthing in New 
Zealand in 2014 (15.9 percent of mothers smoking at either registration or two weeks postpartum).
Family violence was known to be present in the index pregnancy in at least 10 percent of maternal deaths in 2006–2014, and 
family violence status was unknown in a further 39 percent. Evidence of family violence prior to or during pregnancy among 
deaths from any cause from 2011 to 2013 in the UK was reported in 7 percent of cases, with data missing for 42 percent of 






Place of baby's birth
Community (not in a health care facility) 4 4.3
Hospital 55 58.5
Baby not born at time of mother's death 34 36.2
Unknown 1 1.1
Place of maternal death
Hospital 59 62.8
Community 35 37.2
Time of death related to pregnancy
Antepartum (Antepartum/Intrapartum) 34 36.2
Postpartum 60 63.8
n %
























Table 2.3: Details of place and timing of maternal mortalities 2006–2014
115PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: TENTH ANNUAL REPORT 
One-quarter (27 percent) of maternal deaths from 2006 to 2014 occurred in the first 20 weeks of pregnancy, two-thirds of 
these prior to the baby’s birth.
Sixty-nine mothers (73 percent) died at or after 20 weeks gestation. Of these mothers, 17 (25 percent) died prior to the baby’s 
birth and the babies did not deliver; there were 10 perinatal deaths (14 percent) and 42 (61 percent) babies survived.
Of babies born alive coincident with maternal death (46), 42 (91 percent) survived beyond one month of age. 
Perimortem caesarean section
Perimortem caesarean section can save the life of both the mother and the infant.
Perimortem caesarean section was undertaken in eight maternal deaths as part of the resuscitation of the mother to improve the 
chance of survival following a collapse from 2006 to 2014. Five babies were live born, three babies were stillborn and one 
live born baby died as an early neonatal death.
Contributory factors and potentially avoidable maternal deaths
Thirty-six percent of maternal deaths were identified as potentially avoidable from 2006 to 2014. Contributory factors 
were identified in 62 percent of maternal deaths in the years 2006 to 2014. The presence of contributory factors and the 
assessment of potentially avoidable death did not vary by whether maternal deaths were classified as direct or indirect.
Contributory factors were identified in each of organisational/management, personnel, and barriers to access and/or 
engagement with care in 38 to 40 percent of cases overall, but barriers were less often identified among direct deaths (25 
percent) than among indirect (54 percent).
Similar rates were identified in the MBRRACE-UK in-depth review of maternal deaths in the UK for the years 2009–2013, 
which reported substandard care in 59 percent of cases overall, with this contributing significantly to the death in 38 percent 
of cases. 
Approximately two-thirds of maternal deaths occurred in hospital and one-third in the community. 
Approximately a third (36 percent) of maternal deaths occurred during pregnancy, half prior to 20 weeks and almost all of the 
remainder prior to term (37 weeks). 
Of postpartum deaths, half occurred after the baby’s birth at term. A quarter occurred within the first day of birth and half within the 
first week. 




n % n % n %
Maternal death <20 weeks 25 26.6 17 50.0 8 13.3
Maternal death ≥20 weeks
Did not deliver 17 18.1 17 50.0 - -
Stillborn 6 6.4 - - 6 10.0
Early neonatal death 4 4.3 - - 4 6.7
Late neonatal death - - - - - -








Table 2.5: Contributory factors and potentially avoidable maternal death 2006–2014
 
n % n % n % n %
Was death potentially avoidable?
Yes 34 36.2 13 40.6 21 37.5 - -
No 56 59.6 19 59.4 35 62.5 2 33.3
Unknown 4 4.3 - - - - 4 66.7
Contributory factors present 58 61.7 21 65.6 36 64.3 1 16.7
Organisational/Management factors 36 38.3 16 50.0 20 35.7 - 0.0
Poor organisational arrangements of staff 6 3 3 -
Inadequate education and training 11 6 5 -
Lack of policies, protocols or guidelines 22 10 12 -
Inadequate numbers of staff 1 1 - -
Poor access to senior clinical staff 3 1 2 -
Failure or delay in emergency response 4 3 1 -
Delay in procedure (eg, caesarean section) 2 1 1 -
Inadequate systems/process for sharing of clinical information between services 14 3 11 -
Delayed access to test results or inaccurate results 3 2 1 -
Equipment (eg, faulty equipment, inadequate maintenance, inadequate quality or lack of  
equipment)
1 1 - -
Building and design functionality (eg, space, privacy, ease of access, lighting, noise, power 
failure, operating theatre in distant location)
3 3 - -
Other 8 3 5 -
Personnel factors 37 39.4 15 46.9 21 37.5 1 16.7
Knowledge and skills of staff were lacking 16 7 8 1
Delayed emergency response by staff 8 5 3 -
Failure of communication between staff 11 4 7 -
Failure to seek help/supervision 7 3 4 -
Failure to offer or follow recommended best practice 8 2 5 1
Lack of recognition of complexity or seriousness of condition by care giver 22 7 15 -
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Continued Table 2.5: Contributory factors and potentially avoidable maternal death 2006–2014
 
n % n % n % n %
Barriers to access and/or engagement with care 38 40.4 8 25.0 30 53.6 - -
No antenatal care 5 1 4 -
Infrequent care or late booking 9 4 5 -
Declined treatment or advice 13 3 10 -
Obesity impacted on delivery of optimal care (eg, USS) 4 2 2 -
Substance use 9 - 9 -
Family violence 7 1 6 -
Lack of recognition of complexity or seriousness of condition by the woman and/or family 17 3 14 -
Maternal mental illness 8 - 8 -
Cultural barriers 1 - 1 -
Language barriers 2 - 2 -
Not eligible to access free care 1 - 1 -
Environment (eg, isolated, long transfer, weather prevented transport) 2 1 1 -
Other 6 - 6 -
Maternal deaths Direct maternal deaths Indirect maternal deaths Unclassifiable
n=94 n=32 n=56 n=6
USS = ultrasound scan.
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Diagnostic criteria for amniotic fluid embolism
EITHER 
a)      A clinical diagnosis of AFE (acute hypotension or cardiac arrest, acute hypoxia (including respiratory distress, chest 
tightness and restlessness) and coagulopathy in the absence of any other potential explanation for the symptoms 
and signs observed)
AND/OR 
b)      A pathological/post-mortem diagnosis (presence of fetal squames/debris in the pulmonary circulation).
2.5 Review of amniotic fluid embolism 2006–2013
Background 
Amniotic fluid embolism (AFE) is an unpredictable, rare, and often rapidly fatal complication of pregnancy where amniotic 
fluid or fetal cells enter the maternal circulation and cause an allergic-type reaction. This usually occurs around the time of 
birth.
Justification for review
The ninth report of the PMMRC (PMMRC 2015) reported 12 AFE deaths and a cause specific maternal mortality ratio for 
AFE in New Zealand for 2006–2013 of 2.37/100,000 maternities (95% CI 1.23–4.14), 5.6 times that reported in the UK 
(p<0.0001). 
The potential explanations for this 5.6-fold discrepancy in mortality are that (1) AFE is over-diagnosed in New Zealand; (2) 
there are higher rates of risk factors for AFE such as induction of labour and caesarean section in New Zealand; or that (3) 
there is potential for improvement in the management of AFE in New Zealand to reduce the case fatality rate.
International comparisons
A review of incidence and mortality in the UK, Netherlands, USA, Canada and Australia (Knight et al 2012) showed that 
incidence varied by data collection methodology, but mortality ratios did not. Incidence rates varied from 1.9/100,000 
maternities in the UK to 6.1/100,000 in Australia. Mortality ratios varied from 0.4/100,000 live births in the Netherlands 
1993–2005 to 1.3 in the USA from 1997–2005. In New Zealand the mortality ratio was 2.37/100,000 maternities (95% CI 
1.23–4.14) for 2006–2013. Although this is a later time period, these data would suggest that the AFE mortality ratio in New 
Zealand is significantly higher than in most other first world countries. 
Risk factors for AFE identified from the 2012 review by Knight et al and reported across most countries include maternal age, 
placenta praevia or abruption, induction of labour, and caesarean section or operative vaginal modes of birth.
The caesarean section rate in New Zealand in 2014 was 25.9 percent compared to 26.2 percent for 2013–2014 in the UK, 
and the induction rate in New Zealand was 24.4 percent compared to 25.0 percent in the UK. The similarity in these rates 
does not support a higher rate of risk factors for AFE as an explanation for the higher rate in New Zealand compared to the 
UK.
Review of cases 2006–2013 
Methodology
Cases included 13 maternal deaths (nine from 2006 to 2009 and four from 2010 to 2013) where AFE was diagnosed, and 
eight non-fatal cases reported to the Australasian Maternity Outcomes Surveillance System (AMOSS) from 2010 to 2013. 
Table 2.1 reports 12 deaths attributed to AFE; however, this further review includes an additional case where the MMRWG 
attributed the main cause of death as postpartum haemorrhage with inadequate resuscitation rather than AFE.
The hypotheses addressed in the review included the following:
• AFE is over-diagnosed in New Zealand.
• The management of AFE in New Zealand is associated with a high case fatality rate due to delayed recognition or 
suboptimal resuscitation.
A sub-group of the MMRWG extracted data from each case individually using the original case records. The specific UK 
Obstetric Surveillance System (UKOSS)/AMOSS case definition, as outlined in the text box below, was used. Each sub-group 
member reviewed specific cases prior to meeting. Cases where there were concerns related to the validity of the diagnosis 
were discussed by the whole group to determine if they fit the diagnostic criteria.
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Findings
The review found that these diagnostic criteria were met in all 13 fatal cases, but that these diagnostic criteria were not 
reached in three of the eight cases where women did not die (morbidity cases). The diagnosis was supported by the 
pathological finding of fetal squames or hair in the lungs at post-mortem in eight of the 11 (73 percent) deaths where a post-
mortem was performed. Of the fatal cases that did not have post-mortem confirmation, all had cardiac arrest as part of their 
presentation, and all but one had coagulopathy. This last case had a raised tryptase.
Removing the three morbidity cases where the diagnostic criteria were not reached from the time period 2010–2013 reduces 
the New Zealand incidence of AFE to 3.6/100,000 maternities (9/250,192) (95% CI 1.6–6.8), and increases the case-
fatality rate to 44 percent (4/9) during the same time period. The incidence rate is difficult to compare as discussed above, 
and the case fatality rate is at the upper end of the range reported (19–43 percent) (Knight et al 2012).
The findings presented here pertain to the 18 cases (13 mortality and 5 morbidity) confirmed on further review. 
Presentation of AFE
The median age of women at presentation was 33 years and the median parity was two. Ten of the 18 cases had labour 
induced: seven with prostaglandin and four with syntocinon. No spontaneous labour was augmented with syntocinon. 
Membranes were artificially ruptured in eight cases. No cases of placenta praevia were reported in this cohort.
There were eight caesarean births, four of which were perimortem. Of the four caesarean sections that were not performed as 
part of resuscitation, AFE appeared to occur after commencement of surgery but prior to birth in two cases and after birth in 
two cases. There were 10 spontaneous vaginal births.
Seven of the 18 women presented with symptoms of AFE in the first stage of labour or at the time of birth, and in the remaining 
11 cases symptoms developed after birth. 
The median number of presenting features of AFE was 4.5 (range 1–8). In the UKOSS review, the median number of features 
of AFE that women presented with was 4 (range 1–9). 
Cardiac arrest occurred in 12 of the 13 fatal cases (92 percent) and was the first presenting sign in two cases (15 percent). 
Cardiac arrest did not occur in any non-fatal case. Time at cardiac arrest was available for 10 of 12 cases. Arrest occurred 
within two minutes of onset of symptoms in three cases, within 36 minutes in a further two cases, and from 1 hour and 10 
minutes to 4 hours and 21 minutes in the remaining five cases. In the UK series, 87 percent of those who died presented with 
cardiac arrest (compared to 36 percent of those who survived); cardiac arrest was the first recognised event in 26 percent of 
women who died compared to 5 percent of women who survived.
Acute fetal compromise occurred in five cases, and was the presenting feature in three cases. Coagulopathy was evident in 
14 cases, but was not the first sign in any case. Maternal hypotension was reported in 13 cases and was the presenting sign 
in two cases, one fatal and one non-fatal. Maternal haemorrhage occurred in 15 cases and was the presenting sign in three 
cases. None of these symptoms was associated with fatality or survival.
Premonitory symptoms, such as restlessness, numbness, agitation and tingling, occurred in 11 cases and were recognised as 
the first sign in two cases. Five women who died had premonitory symptoms which were not recognised as being due to AFE 
before another event occurred: seizure (1), acute fetal compromise (2), hypotension (1), haemorrhage (1). Of the deaths that 
did not have premonitory symptoms, one presented with shortness of breath, one with a seizure and two with cardiac arrest. 
Five women had seizures and this was the first presenting sign for two women, both of whom died.
Management
Of the 12 cases where there was data on the time between first symptom and AFE first being considered, the median time was 
27 minutes (range 0–145 minutes). This is consistent with 33 minutes (zero minutes to two days) in the UKOSS data. 
All five surviving AFE cases occurred in level 3 maternity units. Of the 13 AFE-related deaths, six occurred in level 3 units, five 
in level 2, one in a birthing unit, and one at home (Fisher’s Exact p=0.10 for survival given birth in a level 3 unit compared to 
all other places of birth). 
Perimortem caesarean section was performed in four cases, at 4, 14, 14, and 84 minutes after the AFE was considered to 
have occurred. 
Five women had a hysterectomy (28 percent), and these women all died. This is consistent with the UKOSS data. In the UK 
series, 26 percent of women had a hysterectomy; 40 percent of those who died or had permanent neurological damage and 
21 percent of those without a severe outcome.
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Among the AFE deaths in New Zealand, women who received cryoprecipitate (n=6) died a median of 38 hours and 9 
minutes after the AFE occurred whereas women who did not receive cryoprecipitate (n=7) died a median of 99 minutes after 
first signs of AFE. All five women who survived received cryoprecipitate but it was given to only 46 percent of the women who 
died (6 of 13 women) in the New Zealand series (Fisher’s Exact test p=0.10). These data are consistent with UKOSS data that 
found women who died or had permanent neurological damage were less likely to have received cryoprecipitate. 
The UKOSS study also found that women who didn’t get cryoprecipitate died earlier than those who did, however this might 
be due to insufficient time, given the severity of the maternal condition, to administer cryoprecipitate. 
Recombinant factor VIIa was given to three women with AFE who died and in one woman who survived. All survivors received 
platelets and fresh frozen plasma compared with nine of the 13 deaths. Only one death and one survivor received fibrinogen.
In New Zealand median time from AFE presentation to death was 3 hours 22 minutes (range 4 minutes to 23 days). Nine 
women died within 5.1 hours of presentation and the remaining four women died after 1 day. In the UK, median time from 
first presentation of AFE to death was 1 hour and 42 minutes.
Adequacy of resuscitation
At review, ongoing resuscitation was thought to be suboptimal in five of the 13 fatal cases (38 percent) and 20 percent (1 in 
5) of non-fatal cases. Issues noted included delayed transfer to an area of appropriate acuity associated with delayed onset of 
treatment, inadequate transfusion in two cases (needed products consistent with the Massive Transfusion Protocol), inadequate 
fluid management, and non-standard response to cardiac arrest (delay in cardiopulmonary resuscitation).
Implication of findings
New Zealand has a comparatively high rate of maternal mortality due to AFE, and the case fatality rate is also high. However, 
the actual number of cases, fatal and non-fatal, is small. While some comparison is possible with the UKOSS AFE cases, the 
limited numbers mean that it is hard to draw definitive conclusions, but some issues have been raised by this retrospective 
review. 
AFE incidence appears to have been over-estimated during the collection of data for the AMOSS project, and this is consistent 
with previous reports of difficulties with different methods of case ascertainment (Knight et al 2012). However AFE mortality 
ratios do not appear to be affected by case ascertainment methodologies, and this is consistent with the confirmation of all 
fatal cases of AFE in this New Zealand review.
The case fatality rate in New Zealand is high compared to the UK (44 percent compared to 19 percent). However, the 
numbers are small and the difference is not statistically significant.
Of note, there were no survivors in the group of women with AFE in New Zealand who presented with cardiac arrest. This 
may reflect the severity of cases of AFE in this cohort but could also be due to suboptimal resuscitation. 
The median time from first symptoms or signs of AFE to death in New Zealand was 3 hours and 22 minutes compared to 1 
hour and 42 minutes in the UK. This may not be a significant difference but suggests that the cases dying in New Zealand 
are less severe rather than more severe at presentation. This interpretation assumes that death is less often avoidable from the 
acute anaphylactoid response to AFE, but possibly remediable from the severe coagulopathy which then unfolds.
Specific issues raised around resuscitation included transfer to an appropriate area for intensive management, early institution 
of appropriate blood replacement using a massive transfusion protocol, and following standard resuscitation protocols for 
cardiac arrest. 
Summary
The maternal mortality ratio from AFE in New Zealand is 5.6 times higher than in the UK. Retrospective review of the data 
does not support the hypothesis that AFE is over-diagnosed in New Zealand. Further, the comparability of induction and 
caesarean section rates between New Zealand and the UK does not support the hypothesis that higher rates of these risk 
factors leads to a higher incidence of AFE.
In addition, the review does not provide any evidence to suggest that fatal cases were more severe in New Zealand than in 
the UK series. 
The data suggest that resuscitation could have been improved in some cases. All clinicians involved in maternity care need to 
be able to recognise the possibility of AFE early in its presentation and need to be able to respond with timely and effective 
resuscitation. 
In its fifth report (PMMRC 2011) the PMMRC recommended that all clinicians involved in the care of pregnant women should 
undertake regular multidisciplinary training in management of obstetric emergencies. Consideration should be given to making 
this training mandatory.
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PRACTICE POINT: AMNIOTIC FLUID EMBOLISM
Diagnosis
Consider AFE in the differential diagnosis when women present with acute behavioural changes such as sudden anxiety, 
agitation (eg, removing IV lines, oxygen masks, aggression) and dyspnoea in labour or immediately postpartum (within 
30 minutes).
Any of the following that occur during labour, caesarean birth, dilation and evacuation or within 30 minutes postpartum 
without other explanation should alert the practitioner to the possibility of AFE (Thongrong et al 2013):
• acute hypotension
• cardiac arrest
• acute hypoxaemia or respiratory distress
• severe haemorrhage or coagulopathy.
Common signs and symptoms (adapted from Thongrong et al 2013)
System Signs and symptoms
General – prodromal Tingling, numbness, lightheaded, chest pain, vomiting, cough
Respiratory Dyspnoea, bronchospasm, pulmonary oedema, acute respiratory distress
Cardiovascular Cyanosis, hypotension, transient hypertension, chest pain, cardiopulmonary arrest
Neurological Seizures, headache, loss of consciousness
Haematological Coagulopathy, disseminated intravascular coagulation
Fetus Fetal bradycardia
Management
A combination of early recognition with early and aggressive resuscitation is essential to achieve favourable outcomes 
for mothers and babies (RCOG 2011). 
If you have any concern regarding the possible diagnosis of AFE:
• If in a primary birthing setting and there is any indication/symptom of AFE, arrange urgent transfer to 
secondary/tertiary care as a life threatening condition. 
• Involve senior obstetric, anaesthetic, intensive, midwifery and neonatal staff early.
If maternal collapse occurs:
• Commence/continue cardiopulmonary resuscitation (CPR) if there is evidence of cardiac arrest or circulatory 
insufficiency such as profound hypotension, loss of consciousness or absence of a palpable pulse. 
• Instigate Left Uterine Displacement (LUD) in women with a palpable uterus. This is ideally done manually but can 
be done with left tilt if there is inadequate staffing to allow manual displacement. Ensure CPR is performed on a 
firm surface.
• Perimortem caesarean section needs to be considered at the commencement of CPR, and if there is no return of 
circulation, aim for delivery within five minutes. (See ‘Practice Point: Perimortem Caesarean Section’ in the ninth 
report of the PMMRC: http://www.hqsc.govt.nz/assets/PMMRC/Publications/PMMRC_Ninth_Report_Practice_
Points.pdf )
• Initiate the massive transfusion protocol, including the use of cryoprecipitate.
• Lifesaving interventions such as defibrillation and medication should not be withheld in the setting of pregnancy.
All clinicians involved in the care of pregnant women should undertake regular multidisciplinary training in management 
of obstetric emergencies (previous PMMRC recommendation).
122
2.6 Review of maternal suicide deaths 2006–2013
Background 
Justification for review 
The ninth report of the PMMRC (PMMRC 2015) reported a cause specific maternal mortality ratio for suicide in New Zealand that 
was 7.5 times that reported in the UK (p<0.0001).
There were 22 maternal deaths from suicide from 2006 to 2013. The suicide specific maternal mortality ratio in New Zealand for 
the eight years from 2006 to 2013 is 4.3/100,000 maternities. 
Previous PMMRC review of maternal suicide
The sixth report of the PMMRC (PMMRC 2012) reviewed maternal suicide as it was noted to be the leading cause of maternal 
death at that time. 
Health Quality & Safety Commission survey of LMCs 2010–2011 (PMMRC 2012)
The results of a maternal mental health survey of LMCs undertaken by the Health Quality & Safety Commission in 2010–2011 on 
behalf of the PMMRC were also reported in the sixth report of the PMMRC. 
There were 398 respondents, which was 40 percent of those contacted. The respondents were midwives (89.6 percent), 
obstetricians (9.3 percent) and paediatricians (1.1 percent).
Three-quarters of respondents routinely screened pregnant women for depression using specific questions, and 61 percent said 
there was a specific referral pathway for women identified as being at risk of developing mental health problems during or after 
pregnancy. Only 46 percent felt completely comfortable asking women about their mental health history, and 84 percent felt 
they would benefit from more training. At the time, 32 percent of respondents felt that services for maternal mental health were 
overwhelmed, poorly coordinated or insufficient. 
International comparisons
As noted previously, international comparisons of maternal mortality are difficult because of uncertainty around case 
ascertainment and differences in classification methods. However, the reported data show that maternal suicide is seven times 
more common in New Zealand than in the UK, while all other indirect causes occur with similar mortality ratios (Figure 2.4).
Nine of the 21 New Zealand suicide deaths (43 percent) noted in the ninth report of the PMMRC were reported by either the 
Mortality Collection or by pathologists, compared to reporting of 10 percent of other causes of maternal mortality (which are 
reported almost entirely by DHB local coordinators or clinicians). This would suggest that suicide ascertainment may not occur in 
the same way as ascertainment of other causes of maternal mortality and so may be undercounted in some countries.
United Kingdom 
The UK’s most recent maternal mortality report details deaths for the triennium 2011 to 2013 and lessons learned from 
deaths 2009–2013 (Knight et al 2015). There were 19 deaths in the 2011–13 triennium from psychiatric causes, a ratio of 
0.80/100,000 (CI 0.48–1.25). Deaths from psychiatric causes represent the fifth most common individual cause of maternal 
death in the UK during or up to six weeks after the end of pregnancy.
The UK also reported on late maternal deaths (deaths occurring more than six weeks and up to one year after the end of 
pregnancy). This report noted that deaths from psychiatric causes in the UK make a significant contribution to late maternal 
deaths, making up almost a quarter of  late maternal deaths, which suggests that the first year postpartum poses a greater risk 
than the antepartum period in the UK. One hundred and one women died by suicide and 58 women died as a consequence 
of substance use either during pregnancy or up to one year after the end of pregnancy in the UK between 2009 and 2013. A 
further two women died from other mental health related causes, making a total of 161 women who died from mental health 
related causes during or up to one year after the end of pregnancy. There was no evidence of higher risk among teen mothers 
or mothers of black or other minority ethnic groups, but an apparent increase in risk among women in higher socioeconomic 
deprivation groups. Domestic abuse was noted to have ‘ever’ occurred in 17 percent of cases, and 24 percent of the women 
were known to social services. 
Of the 101 deaths from suicide; 57 percent had a diagnosis of recurrent mental health disorder (ie, mental health history), 82 
percent died by violent means (most often hanging), 14 women had comorbid substance use (usually polysubstance use, rarely 
alcohol alone). Fifty-one percent of suicide deaths were noted to be potentially avoidable (‘improvements to care were noted 
which would have made a difference to the outcome’), and a further 18 percent had contributory factors only (‘improvements 
to care were noted which would not have made a difference to outcome’). However, there were insufficient records to classify 
quality of care in 19 percent of cases.
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Australia 
It is difficult to make comparisons with Australian maternal (suicide) deaths due to Australia’s limited maternal mortality review 
process, likely incomplete case ascertainment and differences in approach to categorisation of deaths.
Australia’s most recent maternal mortality report covers deaths from 2006 to 2010 (Johnson et al 2014). Out of the 99 reported 
maternal deaths, 13 were from ‘psychosocial morbidity’. Nine of these deaths were by suicide, and the other four by homicide 
(2) and overdose (2). The maternal mortality ratio for deaths from psychosocial morbidity was 0.9/100,000 maternities. 
Maternal deaths from psychosocial morbidity were the second leading cause of indirect maternal deaths in this reporting period. 
Eight (62 percent) of these deaths occurred antenatally. A previous psychiatric history was noted for eight women (62 percent) 
with four (31 percent) having contact with a psychiatric service perinatally. 
New Zealand initiatives
In the last few years there have been a number of national initiatives aiming to improve the mental health care of women in 
pregnancy and the postpartum period.
The Healthy Beginnings report (Ministry of Health 2012b) provided guidance to DHBs, planners, funders and providers 
of mental health services, and alcohol or other drug services around meeting the needs of the mothers and babies in their 
services. The report highlighted a number of issues; for example, under-provision of services for mothers with alcohol or 
other drug problems, a need for services to be flexible and adaptable for the group they are serving, for clinicians to be 
appropriately skilled, and, at the time, the lack of mother and baby mental health beds in the North Island.
Following on from Healthy Beginnings, new funding was made available to the Northern region of the North Island to expand 
the continuum of acute mental health services available for mothers and babies. This has led to the establishment of three 
mother and baby beds at Starship Hospital in Central Auckland, and is proving a valuable resource in the treatment of acutely 
unwell mothers with their babies. There also has been development and extension of services across the continuum of care, 
including increased resourcing of community mental health perinatal services, and extension of respite and non-governmental 
organisation services. This includes 24-hour perinatal phone advice for general mental health services dealing with acute 
presentations of mothers.
The importance of having clearly defined pathways of care has previously been identified, with a significant proportion of 
LMCs reporting feeling confused about where to refer mothers who were mentally unwell (PMMRC 2012). Anecdotally, it is 
still likely that maternal mental health services throughout New Zealand operate with different models of care and referral 
processes. Pathways for maternal mental health care have been a focus of the work plan of the National Maternity Monitoring 
Group (NMMG) in New Zealand (NMMG 2013). The NMMG was established by the Director General of Health in 2012 to 
provide oversight of the New Zealand maternity system. 
DHBs have been asked to report to the NMMG specifying their pathways of care – this is a work in progress but should 
ultimately lead to clear, consistent and easily accessible pathways of care.
Midwives attend a mandatory Practice Day once every three years as part of the Midwifery Council’s Recertification 
Programme, along with other compulsory and elective education activities. One of the key topics included within the current 
Practice Day (for the current three-year recertification cycle (2014–2017)) is maternal mental health. The focus of this 
education has been on the midwifery role of screening, identifying and referring women with mental health concerns. The 
feedback from midwives attending these workshops has identified an interest in ongoing access to more in-depth education on 
maternal mental health. 
There are a range of other maternal mental health ongoing education programmes available throughout New Zealand. 
However, the accessibility and content of these programmes vary. A funded, nationally consistent approach is desirable, 
similar to the education provided for smoking cessation and family violence. 
An important initiative in the area of suicide review has been the establishment of the Suicide Mortality Review Committee in 
2014. The group has been set up for a time-limited trial period with the goals of providing additional information about trends 
in suicide deaths, identification of intervention points, and to consider how a more permanent suicide group would function 
and operate.
The importance and ongoing need for New Zealand initiatives has been underlined by the findings of this current report – that 
is, maternal suicide remains a leading cause of death, and our national rate is much higher than the UK.
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Maternal suicide deaths 2006–2013 (n=22)
During the years 2006–2013, 22 women in New Zealand died during or within six weeks of pregnancy of suicide. For 13 
women the suicide occurred in pregnancy, six before 20 weeks and seven between 20 weeks and term. Two deaths occurred 
after term births, five after termination of pregnancy, and two following miscarriage.
Approximately two-thirds of the 22 suicides were deaths due to hanging. This is consistent with suicide among young people 
outside of pregnancy. Hanging, strangulation and suffocation collectively were the predominant method used for suicide 
by both males and females in all life-stage age groups in New Zealand in 2012. Poisonings generally increased with age, 
particularly for female suicides, to nearly the same proportion as hanging, strangulation and suffocation (Ministry of Health 
2015c). 
National review of cases by the maternal working group found that there were contributory factors to 14 (64 percent) deaths. 
There were barriers to access and/or engagement with care in 13 cases (59 percent) and organisation and management 
and personnel factors in eight cases (36 percent). Lack of policies, protocols or guidelines and inadequate systems for sharing 
of clinical information between services were noted to be contributory factors in four and three post-termination suicides 
respectively. 
Seven cases (32 percent) were assessed as potentially avoidable. 
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Maternal death by suicide was more common among Māori mothers and young mothers (<20 years old), and increased with 
increasing socioeconomic deprivation, but none of these trends was statistically significant.
Table 2.6: Maternal suicide deaths and demographic characteristics 2006–2013
* * not estimated where n≤1
# Defined prior to conception of the index pregnancy.
 
n % n % ratio 95% CI
Ethnicity (prioritised)
Māori 116,606 23.05 12 55 10.3 5.9–18.0
Pacific 53,335 10.54 2 9 3.7 1.0–13.7
Indian 18,390 3.63 *
Other Asian 39,304 7.77 1 5 *
Other (including unknown) 45,309 8.95 *
New Zealand European 233,046 46.06 7 32 3 1.5–6.2
Deprivation quintile
1 (least deprived) 80,545 15.92 3 14 3.7 1.3–11.0
2 89,266 17.64 2 9 2.2 0.6–8.2
3 95,574 18.89 4 18 4.2 1.6–10.8
4 105,390 20.83 3 14 2.8 1.0–8.4
5 (most deprived) 132,384 26.16 10 45 7.6 4.1–13.9
Unknown 2,831 0.56
Age (years)
<20 35,769 7.07 6 27 16.8 7.7–36.6
20–24 92,282 18.24 4 18 4.3 1.7–11.1
25–29 125,511 24.81 6 27 4.8 2.2–10.4
30–34 143,005 28.26 3 14 2.1 0.7–6.2
35–39 89,213 17.63 2 9 2.2 0.6–8.2
>40 20,205 3.99 1 5 *
0 22,164 39.7 11 50
1–3 30,966 55.4 8 36















‘Prior’ psychiatric history 14 64
Psychiatric history in previous pregnancy 4 18
New psychiatric illness diagnosed this pregnancy 2 9
New psychiatric illness diagnosed postnatally 2 9
Received psychiatric care during pregnancy 6 27
Deliberate self-harm before pregnancy 8 36
Deliberate self-harm during pregnancy 5 23
Family psychiatric history 9 41








Family violence in this pregnancy
Yes 5 23
No 10 45
Not asked 2 9
Unknown 5 23
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Data were not available for all maternities to provide a comparison for suicides in Table 2.7, but it is evident that women 
who die by suicide in and soon after pregnancy are vulnerable, with high rates of substance use (50 percent), high rates of 
smoking (50 percent), and high rates of exposure to family violence both before the index pregnancy (36 percent) and in the 
index pregnancy (23 percent). Numbers are small and the differences are not statistically significant, but these characteristics 
tended to occur less commonly among women who died by suicide later in pregnancy (20 weeks to term) (p=0.08 for all 
associations).
Review of cases 
This section describes the findings of a review of reports from the initial contemporaneous independent review of the 22 cases 
of suicide from 2006 to 2013 by the MMRWG. This review was undertaken by a subgroup of the MMRWG with each case 
reviewed by two members of the subgroup. The findings of each team were discussed and consensus of opinion was reached 
on important themes raised. The suicides were grouped as follows for the purposes of this review:
• antenatal (suicides in pregnancy and prior to 20 weeks gestation (6) and suicides in pregnancy from 20 weeks but 
prior to birth (7))
• postnatal (suicides after termination of pregnancy (5), suicides after miscarriage (2), and suicides after live births (2)).
Antenatal suicides in pregnancy and prior to 20 weeks gestation
There were six deaths from suicide early in pregnancy. These occurred between 3 and 15 weeks, three between 3 and 6 
weeks. Of these women, three were in their teens. Four were of Māori and two of Pacific ethnicity. 
Four of these women had a past history of mental illness, including postnatal depression, prior suicide attempts or self-harm; 
three had a history of alcohol or other substance use; and three had a history of family violence. It was common for women to 
have two or three of these risk factors. Five of these six women had relationship difficulties at the time of their suicide.
These women did not readily access services, only three having consulted with primary care (general practice) in this 
pregnancy. 
It was often difficult to identify where to request health care provider information to conduct the death review.
Antenatal suicides from 20 weeks but prior to birth 
There were seven deaths among pregnant women from 20 weeks gestation. These women had some differences from the other 
groups of maternal deaths from suicide. They were less often Māori (p<0.01), and none were teenagers (p=0.05). They were 
also less often smokers, alcohol or other substance users or exposed to family violence, although these differences were not 
statistically significant (p=0.08). All of these women were living in areas where specialist perinatal services were available. 
Women with pre-existing illness  
Four women had pre-existing significant mental health history of severe/significant and complex disease. Although they may 
have been well or stable prior to pregnancy (not in every case), in all cases the pregnancy seemed to be a catalyst for a 
deterioration in mental wellbeing.
All four were under the care of specialist mental health services during the pregnancy, and at the point of suicide. Maternal 
mental health services were involved or had been referred to in three cases. Interfaces between services were an issue for two 
women with barriers between the public and private sector, maternal mental health and general adult mental health. 
Admission could have been considered in two cases and may have helped with diagnostic clarification/risk management. It 
should be noted that in New Zealand, admission during pregnancy is usually to an adult general mental health in-patient unit 
(rather than a Mother and Baby unit) and this may impact on the decision to admit.
Overall, these women’s clinical presentation seemed to be complicated/fluctuant. There was often frequent contact with 
mental health services and a changing clinical picture in some (which may have falsely reassured clinicians), with an unclear 
diagnosis.
In one case maternal mental health was not involved and had not been referred to. All pregnant or breastfeeding women with 
serious mental illness should have at least a consultation with maternal mental health. We also note that maternal mental health 
services often interface with other services such as general adult services, and thus good communication and information 
sharing is paramount. It is also noted that maternal mental health services often operate with different models of care, which 
may make referral processes and information sharing more difficult.
Women without pre-existing illness
For the three women without a significant mental health history, the limited information available suggested relationship stress 
was a significant factor. Of note, information on family violence and family psychiatric history did not appear to have been 
collected in all cases. 
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General themes relevant to all cases from 20 weeks but prior to birth
Information sharing between various services was a theme in three cases, in relation to mental health history, and when a 
number of agencies or services were involved, not all providers had access to all of the relevant information.
It was difficult to assess the quality of confiding/supportive relationships from the information that was available, although in 
general these women seemed to be lacking in social support. Relationship stress of some sort, either currently or previously 
seemed to be a clear theme in almost every case, including the women with significant history. This highlights the importance 
of examining suicides in their full social context to inform on potential improvements in service provision, including public 
education.
Disconnection from the pregnancy or unborn baby was also a theme that was noted in two of the cases. 
In summary, the women who died from suicide in pregnancy from 20 weeks were older, more likely to have severe and 
complex mental illness, and often had major relationship stress and problems with their primary support system. Disconnection 
from the pregnancy was noted in two cases, and may have been a ‘red flag’.
Postnatal deaths after live births (2) 
Only two of the 22 deaths from suicide were following term birth. Both were of Māori ethnicity. Alcohol or drug use and family 
violence were present. Both women were in their mid-twenties, had a history of mental health illness, and issues with access 
and/or health service engagement were identified. 
Postnatal deaths after termination of pregnancy (5)  
Five of the 22 maternal deaths by suicide that occurred between 2006 and 2013 followed termination of pregnancy. These 
women were aged 25 years or under and three were in their teens. Four women identified as Māori. These are high rates 
of young and Māori women among deaths by suicide after termination of pregnancy, but given the small sample size it is 
not possible to say whether this is a significant feature or whether it differs from all women undergoing early termination of 
pregnancy.
The risks identified in review of these cases included young age, drug and alcohol use, history of sexual assault, current mental 
health illness and dysfunctional relationships. All of the women who committed suicide following termination had three or four 
of these factors identified.
Multiple services were involved in the care of these women during pregnancy and leading up to their death (2–5 services) 
including primary care, mental health, drug and alcohol, termination of pregnancy, maternity, and Child, Youth and Family 
services. The full extent of women’s mental health history was not known by all services because of a lack of communication. 
Further, the accumulation of risk factors was not identified by any one service. 
Postnatal deaths after miscarriage (2) 
Two suicides followed first trimester miscarriage. One of these women had a history of mental health illness. There was no 
evidence of either woman receiving pregnancy loss counselling. 
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Summary
The Healthy Beginnings report (Ministry of Health 2012b) provided guidance around meeting the mental health needs of 
mothers and babies. Following this, new funding resulted in the provision of three mother–baby unit beds in Auckland, and 
development and extension of services across the continuum of care. 
However, there remains a lack of clearly defined pathways for many DHBs. The NMMG has taken some leadership in this 
area. There is an impression that LMCs still feel unsupported in the provision of maternal mental health support. 
A review of the 22 maternal deaths by suicide between 2006 and 2013 produced the following findings:
• Thirteen maternal deaths by suicide occurred during the antenatal period: six before 20 weeks and seven beyond 20 
weeks; two occurred after miscarriage; five occurred after termination; and two occurred after term births.
• Approximately two-thirds of the deaths were due to hanging, consistent with deaths by suicide among all young 
women in New Zealand. 
• Maternal death by suicide was more common among Māori women and among teenagers, and the ratio increased 
with increasing socioeconomic deprivation, but none of these demographic trends was statistically significant.
• Two-thirds of women had a prior psychiatric history and one-third had a history of deliberate self-harm prior to 
pregnancy.
• Alcohol and other substance use (often polysubstance use) and smoking were common.
• A third of women had a history of family violence at some time in their lives.
• Women who died by suicide while pregnant in the first 20 weeks of pregnancy (6) often had two or three risk factors, 
such as a history of mental illness, a history of self-harm, alcohol and other substance use, and family violence. This 
was also true of women who died by suicide after termination of pregnancy (5).
• Lack of communication between services and lack of recognition of multiple risk factors, or of a crisis plan for at-risk 
women, was evident among women who died after termination of pregnancy.
• Women who died by suicide while pregnant in the second half of pregnancy (7) were older and less often Māori. They 
did not tend to have a history of alcohol or substance use or family violence. Four of these women had a history of pre-
existing and often complex illness, which deteriorated in pregnancy. All were under care, although there were some 
communication issues between services.
• Relationship stress was a feature of almost all women who died by suicide in pregnancy.
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PRACTICE POINT: MATERNAL SUICIDE
Pregnancy and the postpartum period are not protective against mental illness, and can be a trigger for onset and for 
deterioration of mental illness.
Early during a woman’s contact with services, ask about:
• past or present mental illness
• past or present treatment by a specialist mental health service, including in-patient care
• family history of severe mental illness, including perinatal mental illness in a first degree relative.
Women who have a history of severe mental illness should be referred to a secondary mental health service even if 
currently well, as their risk of relapse in the postpartum period may be high. They need an appropriate mental health 
birth plan and monitoring for the peripartum period. 
Any of the following suggests a serious mental illness and requires urgent assessment by mental health services, 
including early consultant psychiatrist review and consultation with perinatal mental health services:
• suicidal ideation (especially if violent)
• psychotic symptoms
• recent significant change in mental state including fluctuating or emergence of new symptoms
• pervasive guilt or hopelessness
• ongoing beliefs of inadequacy as a mother
• a sense of estrangement or disconnection from the infant.
Women should have continuity of, and culturally appropriate, mental health care. During pregnancy and the 
postpartum period there may be more than one mental health team involved – in such cases there should be one 
identified individual who coordinates care.
All clinicians involved in a woman’s care need relevant mental health history and current knowledge of a woman’s 
pregnancy to support them to provide the best care. Routine sharing of relevant information across general practice, 
LMC and mental health services interfaces will enable better informed care. Any concerns regarding risk need to be 
clearly communicated by all clinicians involved.
Pregnant and postpartum women who use substances often have complex social and mental health needs, and face 
additional barriers in accessing services. 
Previous PMMRC Recommendations
1. Maternal mental health screening should be included as part of standard antenatal care, and women with a 
previous history of serious affective disorder or other psychoses should be referred for psychiatric assessment 
and management even if they are currently well.
2. Strategies are required to improve communication and coordination between the full range of primary 
maternity providers (eg, LMC, GP) and secondary providers (eg, mental health services, maternal mental 
health services, maternity, including termination of pregnancy services).
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2.7 Maternal Mortality Appended Tables




Maternal deaths Maternal 
mortality 
ratio 2006 2007 2008 2009 2010 2011 2012 2013 2014 
2006–
2014 
n=564,637 n=15 n=11 n=9 n=14 n=9 n=9 n=10 n=13 n=4 n=94 
/100,000 
maternities 
n % n n n n n n n n n n % 
Maternal age (years)                             
<20 38,809 6.9 - - 1 1 1 1 2 - - 6 6.4 15.46 
20–24 102,571 18.2 3 2 - - - 1 3 3 - 12 12.8 11.70 
25–29 141,118 25.0 3 1 3 4 3 3 1 5 2 25 26.6 17.72 
30–34 160,485 28.4 2 5 3 4 1 1 2 3 - 21 22.3 13.09 
35–39 98,918 17.5 4 2 2 3 2 2 2 - 1 18 19.1 18.20 
≥40 22,731 4.0 3 1 - 2 2 1 - 2 1 12 12.8 52.79 
Ethnicity (prioritised)                             
Māori 129,548 22.9 9 2 4 4 3 5 8 4 - 39 41.5 30.10 
Pacific peoples 59,213 10.5 1 2 - 6 3 3 - 1 1 17 18.1 28.71 
Indian 21,167 3.7 1 1 - 1 - - - - - 3 3.2 14.17 
Other Asian 45,797 8.1 - - 2 1 - - - 2 - 5 5.3 10.92 
Other (including unknown) 50,740 9.0 1 1 - - - - - - - 2 2.1 3.94 
NZ European 258,172 45.7 3 5 3 2 3 1 2 6 3 28 29.8 10.85 
Deprivation quintile                             
1 (least deprived) 89,862 15.9 - 2 1 1 3 - - 2 - 9 9.6 10.02 
2 99,549 17.6 - 2 2 - - 1 1 1 2 9 9.6 9.04 
3 106,940 18.9 4 - 1 4 1 1 2 3 1 17 18.1 15.90 
4 117,652 20.8 4 2 4 5 3 2 - 2 - 22 23.4 18.70 
5 (most deprived) 147,525 26.1 7 5 1 4 2 5 7 5 1 37 39.4 25.08 
Unknown 3,109 0.6 - - - - - - - - - - - - 
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3 Neonatal encephalopathy 2014
3.1 Methodology
Case definition
Neonatal encephalopathy (NE): a clinically defined syndrome of disturbed neurological function within the first week of life in 
the term (≥37 weeks) infant, manifested by difficulty in initiating and maintaining respiration, depression of tone and reflexes, 
subnormal level of consciousness and often seizures. This dataset includes Sarnat stages 2 or 3 equivalent to moderate and 
severe only.
Although hypoxia-ischemia is the predominant pathology, reported cases of term infants with neonatal encephalopathy 
are included in this dataset whatever the cause. Therefore, the full cohort includes a small number of cases where neonatal 
encephalopathy is associated with hypoglycaemia, congenital abnormality of the central nervous system, or infection.
Cases were initially identified with the assistance of the New Zealand Paediatric Surveillance Unit and the collection of data 
facilitated by paediatricians, LMCs and the national coordination service of the PMMRC, as described in detail in the fifth 
report of the PMMRC (PMMRC 2011). Since 2012, cases have been notified by key clinicians in neonatal units and the 
PMMRC local coordinators. 
From 2016 the Neonatal Encephalopathy Working Group has widened the inclusion criteria for the neonatal encephalopathy 
cohort and will include cases from 35 weeks at birth in line with international literature and practice of cooling down to this 
age (The American College of Obstetricians and Gynecologists 2014). 
Denominator data, as used elsewhere in this report, are the births included in the birth registration dataset of New Zealand 
collated by BDM. For calculation of rates, the denominator set was restricted to births at term (as is the numerator).
In this report, the MAT dataset of births in 2014 has been used to provide comparative data for some demographic and 
clinical characteristics; for example, smoking, BMI, parity and maternity care.
For information on data analysis methods, please refer to Perinatal Mortality 2014 section 1.2: Methodology.
3.2 Findings
In 2014 there were 55 cases of moderate and severe neonatal encephalopathy reported to the national dataset. This is the 
lowest number of cases reported since 2010 when data were first collected (82 cases in 2010, 67 in 2011, 79 in 2012, 70 
in 2013). While this is encouraging, there is no statistically significant reduction in rate and the observed drop in 2014 may 
reflect random variation.
The neonatal encephalopathy rate for 2010–2014 was 1.14/1000 total births (95% CI 1.02–1.26), or 1.24/1000 term 
births (95% CI 1.11–1.37). 
International comparisons
In a 2013 paper, Lee et al estimated that in countries with a neonatal mortality rate <5/1000 births, such as New 
Zealand, the median incidence of neonatal encephalopathy associated with intrapartum events (including mild neonatal 
encephalopathy) was 1.60/1000 births (range 0.68–3.75/1000) for 1980 to 2013 with evidence of reduced incidence 
over time from some studies (Lee et al 2013). This would suggest that at 1.14/1000 births for moderate and severe 
neonatal encephalopathy, New Zealand is within international incidence rates. Case fatality rate among babies with severe 
neonatal encephalopathy was 76.8 percent (range 61.9–91.7 percent) compared to 59 percent in the New Zealand 
cohort. Of survivors reported in the Lee et al paper, 26.4 percent (range 22.1–30.8 percent) developed moderate to severe 
neurodevelopmental impairment, and 14 percent (range 8.8–19.2 percent) developed mild neurodevelopment impairment.
Demography and neonatal encephalopathy
Mothers of Māori, Pacific and Indian ethnicity are at increased risk of having a baby with neonatal encephalopathy, although 
only the rate in Pacific mothers is significantly higher than that of Other Asian, Other, and New Zealand European mothers. 
Increasing socioeconomic deprivation is also associated with increased risk of neonatal encephalopathy. There is no 
statistically significant association between maternal age and neonatal encephalopathy risk. Maternal Pacific ethnicity remains 
a predictor of neonatal encephalopathy after adjusting for gestation at birth, year of birth, deprivation quintile, multiple 
pregnancy and maternal age.
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Figure 3.1: Neonatal encephalopathy rates (per 1000 term births) by maternal prioritised ethnicity 2010–2014





















































DHB of maternal residence
Figure 3.3 includes combined data for neonatal encephalopathy by DHB of maternal residence for 2010–2014. 
In 2014, Taranaki DHB has become an outlier DHB with a statistically significantly higher neonatal encephalopathy rate than 
the national rate when cases are combined for the years 2010–2014. Capital & Coast DHB was identified as an outlier in 
the 9th PMMRC report (PMMRC 2015). The rate at Waikato DHB, a previous outlier, is now consistent with the national rate. 
Numbers of cases reported by both Capital & Coast and Waikato DHBs are lower (but not statistically significantly lower) in 
the years since they were first noted to be outliers. 
There have been 17 cases reported among mothers resident in Taranaki DHB from 2010 to 2014, and the rate overall for 
these five years was 2.37/1000 term births (95% CI 1.38–3.79). There have been 32 cases reported among mothers resident 

























DHB of maternal residence  
NE rate/1000 term births NE rate NZ
* Excludes any DHB with fewer than three cases.
Figure 3.3: Neonatal encephalopathy rates (per 1000 term births) by DHB of maternal residence* (with 95% CIs) compared to 
New Zealand neonatal encephalopathy rate 2010-2014
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Gestation, gender, birthweight and plurality
Table 3.1: Neonatal encephalopathy rate (per 1000 term births) by gestation, gender, birthweight and plurality 2010–2014
 
  




(/1000 term births) 
n=284,145 n=353   
n % n % /1000 95% CI 
Gestation at birth (weeks)             
37 19,402 6.8 39 11.0 2.01  1.43–2.75  
38 48,413 17.0 58 16.4 1.20  0.91–1.55  
39 80,267 28.2 79 22.4 0.98  0.78–1.23  
40 83,502 29.4 87 24.6 1.04  0.83–1.29  
41 45,344 16.0 82 23.2 1.81  1.44–2.24  
≥42 7,217 2.5 8 2.3 1.11  0.48–2.18  
Gender             
Male 145,348 51.2 197 55.8 1.36  1.17–1.54  
Female 138,797 48.8 156 44.2 1.12  0.95–1.30  
Birthweight (g)             
<2,500 5,488 1.9 15 4.2 2.73  1.53–4.51  
2,500–3,999 232,923 82.0 291 82.4 1.25  1.11–1.39  
4,000–4,499 37,781 13.3 33 9.3 0.87  0.60–1.23  
≥4,500 7,859 2.8 14 4.0 1.78  0.97–2.99  
Unknown 94 0.0 - - -                      -  
Plurality             
Singleton 280,478 98.7 347 98.3 1.24  1.11–1.37  
Twins 3,667 1.3 6 1.7 1.64  0.60–3.56  
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Gestation at birth (weeks) 
There is a significant association between gestation at birth and neonatal encephalopathy risk. There is a significantly higher 
rate of neonatal encephalopathy among babies born at 37 and at 41 weeks than among babies born at 38-40 weeks. The 
risk at 42 weeks and above is difficult to estimate as numbers are small and the CIs are necessarily wide.
There is no significant association between baby sex and neonatal encephalopathy. 
Babies <2500g at term were significantly more likely to suffer neonatal encephalopathy than babies 2500–4499g. 
There is no significant increase in neonatal encephalopathy among multiple births at term compared to singleton births. 
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Currently smoking     
Yes 68 19.3 
No 281 79.6 
Unknown 4 1.1 
Parity*     
Primiparous (=1) 201 56.9 
Multiparous (≥2) 152 43.1 
Maternal BMI (kg/m2)      
<18.50 2 0.6 
18.50–24.99 111 31.4 
25.00–29.99 107 30.3 
≥30.00 110 31.2 
Missing data for height and or weight 23 6.5 
Gestation first antenatal visit (weeks)     
≤13 207 58.6 
14–19 50 14.2 
≥20 50 14.2 
Unknown  46 13.0 
 * Defined after birth of the index case.
Table 3.2: Maternal smoking, parity, body mass index (BMI) and gestation at first antenatal visit among neonatal encephalopathy 
cases 2010–2014
Table 3.2 shows the smoking, parity, BMI and antenatal care characteristics of mothers of babies diagnosed with neonatal 
encephalopathy from 2010 to 2014. 
The MAT dataset is still incomplete in 2014 due to incomplete data for about 5 percent of New Zealand mothers who were 
under DHB primary maternity care. While these missing data may alter background rates, missing data represent a small 
proportion of all mothers and so the MAT data likely provides the best current estimate of true national maternal averages 
for smoking, BMI and parity. An overview of the MAT dataset can be found in Perinatal Mortality 2014  section 1.2: 
Methodology.
Among all mothers birthing in New Zealand with data in the MAT dataset in 2014, 15.9 percent were smokers either 
at registration or at two weeks postpartum, compared to 19.3 percent of mothers of babies diagnosed with neonatal 
encephalopathy. 
Mothers having their first birth are over-represented among mothers of babies with neonatal encephalopathy (56.9 percent) 
compared to 39.7 percent of all births in New Zealand in 2014. 
Among mothers of babies diagnosed with neonatal encephalopathy, 31 percent had a BMI of 30 or greater compared to 
24.8 percent among all mothers birthing in New Zealand in 2014, suggesting an increase in risk of neonatal encephalopathy 
with increased maternal BMI. This is consistent with increased risk of other adverse perinatal outcomes with increasing 
maternal BMI (Aune et al 2014; Cedergren 2004). 
At least some of the association between BMI and neonatal encephalopathy, and smoking and neonatal encephalopathy, may 
be due to confounding factors such as socioeconomic status.
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Customised birthweight, antenatal complications and maternal outcome
 
 
n % n % n % n % n %
Customised birthweight centiles
Small for gestational age 67 19.0 41 20.4 26 17.1 48 20.1 19 16.7
Appropriate for gestational age 256 72.5 148 73.6 108 71.1 167 69.9 89 78.1
Large for gestational age 30 8.5 12 6.0 18 11.8 24 10.0 6 5.3
Antenatal complications
APH (≥20 weeks vaginal bleeding) 36 10.2 19 9.5 17 11.2 24 10.0 12 10.5
Hypertension 44 12.5 29 14.4 15 9.9 34 14.2 10 8.8
Pre-eclampsia 5 1.4 4 2.0 1 0.7 5 2.1 - -
Gestational hypertension 14 4.0 10 5.0 4 2.6 13 5.4 1 0.9
Unspecified hypertension 2 0.6 2 1.0 - - 1 0.4 1 0.9
Maternal trauma (antenatal)* 6 1.7 4 2.0 2 1.3 3 1.3 3 2.6
Induction of labour 85 24.1 58 28.9 27 17.8 61 25.5 24 21.1
Augmentation of labour 130 36.8 92 45.8 38 25.0 101 42.3 29 25.4
Epidural anaesthesia 94 26.6 71 35.3 23 15.1 72 30.1 22 19.3
Maternal outcome
Deceased 3 0.8 1 0.5 2 1.3 1 0.4 2 1.8
Alive but with serious morbidity 8 2.3 3 1.5 5 3.3 3 1.3 5 4.4






Primiparous (=1) Multiparous (≥2)
Table 3.3: Customised birthweight, antenatal complications and maternal outcome among neonatal encephalopathy cases by 
Sarnat stage 2010–2014 
* Vehicular, violent personal injury, other.
APH = antepartum haemorrhage.
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Among babies with neonatal encephalopathy, 19 percent were small by customised centile, and this is probably higher than 
expected (around 12 percent in the birthing population). Maternal height and weight, which are required to calculate centile, 
are not collected in the MAT dataset, only BMI, and so customised birthweight centile is not available for the population as 
a comparison. The rate of SGA in the birthing population is likely to be greater than 10 percent because the algorithm for 
calculating customised centile is based on an optimal birthweight after excluding at-risk pregnancies (Anderson et al 2012).
The national rate of induction of labour (all births) was 24.4 percent in 2014 (28.7 percent among women having their 
first baby and 20.4 percent among women having subsequent babies), which is the same as that among mothers of babies 
diagnosed with neonatal encephalopathy (24.1 percent, 28.9 percent and 17.8 percent respectively) (Ministry of Health 
2015b). 
Among mothers of babies diagnosed with neonatal encephalopathy, 26.6 percent had an epidural in labour compared to a 
national rate in 2014 of 27.1 percent (42.4 percent of women having their first baby, and 15.3 percent of women having 
subsequent babies).
Over the five years of neonatal encephalopathy data collection, there have been three cases associated with maternal death 
and eight with severe maternal morbidity. Of these 11 babies, seven had severe neonatal encephalopathy (64 percent) 
compared with 32 percent severe neonatal encephalopathy among all 353 cases. The numbers are small and this high 
proportion of severe disease associated with adverse maternal outcome may be due to chance.
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Table 3.4: Peripartum complications and mode of birth among neonatal encephalopathy cases 2010–2014
Peripartum complications and mode of birth
Acute peripartum events were reported in 82 cases (23 percent). Of these, abruption (27 cases) and shoulder dystocia (21 
cases) were the most common. Other complications included amniotic fluid embolism, maternal collapse, complications at birth 
of the second twin, vasa praevia and drug error. Blood stained liquor was noted in 9 percent of cases and meconium in 33 
percent. 
Among babies diagnosed with neonatal encephalopathy, 44 percent were born by caesarean section, 32 percent by in labour 
Caesarean section, which was most often performed for suspected fetal distress. This compares with a national caesarean 
section rate of 25.9 percent among all births in 2014 (Ministry of Health 2015b). 
Seven babies (2.0 percent) were breech vaginal births at term, compared to 0.5 percent vaginal breech births in New Zealand 
in 2014 (Ministry of Health 2015b).
 
n %
Acute peripartum events 82 23.2
Cord prolapse 13 3.7
Abruption 27 7.6
Uterine rupture 7 2.0
Shoulder dystocia 21 5.9
Breech complication 8 2.3
Other complication 9 2.5
Liquor
Blood stained 30 8.5
Thick meconium 75 21.2
Thin meconium 41 11.6
Mode of birth
Normal vaginal birth 140 39.7




Vaginal breech birth  7 2.0
Caesarean section birth 154 43.6
Elective 8 2.3
Prelabour emergency 33 9.3
Antepartum haemorrhage/Abruption 5 1.4
Suspected fetal distress 22 6.2
Failed induction 1 0.3
Other 5 1.4
In labour emergency 113 32.0
Antepartum haemorrhage/Abruption 8 2.3
Suspected fetal distress 80 22.7
Failure to progress/Cephalopelvic disproportion 10 2.8
Other 14 4.0
Unknown 1 0.3
Attempt at operative vaginal birth before caesarean 8 2.3
Total NE cases
n=353
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Table 3.5: Type of birth facility and transfer prior to or in labour among neonatal encephalopathy cases by induced cooling status 
2010–2014 
Place of birth
From 2010 to 2014, there were seven babies with neonatal encephalopathy who were birthed at home as intended. This is 
2.0 percent of all cases of moderate or severe encephalopathy. In 2014, 3.4 percent of babies were born at home in New 
Zealand (9.1 percent in a primary unit, 41 percent in a level 2 hospital and 46.4 percent in a tertiary hospital) (Ministry of 
Health 2015b).
More detail on intended and actual place of birth can be found in Table 3.13.
Table 3.5 shows rates of induced cooling by place of birth and by transfer prior to or during labour. These data suggest there 
is no association between place of birth and receiving induced cooling among babies with moderate and severe neonatal 
encephalopathy.
 
  2010 2011 2012 2013 2014 















  N n % N n % N n % N n % N n % 
Type of birth facility                               
Home 2 - - 3 1 33.3 - - - 2 2 100.0 3 3 100.0 
Birthing unit 3 2 66.7 3 3 100.0 4 4 100.0 1 1 100.0 4 4 100.0 
Hospital level 1 3 2 66.7 2 2 100.0 2 2 100.0 1 - - - - - 
Hospital level 2 27 19 70.4 29 21 72.4 30 20 66.7 34 28 82.4 24 20 83.3 
Hospital level 3 47 33 70.2 30 24 80.0 43 36 83.7 32 27 84.4 24 18 75.0 
Transfer prior to labour 7 6 85.7 4 2 50.0 4 2 50.0 3 2 66.7 6 5 83.3 




Sixty percent of the babies diagnosed with moderate or severe neonatal encephalopathy from 2010 to 2014 had an Apgar 
score under 3 at one minute, 82 percent under 5 at one minute, 79 percent under 7 at five minutes, and 53 percent still had 
a score under 7 at 10 minutes. Sixty-five percent had abnormal arterial or venous cord blood gases (defined as pH of ≤7.0 
and/or base excess of ≤−12mmol/l and/or lactate of ≥6mmol/l), and a further 13 percent who had no gas result had an 
Apgar score of ≤6 at one minute. These data indicate the majority of babies diagnosed with moderate and severe neonatal 
encephalopathy have evidence of asphyxia at birth.
There has been a statistically significant reduction in the proportion of babies without cord gases reported since 2010 (chi-
squared test for trend p=0.02). 
In 2014, all eight babies who did not have a cord gas taken at birth had an Apgar score <7 at one minute of age.
 
  
2010 2011 2012 2013 2014 Total 
n=82 n=67 n=79 n=70 n=55 n=353 
n % n % n % n % n % n % 
Apgar scores                         
Apgar score <3 at 1 minute 48 58.5 41 61.2 47 59.5 40 57.1 37 67.3 213 60.3 
Apgar score <5 at 1 minute 65 79.3 54 80.6 62 78.5 58 82.9 49 89.1 288 81.6 
Apgar score <7 at 1 minute 73 89.0 61 91.0 70 88.6 65 92.9 53 96.4 322 91.2 
Apgar score <7 at 5 minutes 61 74.4 54 80.6 62 78.5 57 81.4 43 78.2 277 78.5 
Apgar score <7 at 10 minutes 39 47.6 38 56.7 49 62.0 32 45.7 29 52.7 187 53.0 
Apgar score <9 at 10 minutes 52 63.4 52 77.6 62 78.5 52 74.3 45 81.8 263 74.5 
Cord blood gases: summary data                         
Normal (none of pH ≤7, BE ≤−12, lactate ≥6) 12 14.6 14 20.9 11 13.9 12 17.1 7 12.7 56 15.9 
Abnormal (any of pH ≤7, BE ≤−12, lactate ≥6) 47 57.3 41 61.2 55 69.6 48 68.6 40 72.7 231 65.4 
No gases reported 23 28.0 12 17.9 13 16.5 10 14.3 8 14.5 66 18.7 
No gases and Apgar <7 at 1 minute 14 17.1 8 11.9 8 10.1 7 10.0 8 14.5 45 12.7 
No gases and Apgar ≥7 at 1 minute 8 9.8 4 6.0 5 6.3 3 4.3 - - 20 5.7 
No gases and unknown Apgar 1 1.2 - - - - - - - - 1 0.3 
 BE = base excess.
Table 3.6: Immediate newborn wellbeing among neonatal encephalopathy babies 2010–2014
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Table 3.7: Induced cooling therapy among neonatal encephalopathy babies 2010–2014
Induced cooling
Induced cooling has been shown to reduce mortality by 25 percent and neurodevelopmental disability in survivors of neonatal 
encephalopathy by 23 percent (Jacobs et al 2013).
The increase in proportion of babies with moderate or severe neonatal encephalopathy who were treated with induced cooling 
from 2010 to 2013 has remained stable at 82 percent in 2014. The proportion of those cooled who were cooled within six 
hours as recommended for maximal benefit at 87 percent remains high.




2010 2011 2012 2013 2014 Total 
n=82 n=67 n=79 n=70 n=55 n=353 
n % n % n % n % n % n % 
Yes 56 68.3 51 76.1 62 78.5 58 82.9 45 81.8 272 77.1 
No 26 31.7 16 23.9 17 21.5 12 17.1 10 18.2 81 22.9 
Age at cooling  n=56   n=51   n=62   n=58   n=45   n=272  
≤6 hours 46 82.1 39 76.5 53 85.5 47 81.0 39 86.7 224 82.4 
>6 hours 10 17.9 8 15.7 9 14.5 11 19.0 6 13.3 44 16.2 





n  % n % n %
Resuscitation at birth
Yes 326 92.4 218 91.2 108 94.7
No 27 7.6 21 8.8 6 5.3
Type of resuscitation at birth
Oxygen only 4 1.1 3 1.3 1 0.9
IPPV with mask 221 62.6 153 64.0 68 59.6
IPPV with ETT 201 56.9 120 50.2 81 71.1
Cardiac massage 140 39.7 70 29.3 70 61.4
Adrenaline 66 18.7 21 8.8 45 39.5
Respiratory and ventilation management
Mechanical ventilation 283 80.2 182 76.2 101 88.6
Nitric oxide 78 22.1 51 21.3 27 23.7
Infection
Positive blood culture 13 3.7 8 3.3 5 4.4
Antibiotics 320 90.7 224 93.7 96 84.2
Anticonvulsant therapy 248 70.3 161 67.4 87 76.3
Phenobarbitone 232 65.7 148 61.9 84 73.7
Phenytoin 64 18.1 29 12.1 35 30.7
Benzodiazepines 82 23.2 49 20.5 33 28.9






ETT = endotracheal tube.
IPPV = intermittent positive pressure ventilation.
Table 3.8: Neonatal resuscitation and early neonatal management by Sarnat stage among neonatal encephalopathy babies 
2010–2014 
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Outcomes of babies with neonatal encephalopathy
Babies with severe neonatal encephalopathy were less likely to receive induced cooling (71 percent compared to 80 percent; 
p=0.06) and this is presumably because many of the severe babies are considered too unwell for cooling and are represented 
among the excess mortality in this group (59 percent compared to 1 percent). Of babies with neonatal encephalopathy who 
died, 21 percent died within the first day, 63 percent within the first three days, and 94 percent died within the first week of 
birth. A further four babies died after one week but within six weeks of birth, and a further eight babies died after discharge 
from three months to five years of age.
Table 3.8 (along with Table 3.6) further illustrates the poor condition of many babies who develop neonatal encephalopathy 
at birth. Over the five years, 92 percent of babies required resuscitation at birth, the majority of whom required intermittent 
positive pressure ventilation, with 49 percent requiring cardiac massage and 19 percent requiring adrenalin.
The 18 babies who were not resuscitated at birth from 2011 to 2014 are currently being reviewed to ascertain if these babies 
had an alternative explanation for the encephalopathy or were not recognised as being at risk (of encephalopathy) at birth.
 
  
    Sarnat stage 
NE babies Moderate Severe 
n=353 n=239 n=114 
n % n % n % 
Induced cooling             
Yes 272 77.1 191 70.2 81 29.8 
No 81 22.9 48 59.3 33 40.7 
Deceased             
Yes 70 19.8 3 4.3 67 95.7 
No 283 80.2 236 83.4 47 16.6 
 
Table 3.9: Use of cooling and outcomes of encephalopathy by Sarnat stage among neonatal encephalopathy babies 2010–2014 
146
Investigations and neonatal outcome by Sarnat stage (survivors)
Table 3.10: Investigations and neonatal outcome by Sarnat stage of neonatal encephalopathy survivors 2010–2014
There has been an increasing trend in the proportion of surviving babies who had an MRI investigation since collection of 
neonatal encephalopathy data began, from 70 percent in 2010 to 86 percent in 2014 (chi-squared test for trend p=0.008). 
All but one surviving baby diagnosed with severe neonatal encephalopathy had an MRI during 2010–2014.
Of survivors during 2010–2014, 28 percent had a moderately or severely abnormal MRI and 44 percent had a normal or 
only mildly abnormal scan. Twenty-seven percent of survivors during 2010–2014 did not have an MRI. 
* Typically cot-side monitoring such as BrainZ.
EEG = electroencephalogram.
MRI = magnetic resonance imaging. 
 
Investigations 





n=59 n=54 n=67 n=59 n=44 n=283 n=236 n=47 
n % n % n % n % n % n % n % n % 
Examination on discharge/transfer                                 
Normal 32 54.2 25 46.3 30 44.8 24 40.7 17 38.6 128 45.2 120 50.8 8 17.0 
Mild or moderate abnormality 14 23.7 20 37.0 19 28.4 23 39.0 17 38.6 93 32.9 75 31.8 18 38.3 
Severe abnormality 3 5.1 1 1.9 5 7.5 5 8.5 3 6.8 17 6.0 3 1.3 14 29.8 
Not examined 1 1.7 4 7.4 7 10.4 5 8.5 2 4.5 19 6.7 17 7.2 2 4.3 
Examined but finding unknown 3 5.1 1 1.9 5 7.5 2 3.4 2 4.5 13 4.6 9 3.8 4 8.5 
Missing data 6 10.2 3 5.6 1 1.5 - - 3 6.8 13 4.6 12 5.1 1 2.1 
EEG investigation done at ≤3 days of life* 40 67.8 25 46.3 34 50.7 50 84.7 40 90.9 189 66.8 153 64.8 36 76.6 
MRI (investigation done) 41 69.5 35 64.8 43 64.2 50 84.7 38 86.4 207 73.1 161 68.2 46 97.9 
No MRI or Unknown 18 30.5 19 35.2 24 35.8 9 15.3 6 13.6 76 26.9 75 31.8 1 2.1 
Results of MRI                                  
Moderately/Severely abnormal 16 27.1 11 20.4 17 25.4 22 37.3 13 29.5 79 27.9 49 20.8 30 63.8 
Normal or only mildly abnormal 24 40.7 23 42.6 24 35.8 27 45.8 25 56.8 123 43.5 108 45.8 15 31.9 
Unknown result 1 1.7 1 1.9 2 3.0 1 1.7 - - 5 1.8 4 1.7 1 2.1 
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n=284,145 n=353   
n % n % /1000 95% CI 
Maternal ethnicity             
Māori 63,585 22.4 94 26.6 1.48 1.19–1.81 
Pacific peoples 29,910 10.5 56 15.9 1.87 1.41–2.43 
Indian 11,538 4.1 17 4.8 1.47 0.86–2.36 
Other Asian 26,992 9.5 25 7.1 0.93 0.60–1.37 
Other (including unknown) 25,672 9.0 23 6.5 0.90 0.57–1.34 
NZ European 126,448 44.5 138 39.1 1.09 0.91–1.27 
Maternal age (years)             
<20 17,383 6.1 22 6.2 1.27 0.79–1.92 
20–34 206,606 72.7 262 74.2 1.27 1.11–1.42 
35–39 48,472 17.1 56 15.9 1.16 0.87–1.50 
≥40 11,684 4.1 13 3.7 1.11 0.59–1.90 
Deprivation quintile             
1 (least deprived) 44,715 15.7 38 10.8 0.85 0.60–1.17 
2 50,385 17.7 55 15.6 1.09 0.82–1.42 
3 54,890 19.3 77 21.8 1.40 1.11–1.75 
4 59,689 21.0 65 18.4 1.09 0.84–1.39 
5 (most deprived) 73,272 25.8 117 33.1 1.60 1.31–1.89 






2010 2011 2012 2013 2014
Total
NE cases
n=283,241 n=82 n=67 n=79 n=70 n=55 n=353
n n n n n n n /1000 95% CI
Northland 10,661 2 2 2 1 1 8 0.75 0.32–1.48
Waitemata 36,551 10 6 4 5 9 34 0.93 0.64–1.30
Auckland 29,872 4 8 4 8 5 29 0.97 0.65–1.39
Counties Manukau 39,385 14 11 14 6 5 50 1.27 0.94–1.67
Waikato 25,136 14 9 9 5 6 43 1.71 1.24–2.30
Bay of Plenty 13,372 3 4 2 3 1 13 0.97 0.52–1.66
Lakes 6,996 2 4 2 1 1 10 1.43 0.69–2.63
Tairawhiti 3,395 1 2 2 1 1 7 2.06 0.83–4.25
Taranaki 7,187 2 - 6 5 4 17 2.37 1.38–3.79
Hawke's Bay 10,267 2 1 3 2 3 11 1.07 0.53–1.92
Whanganui 3,945 1 - 2 1 - 4 1.01 0.28–2.60
MidCentral 10,344 2 1 2 3 2 10 0.97 0.46–1.78
Wairarapa 2,424 1 - - - 1 2 0.83 0.10–2.98
Capital and Coast 17,423 6 4 9 10 3 32 1.84 1.26–2.59
Hutt Valley 9,191 4 4 2 5 2 17 1.85 1.08–2.96
Nelson and Marlborough 7,393 - 1 2 5 1 9 1.22 0.56–2.31
West Coast 1,893 - 1 2 - 2 5 2.64 0.86–6.16
Canterbury 28,343 11 6 7 2 6 32 1.13 0.77–1.59
South Canterbury 2,892 1 2 2 1 - 6 2.07 0.76–4.52
Southern 16,435 2 1 3 6 2 14 0.85 0.47–1.43




Other includes Overseas, Unknown and Other
Table 3.12: Neonatal encephalopathy rates (per 1000 term births) by DHB of maternal residence 2010–2014
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Table 3.13: Actual and intended place of birth among neonatal encephalopathy cases 2010–2014
 
Intended place of birth 
NE cases Actual place of birth 
n=353 Home Birthing unit Hospital level 1 Hospital level 2 Hospital level 3 
n % n % n % n % n % n % 
Home 12 3.4 7 58.3 - - - - 3 25.0 2 16.7 
Birthing unit 39 11.0 1 2.6 15 38.5 - - 4 10.3 19 48.7 
Hospital level 1 18 5.1 - - - - 5 27.8 3 16.7 10 55.6 
Hospital level 2 138 39.1 1 0.7 - - 2 1.4 131 94.9 4 2.9 
Hospital level 3 140 39.7 1 0.7 - - 1 0.7 1 0.7 137 97.9 
Unknown 6 1.7 - - - - - - 2 33.3 4 66.7 
Total 353   10 2.8 15 4.2 8 2.3 144 40.8 176 49.9 
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Appendix A: Summary of Key PMMRC Recommendations 
and Progress 2006–2012 data
Recommendation PMMRC 1st – 8th Reports Progress to date (June 2016)
Perinatal mortality
Birth information
All babies, whether stillborn or live born, should be assigned a 
National Health Index (NHI) at the time of birth. 
All DHBs are now issuing NHIs to stillborn babies at time of birth.
Ethnicity
Clinicians and LMCs should be encouraged to collect accurate 
ethnicity details at the time of booking. 
DThe emerging Maternity Clinical Information System should assist 
clinicians and LMCs to collect accurate standardised ethnicity data. 
This process is currently operating in South Canterbury, MidCentral, 
Whanganui and Counties Manukau DHBs. In 2016/2017 there are 
plans to roll it out to a further six DHBs. The Primary Care Ethnicity 




The Ministry of Health, DHBs and professional colleges should 
collaboratively explore barriers to early booking with a view to 
increase the number of women who book with an LMC before 10 
weeks gestation. A national media campaign should be considered.
All DHBs are aware of the need to take actions that will increase 
the number of women who book before 10 weeks gestation. 
Barriers to early booking are being investigated and actions will 
be embedded in each respective DHB Maternal Quality and Safety 
Programme. Many DHBs are promoting media and social media 
campaigns such as the ‘Find Your Midwife’ website, which supports 
women to find and book with an LMC. See the following website 
for more information: http://www.findyourmidwife.co.nz/  
The regional programme ‘5 Things to Do in the First 10 Weeks’ 
has been effective and widely supported. Key messages from this 
campaign are to: 
• engage early with a LMC 
• take folic acid and iodine
• make decisions about screening tests
• eat well and be active 
• avoid alcohol, recreational drugs and smoking.
The Ministry of Health advises that media campaigns and initiatives 
should be targeted at local level for best results.
Strategies to improve awareness of antenatal care services and 
increase access among women who are isolated for social, cultural 
or language reasons should be developed.
Some initiatives have been developed to improve access to 
antenatal care services for women who are isolated for social, 
cultural or language reasons. These include:
• The Language Line. See http://ethniccommunities.govt.nz/
story/using-language-line
• The TAHA Well Pacific Mother & Infant Service, which 
launched a smart phone application that provides 
information on pregnancy and parenting. See www.
tapuaki.org.nz
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Recommendation PMMRC 1st – 8th Reports Progress to date (June 2016)
Disparities
There is a need to recognise the independent impact of 
socioeconomic deprivation on perinatal death, specifically on 
preterm birth, which after congenital abnormality is the leading 
cause of perinatal death. Addressing the impact of poverty requires 
wider societal commitment as has been highlighted in the recent 
health select committee report on improving child health outcomes. 
The PMMRC supports the implementation of the recommendations. 
This report can be found at: http://www.parliament.nz/resource/
en-nz/50DBSCH_SCR6007_1/3fe7522067fdab6c601fb31fe0fd
24eb6befae4a 
There are a number of cross-agency initiatives that are underway to 
respond to, and reduce, the impact of socioeconomic deprivation on 
perinatal death and child health. These include: 
• The Healthy Families New Zealand Initiative. See http://
www.health.govt.nz/our-work/preventative-health-wellness/
healthy-families-nz
• The Child Poverty Monitor. This was first published in 2013 
and provides data on a set of indicators that assess aspects 
of child poverty in New Zealand and their implications for 
child wellbeing. It is supported by the Office of the Children’s 
Commissioner, Child and Youth Epidemiology Service 
(University of Otago), and the JR McKenzie Trust. See http://
www.nzchildren.co.nz/
• The Vulnerable Children Act 2014. On 1 July 2014 the 
Vulnerable Children Act was passed into law. The Act is a 
significant part of a range of comprehensive measures to 
protect and improve the wellbeing of vulnerable children and 
strengthen the child protection system. The chief executives of 
five government agencies are accountable for acting together 
to develop and implement a plan to protect our children from 
harm, working with families, whānau and communities.
• The Children’s Action Plan. The Children’s Action Plan 
operationalises the Vulnerable Children Act. Children’s teams 
have been set up across the country to work with vulnerable 
children, and across a range of local iwi and Māori, health, 
education, welfare and social organisations.
• Social Sector Trials. These have been established to test 
innovative ideas to improve social, health and educational 
outcomes in communities around New Zealand. One of the 
trials has a specific health focus. See http://www.health.
govt.nz/our-work/preventative-health-wellness/social-sector-
trials
• Well Child/Tamariki Ora. The Ministry of Health is 
investigating how to more effectively integrate the Well 
Child/Tamariki Ora programme and GP practice services 
to be more attractive and responsive to women and families 
who are socially deprived or have socially complex needs.
Possible causes for the increase in perinatal related death of babies 
born to Pacific women, Māori women, women  under the age of 
20 or over the age of 40 and women who live in areas of high 
socioeconomic deprivation should be researched. This information 
is necessary in order to develop appropriate strategies to reduce 
these possibly preventable deaths.
The Ministry of Health expects that perinatal mortality will be 
annually reviewed as part of the local Maternity Quality and Safety 
Programmes. Findings from the review process will assist DHBs and 
the wider maternity sector to identify and address local issues and 
risk factors.
Further research is warranted to understand the higher rate of 
perinatal related mortality in the Counties Manukau region.
An independent review of perinatal mortality in their region was 
commissioned by Counties Manukau DHB in late 2012. The 
recommendations from this review are being implemented in an 





Recommendation PMMRC 1st – 8th Reports Progress to date (June 2016)
Clinicians and LMCs should be aware that Pacific women, Māori 
women, women under 20 or over 40 years of age and those 
women who live in areas of high socioeconomic deprivation are at 
higher risk of a perinatal death.
The Ministry of Health expects that this awareness will be promoted 
within the Maternity Quality and Safety Programme of each DHB.
Public health initiatives
A high body mass index (BMI) at booking is an independent risk 
factor for stillbirth. Public health initiatives to prevent obesity prior 
to pregnancy should be supported.
From 2015, the Ministry of Health will report high maternal BMI 
as one of the New Zealand Maternity Clinical Indicators. This is 
expected to support DHBs and maternity services to plan for the 
care of obese pregnant women, as well as identify DHBs that should 
prioritise strategies that support healthy weight gain in pregnancy. 
Other initiatives that support this recommendation include:
• Eating for Healthy Pregnant Women/Ngā Kai Totika mā 
te Wahine Hapā. This is a public health resource and was 
updated in 2014. See https://www.healthed.govt.nz/
system/files/resource-files/HE1805_5.pdf
• A Ministry of Health web page provides information about 
healthy weight gain during pregnancy and provides links 
to helpful resources. See http://www.health.govt.nz/
your-health/healthy-living/pregnancy/healthy-weight-gain-
during-pregnancy
• The Healthy Families NZ initiative. This initiative 
encourages families to live healthy lives – by making good 
food choices, being physically active, sustaining a healthy 
weight, being smoke free and drinking alcohol only in 
moderation. It is funded by the Ministry of Health and 
commenced in September 2014. See http://www.health.
govt.nz/our-work/preventative-health-wellness/healthy-
families-nz
• Investment in workforce development. In July 2013 the 
government announced it is investing $2.28 million in 
a new workforce development programme for health 
professionals who care for pregnant women and babies. 
The training programme will be implemented by Gravida 
and aims to give frontline health workers the latest 
evidence-based research into how pregnancy and early life 




All women with a multiple pregnancy should be offered an 
early specialist consultation, including ultrasound diagnosis of 
chorionicity prior to 14 weeks gestation. 
Women with high-risk monochorionic multiple pregnancies require 
fortnightly scans and specialist care.
This recommendation is promoted through the Ministry of Health’s 
Maternity Quality and Safety Programme. All DHBs recognise that 
monochorionic multiple pregnancies require  early specialist care 
and are high risk. 
Advice is available through the New Zealand Maternal Fetal 
Medicine Network. See http://www.healthpoint.co.nz/public/new-
zealand-maternal-fetal-medicine-network/?solo=otherList&index=5
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Recommendation PMMRC 1st – 8th Reports Progress to date (June 2016)
In order to reduce perinatal related mortality associated with 
multiple pregnancies, the following is advised. 
• All women undergoing assisted reproduction be offered 
single embryo transfer. 
• The use of clomiphene for fertility treatment requires 
monitoring of hormonal response with ultrasound to 
determine the number of follicles. 
• LMCs note that the referral guidelines recommend transfer 
of clinical responsibility for care of all women with multiple 
pregnancies to obstetrician-led care. 
The recommendations have been promoted through the Ministry of 
Health’s Maternity Quality and Safety Programme.
Clomiphene is being replaced with other medications such as 
Letrizole, which has a much lower risk of multiple pregnancy.
The Guidelines for Consultation with Obstetric and Related Medical 
Services (Referral Guidelines) list multiple pregnancies as a reason 
for transfer of clinical responsibility with a clear pathway for 
determining a plan of care that may or may not involve the LMC.
Audit of congenital abnormalities
All primary care providers (if first contact of a pregnant woman with 
the health service) should offer first trimester screening and facilitate 
expeditious registration. 
The National Screening Unit offers online education for practitioners 
who provide services within the antenatal and newborn screening 
programmes. These can be accessed at: https://www.nsu.govt.nz/
health-professionals/antenatal-screening-down-syndrome-and-other-
conditions 
See ‘Practice Point: Antenatal Screening for Down Syndrome and 
Other Conditions’ (page 48).
The importance of timely registration has been promoted through 
the NMMG. The 2015 NMMG Annual Report can be accessed 
at: http://www.health.govt.nz/publication/national-maternity-
monitoring-group-annual-report-2015 
Achieving optimal use of periconceptual folate by young women in 
New Zealand requires a policy for fortification of bread.
The Ministry of Health advice to women planning to become pregnant 
is to take folic acid supplements and continue to do so when pregnant. 
There is voluntary fortification of bread by some manufacturers.
The National Screening Unit review the cost benefit of the current 
algorithms in the first and second trimester screening programme 
so they are calibrated for maximal sensitivity for all chromosomal 
abnormalities.
The National Screening Unit has commenced a project to provide 
feedback to radiology practitioners on the quality of nuchal 
translucency (NT) and crown rump length (CRL) measurements. 
This project includes best practice guidelines for NT and CRL 
measurements. Further information, including guidelines and 
videos, can be found at http://www.nsu.govt.nz. Further analysis 
is occurring on investigating new technology (non-invasive prenatal 
testing) to be included in publicly funded screening.
The National Screening Unit review false negative screening tests. The National Screening Unit is reviewing the cases not detected 
through screening (false negative). This analysis includes a review 
of information provided for screening including the completeness of 
information on request forms provided to the laboratory, the impact 
of changes to the measurements and any trends in demographic 
information of women.
The National Maternal Fetal Medicine Network regularly audit time 
from referral to review to ensure that the majority of women are 
seen within seven days as recommended.
The New Zealand Maternal Fetal Medicine Network completed an 
audit at Auckland DHB in 2015, which confirmed that almost all 
women who had their referral triaged for review in less than seven 
days were seen in this timeframe.
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Sudden unexpected death in infancy (SUDI)
National guidelines should be developed for safe sleeping 
arrangements in postnatal wards to improve ward safety and 
to model safe sleeping practices that parents can follow after 
discharge.
The Ministry of Health will be updating its publication Preventing 
Sudden Unexpected Death in Infancy in 2017. See  http://www.
health.govt.nz/your-health/pregnancy-and-kids/first-year/helpful-
advice-during-first-year/safe-sleep
The Ministry of Health has published guidance on observation of 
mother and baby in the immediate postpartum period in 2012. 
This guidance supports safe sleeping in postnatal wards: http://
www.health.govt.nz/publication/observation-mother-and-baby-
immediate-postnatal-period-consensus-statements-guiding-practice
Guidance on safe sleeping and the Pāpi-pod Sleep Space 
Programme is also available on the Change for Our Children 
website. See http://www.changeforourchildren.co.nz/pepi_pod_
programme
Access to perinatal investigation and supporting parents
The Ministry of Health should require DHBs to ensure all providers 
of maternity services provide support to parents, families and 
whānau who have experienced perinatal and maternal loss, 
including providing access to information, counselling and clinical 
follow-up.
The Ministry of Health requires DHBs to provide appropriate services 
to support parents, families and whānau who have experienced 
perinatal and maternal loss, including providing access to information 
for counselling and clinical follow-up.
See  http://www.nsfl.health.govt.nz/apps/nsfl.nsf/pagesmh/444 
The 2015 Survey of Bereaved Women found that 74 percent of 
women were satisfied or very satisfied with care they received. Most 
women surveyed stated that they had received enough information, 
care and support. The full survey can be found at: https://www.
health.govt.nz/system/files/documents/publications/2015-survey-of-
bereaved-women-sep15.pdf
The low uptake of post-mortems amongst families who experience 
perinatal loss should be investigated.
The 2015 Survey of Bereaved Women looked at the information 
provided to women and their decisions about post-mortem 
examination. 
The full report can be found at: https://www.health.govt.nz/system/
files/documents/publications/2015-survey-of-bereaved-women-sep15.
pdf
The reasons for the difference in rates of optimally investigated 
perinatal deaths between DHBs needs investigation.
DHBs with post-mortem rates less than 50 percent were asked 
to provide a progress update on their implementation of this 
recommendation.
DHBs reported that geographical distances, the length of time families 
are separated from their babies, and family cultural beliefs can all be 
barriers to parents agreeing to a post-mortem.
Further information to help families and whānau who are trying to 





Improved communication between primary and secondary services 
is required. A variety of means should be used such as women-held 
maternity notes, integrated notes systems and electronic transfer of 
information.
The Maternity Clinical Information System is operating in five 
DHBs: South Canterbury, Tairawhiti, MidCentral, Whanganui 
and Counties Manukau. Significant work is being undertaken 
by Counties Manukau DHB to ensure the system works well in a 
secondary tertiary maternity facility. The Ministry of Health intends 
for this system to roll out to a further six DHBs in 2016/2017.
Both the NMMG and the Maternity Quality and Safety Programme 
are working towards improved communication between primary 
and secondary services.
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Recommendation PMMRC 1st – 8th Reports Progress to date (June 2016)
Maternal mental health
Maternal mental health services should be integrated into maternity 
services.
Under the Ministry of Health’s Rising to the Challenge: Mental 
Health and Addiction Service Development Plan 2012–2017, the 
Ministry will work with providers to support service improvement 
and will report on implementation progress over the next five years. 
The Rising to the Challenge document is available online:
http://www.health.govt.nz/publication/rising-challenge-mental-
health-and-addiction-service-development-plan-2012-2017
Clinicians and LMCs should be encouraged to conduct antenatal 
screening and document any mental health history to identify 
women who are at increased risk of mental illness.
Midwives attend a mandatory Practice Day once every three years 
as part of the Midwifery Council’s Recertification Programme. 
One of the key topics included within the current Practice Day is 
maternal mental health. The focus of this education has been on the 
midwifery role of screening, identifying and referring women with 
mental health concerns. 
This recommendation has been revised and included in the practice 
point on maternal suicide: 
• Maternal mental health screening should be included as 
part of standard antenatal care.
See ‘Practice Point: Maternal Suicide’ (page 130).
Access should be provided to a mother and baby unit in the 
North Island.
Following on from the Healthy Beginnings report, a three-bed 
mother-and-baby unit was opened in the Child and Family Unit in 
Starship Hospital in Auckland. This is a valuable resource in the 
treatment of acutely unwell mothers with their babies. 
Services have also been developed and extended across the 
continuum of care, including increased resourcing of community 
mental health perinatal services, and extension of respite and non-
governmental organisation services. This includes 24-hour perinatal 
phone advice for general mental health services managing acute 
presentations of mothers.
Women with a previous history of serious affective disorder or 
other psychoses should be referred for psychiatric assessment and 
management even if well. 
Clinicians are reminded that the most common cause of maternal 
death in New Zealand is suicide.
This recommendation has been revised and included in the practice 
point on maternal suicide. 
• Maternal mental health screening should be included as 
part of standard antenatal care.
• Women with a previous history of serious affective disorder 
or other psychoses should be referred for psychiatric 
assessment and management even if they are currently well.
See ‘Practice Point: Maternal Suicide’ (page 130).
The committee notes the publication of the Healthy Beginnings report 
in January 2012 and supports the recommendations with particular 
regard to the establishment of mother and baby units in the North 
Island and the importance of screening for a history of mental health 
disorders.
A comprehensive perinatal and infant mental health service 
includes:
• screening and assessment
• timely interventions including case management, transition 
planning and referrals 
• access to respite care and specialist inpatient care for 
mothers and babies 
• consultation and liaison services within the health system 
and with other agencies; for example, primary care and 
termination of pregnancy services. 
This recommendation has been revised and included in the practice 
point on maternal suicide. 
• Maternal mental health screening should be included as 
part of standard antenatal care.
• Women with a previous history of serious affective disorder 
or other psychoses should be referred for psychiatric 
assessment and management even if they are currently well.
• Strategies are required to improve communication and 
coordination between the full range of primary maternity 
providers (eg, LMC, GP) and secondary providers (eg, 
mental health services, maternal mental health services, 
maternity, including termination of pregnancy services).
See ‘Practice Point: Maternal Suicide’ (page 130).
156
Recommendation PMMRC 1st – 8th Reports Progress to date (June 2016)
Termination of pregnancy services should undertake holistic 
screening for maternal mental health and family violence and 
provide appropriate support and referral.
The services providing termination of pregnancy to women advise 
that they comply with the Standards of Practice for the Provision 
of Counselling laid down by the Abortion Supervisory Committee. 
These are monitored as part of re-licencing. See http://www.
abortionservices.org.nz/docs/guides98.pdf 
It was noted that there were minimal opportunities in relation to 
training in the field of post-termination of pregnancy counselling 
practice.
Team approach to care
Women with complex medical conditions require a multidisciplinary 
approach to care, including a multidisciplinary management plan 
for the pregnancy, birth and postpartum period. This plan must be 
communicated to all relevant caregivers. Each woman requiring 
such care should be assigned a key clinician to facilitate her 
care. Pregnant women who are admitted to hospital for medical 
conditions not related to pregnancy need to have specific pathways 
for perinatal care.
The Ministry of Health expects maternity services (LMCs and DHBs) 
to ensure all women in New Zealand have access to continuity of 
maternity care, and for DHBs to ensure 95 percent of pregnant 
women in their region receive continuity of primary maternity care. 
As outlined in the New Zealand Maternity Standards, DHBs are 
also expected to provide or accommodate continuity of specialist 
secondary or tertiary care where possible. 
DHBs are required to staff appropriately under the primary, 
secondary and tertiary maternity facilities and services 
specifications. 




Information about support for pregnant women and their babies 




Women who are unstable or clinically unwell should be cared for 
in the most appropriate place within each unit in order for close 
observation to occur. When observations are abnormal, clear 
documentation, early review by a senior clinician and development 
of a detailed management plan are required.
DHBs support this recommendation and advise that unstable or 
clinically unwell women are cared for in the most appropriate place 
within their hospital. They also indicated that detailed management 
plans are developed if observations are abnormal.
In 2016 the Ministry of Health intends to revise The Guidelines for 
Consultation with Obstetric and Related Medical Services (Referral 
Guidelines) developed for LMCs and DHBs. The aim is to improve 
the safety and quality of maternity care and to ensure women are 
referred by their LMC to the most appropriate level of care for their 
particular condition.
Emergency obstetric training
All clinicians involved in care of pregnant women should undertake 
regular multidisciplinary training in management of obstetric 
emergencies. 
The Midwifery Council requires that midwives attend training in 
resuscitation and management of obstetric emergencies annually. 
A number of DHBs are supporting DHB and community-based 
clinicians to attend multidisciplinary emergency obstetric training 
programmes, with some DHBs making such training compulsory for 
medical staff every two years. 
Consideration should be given to making this training mandatory.
See ‘Practice Point: Amniotic Fluid Embolism’ (page 121). 
Investigation of maternal deaths
In maternal deaths, where the coroner declines jurisdiction, a post-
mortem should be offered as part of full investigation of cause of 
death.
DHBs have advised that in cases of maternal death where the 
coroner declines jurisdiction, a post-mortem is offered as part of full 
investigation of cause of death.
157PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: TENTH ANNUAL REPORT 
Recommendation PMMRC 1st – 8th Reports Progress to date (June 2016)
Neonatal encephalopathy
Arterial and venous cord gases should be performed on all 
babies born with an Apgar <7 at one minute; and If neonatal 
encephalopathy is clinically suspected in the immediate hours 
after birth, early consultation with a neonatal paediatrician is 
recommended in order to avoid a delay in commencing cooling. 
The Ministry of Health expects this recommendation will become 
part of ongoing professional development and will be discussed 
with each DHB Maternity Quality and Safety Programme.
Strategies to reduce neonatal encephalopathy include continually 
improving the standard of neonatal resuscitation by all health 
professionals involved in providing peripartum care.
Neonatal resuscitation is an annual continuing education 
requirement for all midwives.
The New Zealand Resuscitation Council provides training for 
clinicians to deliver newborn life support courses in their region or 
organisations. See http://www.nzrc.org.nz/training/ 
ACC has facilitated a cross-Ministry initiative to look at reducing the 
incidence of treatment injury by developing a strategy to address 
the issues raised by the Neonatal Encephalopathy Working Group.
In cases of neonatal encephalopathy (Sarnat stages 2 and 3): 
• all babies with encephalopathy should undergo 
investigation to predict prognosis, including formal 
neurological examination, cerebral magnetic 
resonance imaging (MRI) and, if available, formal 
electroencephalography (EEG)
• all parents of an affected child should have a formal 
discussion with the neonatologist/paediatrician providing 
care in order to review the prognosis and ongoing care of 
their child.
Most DHBs have advised that all babies with moderate or severe 
neonatal encephalopathy (Sarnat stages 2 and 3) undergo 
investigation to predict prognosis. 
Parents have a formal discussion with the neonatologist/
paediatrician providing care to review the prognosis and ongoing 
care of their child.
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Recommendation Progress June 2016
Perinatal mortality
Early booking
All women should commence maternity care before 10 weeks. This 
enables:
• opportunity to offer screening for congenital abnormalities, 
sexually transmitted infections, family violence and 
maternal mental health, with referral as appropriate
• education around nutrition, smoking, alcohol and drug use 
and other at-risk behaviour
• recognition of underlying medical conditions, with referral 
to secondary care as appropriate
• identification of at-risk women (maternal age, obesity, 
maternal mental health problems, multiple pregnancy, 
socioeconomic deprivation, maternal medical conditions). 
This recommendation has been integrated into core work by the 
NMMG, Ministry of Health.
Teenage mothers (<20 years old)
LMCs should be aware that teenage mothers are at increased risk 
of stillbirth and neonatal death due to preterm birth, fetal growth 
restriction and perinatal infection. Maternity services need to 
address this risk, paying attention to: 
• maternity care before 10 weeks
• smoking cessation, prevention of preterm birth, screening 
for fetal growth restriction
• antenatal education
• undertaking research on the best model of care
• engagement with the Ministry of Education regarding 
education in the school setting.
This recommendation has been integrated into core work by the 
NMMG, Ministry of Health.
Contributory factors and potentially avoidable perinatal deaths
Key stakeholders providing health and social services to women at 
risk should work together and identify:
• reasons for barriers to accessing maternity care
• interventions to address barriers. 
Clinical services and clinicians have the following responsibilities: 
• continuing education
• local review linked to quality improvement
• up-to-date policies and guidelines that are implemented 
and audited
• culture of teamwork
• culture of practice reflection on patient outcomes linked to 
quality improvement 
• staff arrangements ensuring timely access to specialist 
services.
Ministry of Health to develop a plan to translate these 
recommendations into clinical practice.
This recommendation has been integrated into core work by the 
NMMG, Ministry of Health.
Previous PMMRC recommendations that have been 
implemented 
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Recommendation Progress June 2016
Birth information
Continued support and funding is required for DHBs and LMCs 
for collection of complete perinatal mortality statistics. 
This recommendation has been integrated into core work by the 
Ministry of Health.
Antepartum haemorrhage
All women with bleeding during pregnancy, regardless of the 
apparent cause, should be monitored more closely for fetal growth 
and preterm birth.
This recommendation has been integrated into core work by the 
Ministry of Health.
Sudden unexpected death in infancy (SUDI) 
The Ministry of Health should prioritise the preparation and 
dissemination of a comprehensive statement for parents and 
caregivers on risk factors and methods of prevention of SUDI to be 
provided to pregnant women.




Support is required for national reporting of maternal deaths. The Ministry of Health funds DHBs in their reporting of mortality data 
and collection of complete perinatal mortality statistics.
Seatbelts during pregnancy 
There is a need for greater public awareness of the importance 
of wearing a seatbelt during pregnancy. All pregnant women 
should know that three-point seatbelts should be worn throughout 
pregnancy, with the lap strap placed as low as possible beneath 
the ‘bump’, lying across the thighs, and the diagonal shoulder 
strap placed above the ‘bump’, lying between the breasts.




Health care practitioners should follow the evidence-based 
management of hypertension in pregnancy recommended by the 
Society of Obstetric Medicine of Australia and New Zealand.
This can be accessed at:
https://somanz.org/documents/HTPregnancyGuidelineJuly2014.
pdf 
The Ministry of Health will fund the development of a 
multidisciplinary clinical guideline for the treatment of hypertension 
in pregnancy in 2015–2016. This was a recommendation from the 
NMMG.
Postpartum haemorrhage 
Acute obstetric units should develop a massive transfusion protocol 
to respond to major obstetric haemorrhage.
A national guideline for the treatment of postpartum haemorrhage 
has been developed and distributed to professional colleges and 




ACC Accident Compensation Corporation
AFE Amniotic fluid embolism
AMOSS Australasian Maternity Outcomes Surveillance System
APH Antepartum haemorrhage
BDM Births, Deaths and Marriages
BE Base excess
BMI Body mass index (kg/m2)
CEMACH Confidential Enquiry into Maternal and Child Health
CI Confidence interval
CMACE Centre for Maternal and Child Enquiries





ICSI Intracytoplasmic sperm injection
ILI Influenza-like illness
IPPV Intermittent positive pressure ventilation
IVF In vitro fertilisation
LMC Lead maternity carer
MAT New Zealand National Maternity Collection
MBRRACE Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries
MDAC Maternal Deaths Assessment Committee
MMR Maternal mortality ratio
MMRWG Maternal Mortality Review Working Group
MRI Magnetic resonance imaging
NE Neonatal encephalopathy
NEWG Neonatal Encephalopathy Working Group
NHI National Health Index
NICE National Institute for Health and Care Excellence, UK
NISG National Influenza Specialist Group 
NMDS National Minimum Dataset
NMMG National Maternity Monitoring Group
NT Nuchal translucency
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NZDep New Zealand Index of Deprivation
PMMRC Perinatal and Maternal Mortality Review Committee
PPH Postpartum haemorrhage
PSANZ Perinatal Society of Australia and New Zealand
PSANZ-NDC PSANZ neonatal death classification
PSANZ-PDC PSANZ perinatal death classification
Sands Stillbirth and Newborn Death Support
SGA Small for gestational age
SIGN Scottish Intercollegiate Guidelines Network
SUDI Sudden unexpected death in infancy
UK United Kingdom
UKOSS UK Obstetric Surveillance System
USS Ultrasound scan
VTE Venous thromboembolism
WHO World Health Organization
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Appendix C: Definitions
Perinatal related mortality rate
Definitions of perinatal and infant mortality
Gestation Birth 7 days 28 days 1 year






















(Adapted from New Zealand Health Information Service 2007 and Ministry of Health 2010)
Fetal death
Fetal death is the death of a fetus at 20 weeks gestation or beyond (≥20 weeks) or weighing at least  
400g if gestation is unknown. Fetal death includes stillbirth and termination of pregnancy. Note that the term ‘stillbirth’ does 
not include terminations in this report. Where a termination of pregnancy died after birth, the pregnancy is included as a 
termination of pregnancy and therefore as a fetal death rather than as a neonatal death.
Termination of pregnancy
Termination of pregnancy is the interruption of an ongoing pregnancy. This report only includes termination of pregnancy from 
20 weeks gestation. 
Fetal death rate
Fetal death rate is calculated as fetal deaths per 1000 babies born at 20 weeks gestation or beyond or weighing at least 
400g if gestation is unknown.
Neonatal death
Neonatal death is the death of any baby showing signs of life at 20 weeks gestation or beyond (for the purposes of this 
PMMRC dataset) or weighing at least 400g if gestation is unknown. Early neonatal death is a death that occurs up until 
midnight of the sixth day of life. Late neonatal death is a death that occurs between the seventh day and midnight of the 27th 
day of life.
Neonatal death rate
Neonatal death rate is calculated as neonatal deaths per 1000 live born babies at 20 weeks gestation  
or beyond or weighing at least 400g if gestation is unknown.
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Perinatal mortality rate
Perinatal mortality rate is calculated in New Zealand as fetal deaths and early neonatal deaths per 1000 total babies born 
alive or born dead at 20 weeks gestation or beyond, or weighing at least 400g if gestation is unknown.
In some places, this report refers to a UK definition of perinatal mortality, which was developed for the surveillance of 
perinatal deaths in the UK and is based on the UK legal definition of stillbirths, which excludes fetal deaths before 24 weeks 
gestation (CMACE 2011).
Perinatal related mortality rate
Perinatal related mortality rate refers to fetal deaths and early and late neonatal deaths per 1000 total babies born at 20 
weeks gestation or beyond or weighing at least 400g if gestation is unknown.
International (WHO) perinatal mortality rates
International (WHO) perinatal mortality rates are recommended by the WHO (2006) to facilitate international comparison. 
These are rates of fetal death, neonatal death, perinatal mortality and perinatal related mortality of babies weighing ≥1000g, 
or ≥28 weeks if birthweight is unknown, per 1000 total births of babies ≥1000g, or ≥28 weeks if birthweight is unknown. 
Babies without birthweight or gestation are to be included if they have been registered.
Lethal and terminated fetal abnormalities
Lethal and terminated fetal abnormalities are all perinatal related deaths classified by the PSANZ perinatal death classification 
system as PSANZ-PDC 1 (congenital abnormality) and neonatal deaths classified by the PSANZ neonatal death classification 
system as PSANZ-NDC 1 (congenital abnormality).
Intrapartum stillbirth rate
Intrapartum stillbirth rate calculates deaths of babies of at least 24 weeks gestation without congenital abnormality who 




Contributory factors are defined as modifiable components of the health system and issues of quality of care that cover a 
broad spectrum of organisation and/or management, personnel and access and/or engagement with care factors.
Customised birthweight centiles
Customised birthweight centiles adjust newborn weight for maternal weight, height, ethnicity and parity, as well as for infant 
sex and gestation at birth. For fetal deaths, the gestation at the time of estimated death (not birth) is used to calculate the 
birthweight centile. If gestation at death is unknown or gestation at death is <20 weeks or is seven days or more prior to birth, 
then customised centile is not calculated.
Ethnicity
Mother and baby ethnicities for perinatal related deaths were collected from two sources: from information supplied to the 
BDM Registrar (with priority given to information in the birth registration over information in the death registration) and from 
rapid reporting forms completed by LMCs (eg, in cases where the death had not been registered by the time of analysis), with 
information from BDM taking priority over data from rapid reporting forms. In both instances, ethnicity was recorded as that 
identified by the mother/parents. The ethnicity in the deaths dataset (held by BDM) is not validated. Death registration forms 
are usually completed by either the parents or a funeral director.
Mother and baby ethnicities in the denominator birth registration set are those provided by the parent(s) to BDM at birth 
registration and are thus consistent with numerator data.
Ethnicity has been reported as prioritised ethnicity. This method is frequently used in health statistics in New Zealand. 
Multiple ethnicities can be identified for both mother and baby. The PMMRC follows the guidelines in Ethnicity Data Protocols 
for the New Zealand Health and Disability Sector (Ministry of Health 2004) for prioritising ethnicity. These protocols prioritised 
ethnicity into the following hierarchy: Māori, Pacific peoples, Indian, Other Asian, Other (including Other European and Not 
Stated), and New Zealand European. Indian has been identified as a separate ethnicity from Other Asian because New 
Zealand data suggest that pregnancies of Indian women are at higher risk than those of Other Asian women.
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Where multiple ethnic groups are recorded for an individual the process prioritises minority ethnic groups that might otherwise 
be swamped by New Zealand European. In doing so, it does not allow individuals to identify a group with which they most 
feel affinity. It is a simple system that results in relatively few groups for analysis and, when used across different datasets, 
ensures a standardised process is used.
In 2014, mothers’ ethnicity for the PMMRC dataset of perinatal related deaths has been extracted, in order of priority, from 
BDM registration of birth (71 percent) or PMMRC rapid response forms (29 percent). Babies’ ethnicity for the PMMRC dataset 
of perinatal deaths has been extracted, in order of priority, from BDM registration of birth (71 percent), BDM registration of 
death (7 percent) or PMMRC rapid response forms (22 percent).
In 2014, the denominator birth registration dataset included two ethnicities for 24.8 percent of all babies registered compared 
with two ethnicities for 14.0 percent of mothers registered. The dataset included three ethnicities for 6.1 percent of babies and 
three ethnicities for 1.3 percent of mothers. This difference in the number of ethnicities a mother reports for herself compared 
with the number of ethnicities she gives for her baby means mortality rates may be different depending on whether the 
mother’s or the baby’s ethnicity is used in analyses.
Mother and baby ethnicity specific perinatal related mortality rates have again been reported. 
Lead maternity carer (LMC)
Lead maternity carer (LMC) is defined as the practitioner or caregiver who provides a woman and her baby with continuity of 
care throughout pregnancy, labour and birth, and the postnatal period as described in the Maternity Services Notice Part DA.
Neonatal encephalopathy
Neonatal encephalopathy is a clinically defined syndrome of disturbed neurological function within the first week of life in the 
full-term infant, manifested by difficulty in initiating and maintaining respiration, depression of tone and reflexes, subnormal 
level of consciousness, and often seizures.
New Zealand Index of Deprivation 2006 and 2013 (NZDep2006/2013)
The New Zealand Index of Deprivation 2006 and 2013 (NZDep2006/2013) is an area-based measure of socioeconomic 
deprivation based on variables from the Census of Population and Dwellings in 2006 and 2013 in New Zealand (Atkinson et 
al 2014; Salmond et al 2007).
The score is assigned according to maternal place of residence and is presented as a decile or quintile. Increasing deciles 
of deprivation, from least deprived at decile 1 to most deprived at decile 10, are associated with higher mortality and rates 
of many diseases (Atkinson et al 2014; Salmond et al 2007). Meshblock unit-level data are used throughout this report. 
Generally, data are presented as quintiles rather than deciles so that individual categories are large enough for analysis.
NZDep2013 deciles have been assigned to births and deaths in 2013 while NZDep2006 has been used for previous years. 
It was not possible to assign NZDep2013 to deaths prior to 2013 as in 2013 some meshblocks split and the new meshblock 
for individuals in historical datasets was not available.
Place of birth
Place of birth is defined for the data collection as:
• home: a home environment does not have to be the mother’s own home
• birthing unit: stand-alone birthing centre
• hospital level 1: a hospital with no neonatal or caesarean section facilities
• hospital level 2: a hospital that is unable to provide long-term ventilation for babies
• hospital level 3: a hospital with full neonatal intensive care including facilities for long-term ventilation
• other: for example, car, ambulance
• not registered: the woman has not registered at any facility.
Potentially avoidable death
Potentially avoidable death is when the absence of a contributory factor may have prevented the death.
Registration with a lead maternity carer (LMC)
Registration with a lead maternity carer (LMC) is the process by which a woman selects her LMC. This generally occurs at 
the time of the first antenatal visit with the LMC. Upon registration the LMC assumes clinical responsibility for maternity care. 
Clinical responsibility for care may transfer from the LMC to another service or provider if a woman’s condition warrants 
transfer of clinical responsibility to a specialist.
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Appendix E: Classifications of the Perinatal Society of 
Australia and New Zealand (PSANZ 2009)
PSANZ Perinatal mortality classification
PSANZ perinatal death classification (PSANZ-PDC)
1.       Congenital abnormality (including terminations for congenital abnormalities)
1.1    Central nervous system
1.2    Cardiovascular system
1.3    Urinary system
1.4    Gastrointestinal system
1.5    Chromosomal
1.6    Metabolic
1.7    Multiple/non-chromosomal syndromes
1.8    Other congenital abnormality
 1.81    Musculoskeletal
 1.82    Respiratory
 1.83    Diaphragmatic hernia
 1.84    Haematological
 1.85    Tumours
 1.88    Other specified congenital abnormality
1.9    Unspecified congenital abnormality
2. Perinatal infection
2.1 Bacterial
 2.11 Group B Streptococcus
 2.12 E. coli
 2.13 Listeria monocytogenes
 2.14 Spirochaetal (eg, syphilis)
 2.18 Other bacterial




 2.23 Herpes simplex virus
 2.24 Rubella virus
 2.28 Other viral
 2.29 Unspecified viral
2.3 Protozoal (eg, Toxoplasma) 
2.5 Fungal
2.8 Other specified organism
 2.9 Other unspecified organism
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3. Hypertension
3.1 Chronic hypertension: essential 
3.2 Chronic hypertension: secondary (eg, renal disease)
3.3 Chronic hypertension: unspecified
3.4 Gestational hypertension
3.5 Pre-eclampsia
 3.51  With laboratory evidence of thrombophilia
3.6 Pre-eclampsia superimposed on chronic hypertension
 3.61  With laboratory evidence of thrombophilia
3.9 Unspecified hypertension
4. Antepartum haemorrhage (APH)
4.1 Placental abruption




4.9 APH of undetermined origin
5. Maternal conditions







 5.51  Other maternal thrombophilia (if considered cause of death)
5.6 Obstetric cholestasis
5.8 Other specified maternal conditions
6. Specific perinatal conditions
6.1 Twin–twin transfusion
6.2 Fetomaternal haemorrhage
6.3 Antepartum cord complications
 6.31 Cord haemorrhage
 6.32 True knot with evidence of occlusion
 6.38 Other
 6.39 Unspecified
6.4 Uterine abnormalities (eg, bicornuate uterus, cervical incompetence)










6.8 Other specific perinatal conditions
 6.81 Rupture of membranes after amniocentesis
 6.82 Termination of pregnancy for suspected but unconfirmed congenital abnormality
 6.83 Fetal subdural haematoma
 6.88 Other
 6.89 Unspecified
7. Hypoxic peripartum death (typically infants of >24 weeks gestation or >600g birthweight)
7.1 With intrapartum complications
 7.11 Uterine rupture
 7.12 Cord prolapse
 7.13 Shoulder dystocia
 7.18  Other
         7.2 Evidence of non-reassuring fetal status in a normally grown infant (eg, abnormal fetal heart rate, fetal scalp  
   pH/lactate, fetal pulse oximetry without intrapartum complications)
7.3 No intrapartum complications and no evidence of non-reassuring fetal status.
7.9 Unspecified hypoxic peripartum death
8. Fetal growth restriction (FGR)
8.1 With evidence of reduced vascular perfusion on Doppler studies and/or placental histopathology (eg, 
 significant infarction, acute atherosis, maternal and/or fetal vascular thrombosis or maternal floor infarction)
8.2 With chronic villitis
8.3 No placental pathology
8.4 No examination of placenta
8.8 Other specified placental pathology
8.9 Unspecified or not known whether placenta examined
9. Spontaneous preterm (<37 weeks gestation)
9.1 Spontaneous preterm with intact membranes or membrane rupture <24 hours before delivery
 9.11 With chorioamnionitis confirmed on placental histopathology
 9.12 Without chorioamnionitis on placental histopathology
 9.13 With clinical evidence of chorioamnionitis, no examination of placenta
 9.17  No clinical signs of chorioamnionitis, no examination of placenta
 9.19  Unspecified or not known whether placenta examined
9.2 Spontaneous preterm with membrane rupture >24 hours before delivery
 9.21 With chorioamnionitis confirmed on placental histopathology
 9.22 Without chorioamnionitis on placental histopathology
 9.23 With clinical evidence of chorioamnionitis, no examination of placenta
 9.27  No clinical signs of chorioamnionitis, no examination of placenta
 9.29  Unspecified or not known whether placenta examined
9.3 Spontaneous preterm with membrane rupture of unknown duration before delivery
 9.31 With chorioamnionitis confirmed on placental histopathology
 9.32 Without chorioamnionitis on placental histopathology
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 9.33 With clinical evidence of chorioamnionitis, no examination of placenta
 9.37  No clinical signs of chorioamnionitis, no examination of placenta
10. Unexplained antepartum death
10.1 With evidence of reduced vascular perfusion on Doppler studies and/or placental histopathology 
 (eg, significant infarction, acute atherosis, maternal and/or fetal vascular thrombosis or maternal floor 
 infarction)
10.2 With chronic villitis
10.3 No placental pathology
10.4 No examination of placenta
10.8 Other specified placental pathology
10.9 Unspecified or not known whether placenta examined
11. No obstetric antecedent
11.1 Sudden infant death syndrome (SIDS)
 11.11 SIDS Category IA: classic features of SIDS present and completely documented
 11.12 SIDS Category IB: classic features of SIDS present but incompletely documented
 11.13 SIDS Category II: infant deaths that meet Category I except for one or more features
11.2 Postnatally acquired infection
11.3 Accidental asphyxiation
11.4 Other accident, poisoning or violence (postnatal)
11.8 Other specified
11.9 Unknown/Undetermined
 11.91 Unclassified sudden infant death
 11.92 Other unknown/undetermined
PSANZ neonatal death classification (PSANZ-NDC)
1. Congenital abnormality (including terminations for congenital abnormalities)







1.8 Other congenital abnormality
 1.81 Musculoskeletal
 1.82 Respiratory
 1.83 Diaphragmatic hernia
 1.84 Haematological
 1.85 Tumours
 1.88  Other specified congenital abnormality
1.9 Unspecified congenital abnormality




2.9 Unspecified or not known whether resuscitation attempted
3. Cardio-respiratory disorders
3.1 Hyaline membrane disease/Respiratory distress syndrome (RDS)
3.2 Meconium aspiration syndrome
3.3 Primary persistent pulmonary hypertension
3.4 Pulmonary hypoplasia






 4.11 Congenital bacterial
  4.111 Group B Streptococcus
  4.112 E. coli
  4.113 Listeria monocytogenes
  4.114 Spirochaetal (eg, syphilis)
  4.118 Other bacterial
  4.119 Unspecified bacterial
 4.12  Acquired bacterial
  4.121 Group B Streptococcus
  4.122 E. coli
  4.125 Other Gram-negative bacilli (other than E. coli)
  4.126 Staphylococcus aureus
  4.127 Coagulase negative Staphylococcus
  4.128 Other specified bacterial
  4.129 Unspecified bacterial
4.2 Viral
 4.21 Congenital viral
  4.211  Cytomegalovirus
  4.213 Herpes simplex virus
  4.214 Rubella virus
  4.218 Other specified viral
  4.219 Unspecified viral
 4.22 Acquired viral
  4.221  Cytomegalovirus
  4.223 Herpes simplex virus
  4.224 Rubella virus
  4.228 Other specified viral
  4.229 Unspecified viral
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5. Neurological
5.1 Hypoxic ischaemic encephalopathy/Perinatal asphyxia (typically infants of >24 weeks gestation or >600g
 birthweight) 
 5.2 Intracranial haemorrhage
 5.21 Intraventricular haemorrhage
 5.22 Subgaleal haemorrhage
 5.23 Subarachnoid haemorrhage
 5.24 Subdural haemorrhage






7.1 Sudden infant death syndrome (SIDS)
 7.11 SIDS Category IA: classic features of SIDS present and completely documented
 7.12 SIDS Category IB: classic features of SIDS present but incompletely documented
 7.13 SIDS Category II: infant deaths that meet Category I except for one or more features
7.2 Multisystem failure
 7.21  Secondary to intrauterine growth restriction
 7.28 Other specified










 7.91 Unclassified sudden infant death 
  7.911 Bed sharing
  7.912 Not bed sharing
 7.92 Other unknown/undetermined
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Appendix F: PMMRC Classification of Contributory Factors 
and Potential Avoidability (2014 Version)
Systems review – contributory factors
Contributory factors may be highly specific to the death or generalised to the system(s). Identifying contributory factors 
that occur and are inherent in the system is an important part of the review. These factors are commonly sub-classified into 
organisational/management, personnel, and those relating to barriers to access and/or engagement in care.
Please read options below and select if any of the following were present
Have any organisational and/or management factors been identified?  
(eg, inadequate supervision of staff, lack of appropriate clinical management protocols or guidelines, 
lack of communication between services) 
If ‘yes’ please classify – select ALL relevant:
 
Yes    No   
Poor organisational arrangements of staff                   
Inadequate education and training                  
Lack of policies, protocols or guidelines                  
Inadequate numbers of staff                  
Poor access to senior clinical staff                  
Failure or delay in emergency response                  
Delay in procedure (eg, caesarean section)                  
Delayed access to test results or inaccurate results                  
Inadequate systems/process for sharing of clinical information between services                  
Equipment (eg, faulty equipment, inadequate maintenance, quality of or lack of equipment)                  
Building and design functionality (eg, space, privacy, ease of access, lighting, noise, power failure, 
operating theatre in distant location)
                 
Other – if other please state or provide any comments:
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Have factors relating to personnel been identified? 
(eg, staff factors relating to professional care and service provision)
If ‘yes’ please classify – select ALL relevant:
Yes    No   
Knowledge and skills of staff were lacking                  
Delayed emergency response by staff                  
Failure to maintain competence                  
Communication between staff was inadequate                  
Failure to seek help/supervision                  
Failure to follow recommended best practice                  
Lack of recognition of complexity or seriousness of condition by caregiver                  
Other – if other please state or provide any comments:
              
Have barriers to access and/or engagement with care been identified?
(eg, no, infrequent or late booking for antenatal care, woman declined treatment/advice)
If ‘yes’ please classify – select ALL relevant:
Yes    No   
No antenatal care                  
Infrequent care or late booking                  
Declined treatment or advice                  
Obesity impacted on delivery of optimal care (eg, ultrasound scan)                  
Substance use                  
Family violence                  
Lack of recognition by the woman or family of the complexity or seriousness of condition                  
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Cultural barriers                  
Language barriers                  
Not eligible to access free care                  
Environment (eg, isolated, long transfer, weather prevented transport)                  
Other – if other, please state or provide any comments:
Was this death potentially avoidable? 
Complete this after considering the selected contributory factors above.
If ‘yes’, the absence of which contributory factor(s) might have meant the death was avoidable?
Yes    No   
Organisation and/or management                  
Personnel                  
Barriers to access and/or engagement with care                  
 
Name of person completing this form: 
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Appendix G: PMMRC DHB Local Coordinators (April 2016)
DHB DHB local coodinator Contact details
Northland Yvonne Morgan Clinical Charge Midwife
Dr Kristy Wolff Obstetrician
Whangarei Hospital





Auckland Professor Lesley McCowan Obstetrician
Teresa Krishnan Midwife Manager
Auckland City Hospital
Counties Manukau Dr Sarah Wadsworth Obstetrician
Dr Graeme Parry Obstetrician
Debbie Davies Midwife
Middlemore Hospital
Waikato Dr Sarah Waymouth Obstetrician 
Tracey Williams Midwife
Waikato Hospital
Bay of Plenty Margret Norris Midwife Leader Tauranga Hospital
Lakes Amanda Griffiths Midwife Rotorua Hospital
Tairawhiti Sheila Noakes Midwife
Maryclare Reilly Midwife
Gisborne Hospital
Taranaki Sharon Howe Midwife
Belinda Chapman Midwife
Taranaki Base Hospital
Hawke’s Bay Dr Lynda Croft Obstetrician
Sara Paley Midwifery Educator
Hawke’s Bay Hospital
Whanganui Lucy Pettit Midwife
Jo McDonnell Midwife
Whanganui Hospital
MidCentral Carole Collins Midwife Educator
Dr Steven Grant Consultant Obstetrician
Palmerston North Hospital
Wairarapa Michelle Thomas Midwife Masterton Hospital
Capital & Coast Dr Rose Elder Consultant Obstetrician
Hazel Irvine Midwife
Wellington Hospital
Hutt Valley Joanne McMullan Midwife Hutt Hospital




West Coast Denise Stacey Midwife Grey Base Hospital
Canterbury Dianne Leishman Midwife
Sonya Matthews Midwife
Christchurch Women’s Hospital
South Canterbury Hanna Leier Midwife Timaru Hospital
Southern Helen Flockton Charge Midwife
Sheridan Massey Midwife 
Tracey Morris Midwife 
Dr Jana Morgan Obstetrician
Jenny Humphries Director of Nursing and Midwifery
Melanie McTainsh Midwife
Dunedin Hospital
Southland Hospital

